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The respiratory function is supported by a lipid-protein complex produced and secreted by 
alveolar type II cells. This material is termed lung surfactant, and their main functions include 
the alveolar stabilization along the respiratory cycles and the regulation of the innate immune 
response against foreign particles and microorganisms entering the lung. Upon secretion, lung 
surfactant is rapidly adsorbed into the alveolar air-liquid interface, where it constitutes a 
continuum non-soluble film in charge of reducing surface tension in a proportional way to area 
reduction.  Doing so it prevents atelectasis (alveolar collapse), and optimizes the amount of 
energy required to open the respiratory surface when inhalation takes place.  
Lung surfactant is compositionally optimized to fulfil the functions described above, being 
phospholipids its main constituents. A lipid rarely found in most biological membranes, 
dipalmitoyl phosphatidyl choline (DPPC), accounts for 40 wt% of lung surfactant. This 
disaturated phospholipid can attain highly packed structures upon area reduction, becoming the 
main responsible for the extremely low surface tensions reached during exhalation. Other 
surfactant components, such as unsaturated phospholipids including phosphatidyl choline (PC) 
and phosphatidylglycerol (PG) species, and neutral lipids, mainly cholesterol, confer surfactant 
membranes and films optimal properties in terms of fluidity and viscosity. Nevertheless, 
although surfactant is 90 wt% lipids, it requires the presence of surfactant associated proteins 
(SP) to perform its specific associated activities. Surfactant protein A and D (SP-A and SP-D), are 
large hydrophilic proteins principally involved in the innate immune response in the lung. Both 
proteins belong to the collagenous calcium-dependent lectin (collectin) family, and exhibit 
different functions depending on their oligomeric state. Surfactant protein B and C (SP-B and SP-
C), on the contrary, are small hydrophobic proteins that strongly associate to surfactant 
membranes. These two proteins are essential for surfactant to achieve a proper biophysical 
function, and they are responsible for the structural rearrangements of surfactant lipid 
assemblies involved in a fast lipid adsorption into the air-liquid interface, and the efficient re-
spreading of surfactant material along the interface during area expansion (inhalation). The re-
spreading ability of surfactant films is associated with 3D structures promoted by the proteins, 
which lead to the generation of multilayer structures that serve to store lipid material excluded 
from the interfacial film during compression, and newly secreted surfactant complexes. Thus, 
the action of SP-B and SP-C support the generation of an intricate meshwork of lipid structures 
connecting different surfactant extracellular forms, from secreted lamellar bodies to the 
interfacial film. All these structures contribute to provide active surfactant-forms to the 
interfacial film, which once exhausted, are recycled or degraded by lung homeostatic 
mechanisms involving type II alveolar cells and alveolar macrophages.  
The function of SP-B and SP-C is essential for lung surfactant interfacial activity, but whereas 
SP-B absence is lethal, proving its essential activity for the breathing function, the role SP-C is 
still under discussion. SP-C is a small polypeptide (35 amino acids, 4.2 kDa) with an α-helical 
structure and a dually palmitoylated N-terminal segment. Some authors have suggested that it 
is the most hydrophobic protein of the proteome, and it adopts a transmembrane configuration 
in surfactant membranes. At the interfacial film, in vitro studies have suggested that SP-C 
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orientates with the α-helical segment exposed to the air and the positively charged N-terminal 
region interacting with phospholipid headgroups. SP-C is processed from a large precursor in 
alveolar type II cells in a SP-B dependent manner. Besides, it is prone to turn into amyloid 
aggregates, which are responsible for lung cytotoxicity and conformational lung disease. 
Together with the specific tissue-localization of SP-C and its highly conserved sequence, this 
evidence suggests that SP-C has a specific role that has not been elucidated yet.  
Interestingly, SP-C function becomes especially relevant in cholesterol-containing surfactant 
films, an effect particularly associated to SP-C palmitoylation. Considering cholesterol is involved 
in lung surfactant adaptive response to different breathing conditions (i.e. temperature, 
pressure or exercise), mechanisms for cholesterol sensing and mobilization become apparent. 
This is directly linked to the role of cholesterol in modulating surfactant structures and 
properties, which over certain cholesterol/phospholipid ratios, result in lung surfactant 
dysfunction and the development of respiratory disorders. According to recent evidence, SP-C 
is a promising candidate involved in cholesterol regulatory mechanisms, which would explain 
the long-term stabilization of the lung associated to SP-C function.  
Taking into account this evidence, the general objective of the present Thesis has been to 
characterize SP-C properties to a molecular detail in the lung surfactant context. Particularly, we 
have focused on SP-C effects on surfactant membrane structure and properties in the presence 
of cholesterol. This general objective has been approached through the following specific 
objectives:  
1. Examination of the role of SP-C palmitoylation on SP-C structure and lipid-protein 
interactions in membrane multilayers.  
2. Analysis of the effect of SP-C on cholesterol dynamics in native surfactant-derived and 
surfactant-mimicking membranes. 
3. Evaluation of the effect of SP-C and cholesterol on membrane structure and lateral 
phase segregation. 
4. Validation of selective SP-C/lipid interactions in membranes concerning SP-
C/phospholipid, SP-C/cholesterol and protein palmitoylation. 
5. Study of the effect of SP-C and cholesterol on surfactant homeostasis regarding lipid 
endocytosis and metabolism by alveolar macrophages.  
 
OUTCOMES AND CONCLUSIONS 
The experimental work presented in this Thesis reveals specific SP-C modulating activities on 
surfactant membrane structure which, together with cholesterol effects, contribute to the 
understanding of the physiological relevance of SP-C in the framework of lung surfactant 
function and homeostasis. A summary of the main conclusions and outcomes is presented 
below. 
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Initially, the role of SP-C palmitoylation on protein structure and protein/lipid interactions  
was investigated by Attenuated Total Reflectance Fourier Transformed Infrared spectroscopy 
(ATR-FTIR). Membrane multilayered films were generated using different membrane 
compositions: DPPC/POPC/POPG 50:25:15 w/w/w, DPPC/POPC 50:40 w/w and POPC/POPG 
75:15 w/w and the behavior of a native palmitoylated SP-C form was compared to that of a 
recombinant non-palmitoylated version, rSP-C. We observed that SP-C palmitoylation did not 
affect protein structure incorporated in any of the lipid systems analyzed, but it contributed to 
SP-C α-helix stabilization. In general terms, N-terminal acylation of SP-C leaded to a greater 
protein tilting degree with respect to the membrane normal, increasing the polarity at the 
phosphate region of the lipid bilayer and maximizing SP-C-lipid interactions at this level. Thus, it 
could be concluded that SP-C palmitoylation is an important element defining a functionally 
optimal SP-C configuration in lipid bilayers and monolayers. 
To analyze the potential SP-C/cholesterol interaction including SP-C effects on cholesterol 
dynamics, vesicles with different compositions, including surfactant-derived lipid fractions, were 
generated and approached by a partitioning assay. This methodology is based on the extraction 
of a cholesterol fluorescent analog, cholestatrienol (CTL), from membranes by the solubilizing 
agent methyl-β-cyclodextrin. A partitioning coefficient (KX) can be calculated according to 
fluorescence anisotropy measurements, which indicates the affinity of the sterol (CTL or 
cholesterol by analogy) for a certain membrane.  Our results demonstrated that SP-C and the 
native hydrophobic protein fraction of surfactant, incorporating SP-B and SP-C, specifically 
affected cholesterol mobilization in lipid bilayers, an effect detected by a decreased partition 
coefficient. The same behavior was observed for different lipid compositions including POPC 
model membranes, surfactant-derived lipids or surfactant mimicking systems such as 
DPPC/POPC/POPG 50:25:15 w/w/w. This effect suggests a role for SP-C in cholesterol 
mobilization and regulation in surfactant membranes, which could be involved in lung 
homeostasis.  
Particularly, a SP-C-induced membrane-fragmenting behavior was identified, which 
correlated with effects on cholesterol mobilization as detected by the partitioning assay. SP-C 
activity resulted in the generation of small and highly curved vesicles (~30 nm) derived from 
larger liposomes, an effect non-dependent on membrane composition or SP-C palmitoylation.  
SP-C activity was counteracted by the presence of SP-B, which alone exhibited effects that could 
be associated to liposome fusion. This is indicative of either a direct protein/protein interaction 
or balanced SP-B and SP-C modulating effects on membrane structure.  
To further characterize structural effects on membranes derived from SP-C incorporation, 
Deuterium Nuclear Magnetic Resonance (2H-NMR) and Electron Spin Resonance (ESR) studies 
were performed.  2H-NMR studies demonstrated that, in the absence of cholesterol, SP-C 
induced phase segregation in lung surfactant-mimicking membranes (DPPC/POPC/POPG 
50:25:15 w/w/w) at 37oC.  From the two generated phases, one behaved as a liquid crystalline 
phase, which remained essentially unaltered upon SP-C incorporation in comparison with pure 
lipid systems. However, the ordered phase was indicative of restricted lipid motion, exhibiting 
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features consistent with an interdigitated phase. SP-C effects on restricting lipid motion were 
also confirmed by ESR. The ordered “interdigitated” structure accommodated DPPC, POPC and 
POPG to different extents, an effect dependent on protein palmitoylation. SP-C acylation 
maximized the differences between lipid species involved in the ordered phase, in agreement 
with the palmitoylation-derived effects reported by ATR-FTIR. This differential accommodation 
could be involved in structural transformations between different surfactant forms, such as 
those occurring during the generation of the surfactant reservoir with selectively sorted lipid 
species. Cholesterol addition resulted in membranes that exhibited phase segregation at 30oC, 
which also appeared to involve certain lipids differently. This indicates a SP-C contribution on 
cholesterol modulating activity on surfactant structures. 
With the aim of describing particular SP-C/lipid interactions that could particularly contribute 
to the structural membrane modifications induced by the protein, native surfactant suspensions 
and vesicles with varying compositions were analyzed by TLC. Surprisingly, when membranes 
were applied as aqueous suspensions on the silica-plate and left to dryness, selective lipid/lipid 
and lipid/SP-C interactions were preserved upon TLC development with an organic phase. This 
was detected as the generation of particular lipid or SP-C bands, which configured a defined 
migration pattern that we report here for the first time.  Thus, we can conclude that the effects 
on membrane structure induced by SP-C are associated to strong protein/lipid interactions that 
can resist organic solvent solubilization. The TLC-based method developed in the present Thesis 
permits the identification of selective lipid/lipid and different lipid/protein interactions such as 
those described for SP-C.  
Lastly, we aimed to study the importance of the SP-C and cholesterol combined action on 
surfactant membranes in a physiological context. With that purpose, we analyzed the effect of 
different lipid, cholesterol and protein composition in a cell type involved in lung homeostasis, 
the alveolar macrophage.  It was observed that SP-C and cholesterol increased lipid uptake by a 
murine alveolar macrophage cell line, MH-S. However, cell treatment with different endocytosis 
inhibitors and a CD14 blocking antibody revealed that lipid uptake did not follow a unique 
mechanism, in which processes including receptor-unspecific and receptor-specific pathways 
could be involved. After the engulfment event, fluorescently labeled SP-C was detected in 
defined regions of the plasma membrane. This indicates a role for SP-C in lipid uptake and/or 
vesicle endocytic processing. Lipids, however, were accumulated intracellularly in the form of 
lipid droplets as detected by transmission electron microscopy. Lipid uptake elicited alterations 
in the transcriptional estate of alveolar macrophages that depended on vesicle composition. 
Affected genes included those coding for lipid and cholesterol transporters, enzymes implicated 
in lipid metabolism or different transcription factors.   
In conclusion, the evidence presented in this Thesis illustrates how specific SP-C-induced 
membrane reorganizations contribute to the complex and dynamic behavior of lung surfactant 
structures, supporting a physiological role for SP-C and cholesterol relationships in lung 
homeostasis involving alveolar macrophages. SP-C could then be considered as a pivotal 
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molecule linking surfactant biophysics and lung homeostasis, which would explain its particular 
features, lung tissue specific localization and sequence conservation along evolution.  
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La función respiratoria depende del establecimiento de una interfase aire-líquido que tiene lugar 
en los alveolos pulmonares. La estabilización de dicha interfase requiere la presencia de un 
complejo lipoproteico que es sintetizado y secretado por las células epiteliales alveolares de tipo 
II, también llamadas neumocitos tipo II. Este material se denomina surfactante pulmonar y sus 
funciones principales implican la estabilización de los alveolos a lo largo de los ciclos 
respiratorios, así como la regulación de la respuesta inmunológica innata frente a partículas y 
microorganismos exógenos que acceden al organismo por vía pulmonar. Una vez secretado, el 
surfactante pulmonar se adsorbe rápidamente a la interfase aire-líquido respiratoria, donde da 
lugar a una película interfacial continua e insoluble responsable de reducir la tensión superficial 
de manera proporcional a la reducción de área. De esta forma, el surfactante pulmonar previene 
la atelectasis (o colapso alveolar), minimizando la energía requerida para abrir la superficie 
respiratoria durante la inspiración.  
El surfactante pulmonar tiene una composición optimizada para llevar a cabo las funciones 
descritas anteriormente, y en su mayoría está constituido por fosfolípidos. La dipalmitoil 
fosfatifil colina (DPPC), un lípido poco frecuente en membranas biológicas, representa el 40% en 
peso del surfactante. Este lípido insaturado es capaz de soportar altos grados de 
empaquetamiento, por lo que es el principal responsable de los bajos valores de tensión 
superficial que se adoptan durante la espiración. Otros componentes del surfactante, como 
fosfolípidos insaturados tales como especies moleculares de fosfatidil colina (PC) y fosfatidil 
glicerol (PG), y lípidos neutros, mayoritariamente colesterol, proporcionan al surfactante una 
fluidez y viscosidad apropiadas. Sin embargo, aunque los lípidos constituyen el 90% en peso del 
surfactante, para una correcta función tensioactiva depende de la presencia de proteínas 
asociadas (SP). La SP-A y SP-D son proteínas de gran tamaño e hidrófilas relacionadas con la 
función inmunológica del surfactante. Ambas pertenecen a la familia de las colectinas (lectinas 
dependientes de calcio con un dominio similar a colágeno) y exhiben diferentes grados de 
oligomerización. La SP-B y SP-C, por el contrario, son proteínas de bajo peso molecular 
altamente hidrófobas que se asocian fuertemente a las membranas de surfactante. Estas dos 
proteínas son esenciales para la función biofísica del surfactante. Ambas son responsables de 
las transformaciones estructurales de los complejos lipoproteicos implicadas tanto en la rápida 
adsorción interfacial del material, como en su eficaz re-extensión a lo largo de la interfase 
durante la inspiración (incremento de área). La re-extensión del surfactante tras la inspiración 
está asociada con las estructuras tridimensionales propiciadas por la actividad de las proteínas 
SP-B y SP-C, las cuales dan lugar a estructuras multilamelares que sirven como reservorio de 
surfactante. Este reservorio incluye aquellos componentes excluidos de la película interfacial 
durante la compresión, y además, los complejos de surfactante recién secretado. De esta forma, 
mediante la acción de las proteínas SP-B y SP-C, se genera una compleja red de estructuras 
lipídicas que conectan las distintas formas extracelulares de surfactante, desde los cuerpos 
lamelares secretados hasta la película interfacial. Todas esas estructuras proporcionan formas 
2. RESUMEN 
18 
 
activas de surfactante a la película interfacial, que tras varios ciclos de compresión-expansión, 
da lugar a formas inactivas que son recicladas o degradadas mediante los mecanismos 
homeostáticos del pulmón. Tales mecanismos incluyen la participación de las células alveolares 
de tipo II y los macrófagos alveolares. 
La función de las proteínas SP-B y SP-C es esencial para la actividad biofísica del surfactante. 
Sin embargo, mientras que la ausencia de SP-B resulta letal, demostrando que su actividad es 
esencial para la función respiratoria, el papel de la SP-C es más controvertido. La SP-C es un 
polipéptido con estructura α-helicoidal de pequeño tamaño (35 aminoácidos, 4.2 kDa) cuyo 
extremo N-terminal posee dos residuos de palmitoil-cisteína. Algunos autores han sugerido que 
es la proteína más hidrofóbica del proteoma, y adopta una configuración transmembrana en 
bicapas de surfactante. En la película interfacial, experimentos in vitro sugieren que el segmento 
helicoidal de la proteína se orienta hacia el aire, mientras que el segmento N-terminal, que está 
cargado positivamente, interacciona con las cabezas polares de los fosfolípidos. La SP-C es 
expresada como un precursor de mayor tamaño, el cual se sintetiza y se procesa en los 
neumocitos tipo II. Dicho procesamiento requiere la presencia de SP-B. Además, debido a su 
particular secuencia de aminoácidos, la SP-C es propensa a precipitar formando agregados β-
amiloides, los cuales son responsables de la citotoxicidad en el pulmón y de enfermedades 
crónicas pulmonares. Teniendo en cuenta la localización tejido-específica de la SP-C y el elevado 
grado de conservación de su secuencia, esta información sugiere que la SP-C tiene un papel 
específico en el pulmón que a día de hoy aún no se ha demostrado.  
Cabe destacar que la función de la SP-C es especialmente relevante cuando el colesterol 
forma parte de los complejos de surfactante, un efecto que además depende de la 
palmitoilación de la proteína. Dado que el colesterol participa en los mecanismos adaptativos 
del surfactante en respuesta a diferentes condiciones respiratorias (como por ejemplo 
temperatura, presión o ejercicio), es necesaria la existencia de mecanismos que permitan 
detectar sus niveles así como otros implicados en su rápida movilización. Esto está directamente 
relacionado con él carácter modulador del colesterol sobre las propiedades del surfactante. 
Además, incrementos en la relación colesterol/fosfolípido, dan lugar a una inapropiada función 
biofísica que puede desembocar en patologías respiratorias. De acuerdo con estudios recientes, 
la proteína SP-C parece ser un candidato prometedor en los mecanismos reguladores del 
colesterol, lo cual podría explicar la estabilización pulmonar a largo plazo asociada a la actividad 
de esta proteína.  
Teniendo en cuenta los factores anteriormente descritos, el objetivo principal de esta Tesis 
ha sido caracterizar las propiedades de la proteína SP-C a nivel molecular en contextos de 
membrana de surfactante pulmonar. Particularmente, se ha hecho énfasis en la actividad de la 
proteína sobre la estructura y propiedades de membranas de surfactante en ausencia y 
presencia de colesterol. Enmarcados en este objetivo general, se han establecido los siguientes 
objetivos específicos:  
1. Estudio del papel de la palmitoilación en la estructura de la SP-C e interacciones lípido-
proteína en películas de membranas multilamelares.  
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2. Análisis de la actividad de la SP-C sobre la dinámica del colesterol en membranas 
surfactante-miméticas y derivadas de surfactante nativo. 
3. Evaluación del efecto del SP-C y del colesterol sobre la estructura de membranas y 
segregación lateral de fases. 
4. Validación de interacciones selectivas SP-C/lípido en membranas considerando la 
palmitoilación de la proteína. 
5. Estudio del efecto de la SP-C y el colesterol sobre la homeostasis del surfactante en 
relación con la endocitosis y el metabolismo de lípidos por macrófagos alveolares. 
 
RESULTADOS Y CONCLUSIONES 
El trabajo experimental presentado en esta Tesis revela actividades moduladoras de la SP-C 
sobre la estructura y dinámica de membranas de surfactante. Junto con los efectos del 
colesterol, estos resultados contribuyen a la comprensión de la relevancia fisiológica de la SP-C 
en el marco del surfactante y la homeostasis pulmonar. A continuación se presenta un resumen 
de los principales resultados y conclusiones. 
Inicialmente, se investigó el papel de la palmitoilación de la SP-C en la estructura de la 
proteína y las interacciones lípido/SP-C. Para ello, se generaron películas de membranas 
multilamelares empleando diferentes composiciones lipídicas: DPPC/POPC/POPG 50:25:15 
p/p/p, DPPC/POPC 50:40 p/p y POPC/POPG 75:15 p/p. De esta forma, se compararon 
membranas de lípido puro con membranas lipoproteicas que incorporaban una forma de SP-C 
nativa palmitoilada o una versión recombinante no palmitoilada, rSP-C mediante espectroscopia 
infrarroja con transformada de Fourier por reflexión total atenuada (ATR-FTIR). Se observó que 
la palmitoilación SP-C no afectaba la estructura de la proteína en ninguno de los sistemas 
lipídicos analizados. Sin embargo, en términos generales, la acilación del segmento N-terminal 
de la SP-C daba lugar a un mayor grado de inclinación con respecto a la normal de la bicapa. Esto 
además se relacionaba con un incremento en la polaridad de las membranas a nivel de los 
grupos fosfato, lo cual maximizaba las interacciones SP-C-lípido. Por lo tanto, se podría concluir 
que la palmitoilación de la SP-C es un elemento importante para definir una configuración 
funcionalmente óptima en bicapas lipídicas y monocapas. 
Para analizar la posible interacción SP-C/colesterol, incluyendo efectos de la proteína sobre 
la dinámica del colesterol, se generaron vesículas con diferentes composiciones y se estudiaron 
empleando un ensayo de partición. Esta metodología se basa en la extracción de un análogo 
fluorescente de colesterol, el colestatrienol (CTL), desde membranas lipídicas. Para ello se 
empleó metil-β-ciclodextrina, un polisacárido en forma de anillo capaz de albergar moléculas 
hidrófobas en su cavidad interna. A partir de medidas de anisotropía de fluorescencia del CTL, 
es posible calcular el coeficiente de reparto (KX) entre la ciclodextrina y las vesículas lipídicas, 
determinando así la afinidad del esterol (CTL o colesterol) por membranas de una determinada 
composición. Nuestros resultados demostraron que tanto la SP-C nativa como la fracción nativa 
de proteínas hidrófobas del surfactante, SP-B y SP-C, incrementaban de forma específica la 
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movilización de colesterol en bicapas lipídicas, lo cual se traducía en menores valores de KX. El 
análisis de membranas de diferentes composiciones, incluyendo las generadas a partir de POPC, 
la fracción lipídica del surfactante o sistemas surfactante-miméticos (DPPC/POPC/POPG 
50:25:15 p/p/p), demostró que el efecto de la SP-C no dependía de la composición lipídica. Estos 
resultados sugieren que la SP-C puede tener un papel específico en la movilización del colesterol 
y su regulación en el sistema surfactante, un efecto que podría estar relacionado con la 
homeostasis pulmonar.  
En este mismo estudio, se observó que la SP-C daba lugar a la fragmentación de membranas, 
generando vesículas pequeñas (~ 30 nm) y con una curvatura pronunciada a partir de liposomas 
de mayor tamaño. Este efecto, además, no parecía depender de la composición lipídica ni de la 
palmitoilación de la proteína. Asimismo, la movilización de colesterol inducida por SP-C parecía 
estar relacionada con la fragmentación de membranas o inducción de curvatura, dado que 
vesículas pequeñas generadas a partir de lípidos sintéticos también se asociaban a menores 
coeficientes de partición en ausencia de la proteína. Cabe destacar que en presencia de SP-B no 
se observaba el efecto de fragmentación de membranas inducido por SP-C, lo cual indica que la 
actividad de ambas proteínas está relacionada, bien a nivel de interacción proteína/proteína o 
por inducción de efectos que se equilibran en el contexto del surfactante.  
Para caracterizar las consecuencias de la incorporación de SP-C en bicapas lipídicas a nivel 
estructural, se llevó a cabo un estudio espectroscópico mediante resonancia magnética nuclear 
de deuterio (2H-NMR, del inglés deuterium-nuclear magnetic resonace) y resonancia de espín 
electrónico (ESR, del inglés electron spin resonance). Los resultados obtenidos a partir de 2H-
NMR demostraron que, en ausencia de colesterol, la SP-C inducía segregación de fases en 
membranas surfactante-miméticas (DPPC/POPC/POPG 50:25:15 p/p/p) a 37oC. Una de las fases 
generadas presentaba propiedades espectrales características de fases líquido cristalinas. 
Además, esta no mostraba cambios apreciables tras la incorporación de SP-C en comparación 
con sistemas lipídicos puros. Por otro lado, la fase ordenada presentaba características 
consistentes con la formación de una fase interdigitada, donde los lípidos aparecen altamente 
ordenados y con movilidad restringida. Para validar esos resultados, se llevaron a cabo 
experimentos de ESR, los cuales permitieron confirmar la restricción en movilidad mediada por 
la SP-C. El análisis en detalle de los datos de 2H-NMR permitió concluir que los diferentes lípidos 
que formaban parte del sistema, DPPC, POPC y POPG, estaban implicados en diferente medida 
en la fase ordenada o "interdigitada" propiciada por la SP-C. Además, la palmitoilación de la 
proteína parece ser un factor implicado en la selectividad de las diferentes especies lipídicas por 
la fase ordenada, lo cual apoya los resultados mostrados por ATR-FTIR. La participación 
diferencial de determinados lípidos en la fase ordenada podría estar implicada en las 
transformaciones estructurales entre diferentes formas de surfactante, tales como las que 
tienen lugar durante la exclusión de ciertas especies lipídicas de la película interfacial durante 
su compresión y la generación del reservorio por parte de la SP-C.   
La adición de colesterol a este sistema daba lugar a membranas que exhibían una 
segregación de fase a 30oC, la cual también parecía implicar ciertas especies lipídicas 
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preferentemente. Esto podría ser indicativo de la contribución de la SP-C sobre la actividad 
moduladora del colesterol en las membranas de surfactante. 
Con el objetivo de describir interacciones específicas SP-C/lípido que pudieran participar 
particularmente en las modificaciones estructurales de la membrana introducidas por la 
proteína, se realizó un análisis mediante cromatografía de capa fina (TLC del inglés thin layer 
chromatography). Suspensiones acuosas de surfactante nativo y vesículas de diferente 
composición fueron aplicadas sobre la placa de sílice, y tras la evaporación del disolvente, se 
desarrolló la cromatografía empleando una fase móvil orgánica optimizada para la separación 
de lípidos polares. Sorprendentemente, se observó que determinadas interacciones selectivas 
lípido/lípido y lípido/SP-C eran preservadas a pesar del tratamiento con disolvente orgánico. 
Tales interacciones se identificaron como bandas características en la placa, dando lugar a un 
patrón de migración definido para la SP-C que describimos en esta Tesis por primera vez. Por lo 
tanto, podemos concluir que los efectos sobre la estructura de la membrana inducida por SP-C 
están asociados a fuertes interacciones proteína/lípido que resisten a la solubilización por 
disolventes orgánicos. Como hemos visto, esta metodología podría aplicarse a diversos sistemas 
de membranas biológicas, ya que permite la identificación de interacciones lípido/lípido y 
lípido/proteína tales como las descritas para la SP-C. 
Por último, quisimos determinar la importancia fisiológica de la acción combinada de la SP-
C y colesterol sobre las membranas de surfactante. Con ese fin, analizamos el efecto de un 
surfactante clínico y vesículas de diferente composición sobre macrófagos alveolares, un tipo 
celular implicado en la homeostasis pulmonar. La combinación de SP-C y colesterol propiciaba 
la incorporación de lípidos por parte de células MH-S, una línea celular de macrófagos alveolares 
de ratón. Sin embargo, el tratamiento de dichas células con diferentes inhibidores de endocitosis 
o un anticuerpo bloqueante de CD14, dio lugar a índices de incorporación lipídica menores. Esto 
apunta a que no hay un único mecanismo de entrada en las células, donde tanto vías 
independientes como dependientes de receptor pueden estar implicadas. Tras el tratamiento 
con lípidos, se observó que la proteína SP-C marcada fluorescentemente aparecía en regiones 
definidas de la membrana plasmática. Esto indica que esta proteína podría participar en la 
captación de lípidos y/o en el procesamiento endocítico de los mismos. Los lípidos, sin embargo, 
aparecían acumulados intracelularmente en los denominados lipid droplets tal y como se 
observó mediante microscopía electrónica de transmisión.   
Por otro lado, observamos que el tratamiento con lípidos provocaba alteraciones a nivel 
transcripcional en células MH-S. Dichos efectos parecían depender de la composición lipídica y 
proteica de las preparaciones utilizadas. Entre los genes afectados encontramos diversos 
transportadores de lípidos y colesterol, enzimas implicadas en el metabolismo lipídico y 
diferentes factores de transcripción.   
En conclusión, los resultados presentados en esta Tesis ilustran los efectos de la proteína 
SP-C sobre la estructura y dinámica de membranas de surfactante, los cuales contribuyen al 
comportamiento dinámico global de este complejo lipoproteico. Además, los resultados 
obtenidos sugieren un posible papel fisiológico de las relaciones SP-C/colesterol en la 
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homeostasis pulmonar llevado a cabo a través de los macrófagos alveolares. De esta forma, la 
proteína SP-C podría considerarse como una molécula central entre la biofísica del surfactante 
y la homeostasis pulmonar, dando respuesta a sus características particulares, su localización 
específica pulmonar y su alto grado de conservación a lo largo de la evolución.
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The respiratory function allows organisms to retrieve oxygen, an essential element required for 
aerobic functions. Depletion of vital compounds such as water or nutrients is lethal in a time lapse 
ranging from one to several weeks, whereas without oxygen, survival would be unmanageable over 
5-6 minutes.   
Oxygen is required for multiple metabolic processes, and more importantly, it powers the 
production of energy (ATP) through mitochondrial respiration. The amount of oxygen needed to 
sustain vital functions at rest equals 3.5 ml O2/ min-1 kg of body weigth-1 in humans (1), meaning 
that for an average human of 75 kg at atmospheric pressure, approximately 16 liters of O2 would 
be consumed per hour just to maintain the organism alive.   
For such an amount of oxygen to be delivered to the body per time unit, evolution has developed 
the lungs, highly specialized organs in charge of gas exchange. The lungs provide one of the largest 
surfaces in contact with the air from the human body, around 70 m2 (2), maximizing oxygen intake 
and CO2 elimination. This is possible thanks to lungs branched structure, which from top to bottom 
includes trachea, bronchi, bronchioles and alveoli. The functional unit of the lung is precisely the 
latter, alveoli, which consist in small sacs with a mean diameter of 200 µm (3). 
 
Figure 1. (a) Schematic representation of the alveolar structure including type I and II pneumocytes 
(AT1 and AT2) and alveolar macrophages (AMϕ). (b) Amplification of the air liquid interface, where 
different surfactant structures are found, such as lamellar bodies (LB), lamellar body like particles 
(LBPs), tubular myelin (TM) and surfactant multilayers (ML). (c) Zoom in of a surfactant multilayer 
stabilized by surfactant proteins SP-B and SP-C. 
 
3. INTRODUCTION 
28 
 
Gas exchange takes place by passive diffusion, reason why origin and destination, namely air 
and blood and viceversa, need to be spatially close. The thickness O2 and CO2 needs to go through 
is roughly that of two thin cells, approximately 500 nm (4), which constitutes the air capillary 
barrier. From alveoli to erythrocytes, oxygen would encounter the liquid film lining the alveolus, 
alveolar epithelial cells, the interstitial layer, endothelial cells in capillary and finally erythrocytes 
(Fig. 1). 
The delicate structure alveoli possess must sustain those physical forces originated by 
respiratory muscles to allow moving air in and out of the lungs, during inhalation and exhalation. 
Those processes involve great changes in alveolar volume, and for that reason, connective tissue 
supports alveolar cells providing elasticity and consistency to the alveolar structure (5).  
In a healthy subject, three types of cells can be found in alveoli: alveolar type I and type II 
epithelial cells (AT1 and AT2 cells), also termed type I and II pneumocytes, and alveolar 
macrophages (AMϕ). Most of the gas exchange surface (>95%) is covered by the thin AT1 cells (<0.1 
μm) or squamous cells (6), whereas AT2 cells represent the 15% parenchymal lung cells and cover 
the 5% of the alveolar surface (7). AT2 cells are able of self-renewing and differentiate into AT1 cells 
in response to injury and replenishing the cell alveolar cell pool (7, 8). Alveolar macrophages 
constitute the first barrier against pathogenic agents by regulating the immune response in the 
lung, and they have an important role in lung homeostasis (9).  
One of the most important functions of AT2 cell is the synthesis and secretion of lung surfactant.  
This lipid-protein complex is rapidly adsorbed and spread all over the alveolar air-liquid interface 
upon secretion. There, it minimizes surface tension to the extremely low values required upon 
exhalation, avoiding alveolar collapse and sustaining breathing. 
 
In the lung, the fluid lining alveolar cells faces the air establishing the air-liquid interface through 
which gas exchange occurs. Molecules deep into the fluid experience cohesive forces with 
surrounding molecules that are balanced, resulting in a null net force. However, molecules at the 
surface establish much less interactions with the diffuse molecules in gas state (air) and 
consequently, they experience a net attractive force towards the bulk of the fluid (Fig. 2a). This 
tendency to reduce the exposed surface is termed surface tension (γ), and it is defined as the 
energy required to increment the surface of a fluid per area or length unit. In the context of alveoli, 
surface tension at the air-liquid interface would promote alveoli to shrink and collapse, greatly 
increasing the energy demands to open the respiratory surface upon inhalation. In the case of 
water, hydrogen bonding makes interactions between molecules stronger, and consequently 
surface tension can reach values as high as 72 mN/m. 
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Figure 2. (a) Schematic representation of the surface tension (γ) concept. Molecules at the air-liquid 
interface experience a net force toward the bulk of the fluid. The surface of the liquid bends to 
minimize the exposed area. When lung surfactant is present, forces are balanced and surface 
tension is reduced. (b) Representation of the Young-Laplace law for ideally spherical alveoli. With 
no surfactant, the inner pressure (P) experienced by alveoli with different radius (r) would lead to 
collapse of small alveoli toward larger ones.  
 
The alveolar shape could be approximated to spherical chambers diameters ranging from 185 
to 210 µm (3). Because of the difference in size, in the absence of any surfactant the pressure 
experienced by the air in each alveolus would differ according to the Young-Laplace law  (P= 2 γ/r) 
(10) .This pressure (P), also termed Laplace pressure, results from surface tension of a liquid lining 
the inner surface of a curved structure. Lateral interactions between water molecules exert a net 
force towards the center of the curved structure that translates in pressure, which inversely 
correlates with the radius of the structures (Fig. 2b).  Therefore, for two interconnected alveoli with 
different sizes and a given surface tension, the smaller ones would tend to collapse toward those 
of larger size in the absence of surfactant, resulting in the progressive collapse of the lung (Fig. 2b). 
Lung surfactant (surface-active agent) provides an efficient way to reduce surface tension by 
occupying the alveolar air-liquid interface and minimizing water exposure to air at the interface. 
Furthermore, the lung surfactant system reduces surface tension in a proportional way to area 
reduction, therefore compensating differences in pressure and thus, stabilizing alveoli of different 
sizes preventing collapse. Surface tension reduction is achieved by surfactant lipids, which are 
transferred from the aqueous subphase into the air-liquid interface generating a monolayer with 
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the polar headgroup facing the water and the hydrophobic part toward the air. Surfactant is able 
to provide a surface tension reduction to less than 2 mN/m when exhalation takes place (lowest 
alveolar area) thanks to its high content in dipalmitoyl phosphatidyl choline (DPPC) (11). This 
saturated phospholipid can attain an extremely high packing density because of the saturated 
nature of its two hydrocarbon chains.  
 
Lung surfactant consists of a complex network of lipid assemblies, in lamellar and non-lamellar 
forms, modulated by surfactant-associated proteins (SP): SP-A, SP-B, SP-C and SP-D. It is produced 
and secreted by AT2 cells in the form of highly packed organelles termed lamellar bodies. 
The properties of this lipid-protein complex are due to its particular composition (Fig. 3). In most 
mammals, lipids represent approximately 90% of surfactant mass, from which phosphatidyl choline 
(PC) is the predominant specie (60-70%). DPPC, a lipid rarely found in most biological membranes, 
accounts for a 40%, whereas unsaturated PCs represent around 25%. Anionic phospholipids, mainly 
phosphatidyl glycerol (PG) and phosphatidyl inositol (PI), also form part of surfactant (8-15%) (12), 
together with other less abundant phospholipids, such as phosphadityl ethanolamine (PE), 
phosphatidyl serine (PS) or plasmalogens. Neutral lipids, predominantly cholesterol, represent an 
important fraction (5-10% by mass) and they are crucial regulators of surfactant properties adapting 
surfactant in response to diverse stimuli (13). The remaining 10% of surfactant mass is represented 
by the four specific surfactant proteins, which constitute essential elements for surfactant 
biophysical function and immune-protective role. 
 
Figure 3. Representation of lung surfactant composition showing its main fractions: phospholipids 
(PL), neutral lipids (N) and surfactant associated proteins (SP). The inner circle represents the 
proportion of each lung surfactant protein. 
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Surfactant composition is finely tuned to sustain respiratory demands depending on lung 
architecture. For instance, significant differences in terms of lipids and proteins are found between 
lung surfactant composition in mammals and birds, demonstrating how surfactant adapts either to 
a alveolar, branched structure that suffers volume changes during breathing (mammals) or to a 
static tubular lung (birds) (10). Besides, mammals cope with different situations based on their way 
of living such as high pressures (e.g. sea lions, dolphins) (14), sustained changes in body 
temperature (e.g. heterothermic mammals) (10) or diet (15); differences that are also reflected in 
modifications in surfactant composition. 
 
Lipid fraction 
As mentioned earlier, from all lipids forming part of surfactant, phospholipids represent the 
most abundant molecules. They are responsible for the surface tension reduction properties of 
surfactant given their amphipathic character as they are constituted by two moieties, a polar 
“headgroup”, and a hydrophobic part constituted by two hydrocarbon chains (Fig. 4). A glycero-
phosphate group is the central piece in to which the two acyl chains and a variable polar group 
are attached. Phospholipids are usually named after the polar group, which can provide the 
molecule a net charge (zwitterionic phospholipids), as occurs with phosphatidylcholine (PC), or a 
negative charge (acidic or anionic phospholipids), as in the case of phosphatidylglycerol (PG) or 
phosphatidylinositol (PI). The two fatty acids esterifying the glycerol molecule define important 
properties of the lipid depending on their chain length and saturation. 
 
Figure 4. Amphipathic structure of glycerophospholipids. Phospholipids are named according to 
their polar group (R), which also confer a defined electrostatic charge to the molecule. The most 
common in surfactant are choline (PC), glycerol (PG), serine (PS), inositol (PI) and ethanolamine (PE) 
with a charges of 0, -1,-1,-1 and 0 respectively.  
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Lipid polimorfism 
In order to minimize the exposure of hydrophobic groups to a polar environment (i.e. water), 
lipids are able to self-assemble into different supramolecular organizations. Depending on their 
molecular shape, they preferentially organize into certain structures as a consequence of the 
hydrophobic effect giving rise to the so-called lipid polymorphism. Phosphatidyl cholines (PC), for 
instance, keep an almost constant cross-sectional area from the headgroup to the acyl chains, 
reason why there are considered as cylindrical phospholipids (Fig. 5a). This molecular shape favors 
the generation of lamellar structures, in which the spontaneous curvature is virtually zero. Those 
species incorporating a small polar headgroup compared to the cross-sectional area of the acyl 
chains adopt a conical shape (Fig. 5b) such as phosphatidyl ethanolamines (PE), and promote the 
generation of non-lamellar negatively-curved structures like the hexagonal type II phase. The 
opposite situation gives rise to positively-curved structures such as the hexagonal phase I or 
different aggregation states such as micelles (Fig. 5c).  
 
Figure 5. Shape adopted by phospholipids according to their molecular structure. (a) Cylindrical 
phospholipids, such as PC, preferentially assemble into lamellar phases generating membrane 
bilayers. (b) Conical phospholipids organize into type II hexagonal phases or bicontinuos cubic 
phases by inducing negative curvature, as occurs with PE. (c) Inverted conical phospholipids, such 
as lysophospholipids, induce positive curvature leading to the generation of micelles or hexagonal 
I phases. Figure adapted from (16). 
 
In lung surfactant, lipid composition defines the local structure of the lipid network, which is 
able to adopt different configurations in order to fulfil an efficient surfactant function. The structure 
of those lipid assemblies is also subjected to the modulation by surfactant proteins, which have 
extensively proved their capacity to modify and adapt lipid organizations. Many other factors 
including temperature, lateral pressure, pH and hydration state among others, control transitions 
between lipid organizations resulting in optimized structures that respond to specific physiological 
demands.   
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Lateral organization and phase behavior 
Phospholipids arranged in lamellar forms establish molecular interactions between them, 
leading to the generation of thermodynamic phases. In a bilayer, highly packed phospholipids suffer 
motional constraints that are relieved upon an increase in thermal energy, which influence lipid 
mobility and order.  Thus, an ordered phase such as the gel phase or Lβ, transforms into a more 
disordered phase, liquid-crystalline or Lα, at a temperature defined as melting or transition 
temperature (Tm), which is characteristic of every system and depends on chain saturation and 
length and the polar headgroup (17). At that temperature, the entropy of the system changes 
leading to the release of latent heat while the temperature of the system remains constant. The 
two phases (Lβ and Lα) coexist in equilibrium at the melting temperature. This occurs at higher 
values for saturated phospholipids, such as DPPC (Tm=410C), than for non-saturated phospholipids, 
such as POPC or POPG (Tm=-20C).  
For monolayers, temperature also defines lipid packing and order but lateral pressure becomes 
an important factor responsible for the transition between phases. Those lipids exhibiting high 
lateral mobility and conformational freedom are considered as forming part of a liquid expanded 
(Le) phase, which would be equivalent to a Lα phase in bilayers in terms of lipid mobility. However, 
when area per lipid molecule is reduced as a result of lateral compression, phospholipids shift to a 
liquid-condensed (Lc) state, somehow analogous to a Lα phase in bilayers, in which lipid packing and 
order increases and the exposure of water to the air is minimized (18). High lateral pressures can 
result in films adopting a two-dimensional solid state (S0) that may even lead to collapse and 
material loss if the pressure is further increased (19).  
Besides temperature and lateral pressure, cholesterol plays a pivotal role in phospholipid phase 
behavior. This small amphipathic molecule inserts into the bilayer positioning its polar headgroup 
(OH) close to the polar region of the membrane, whereas the four rings and the isoprenoid tail 
remain in the hydrophobic region. When cholesterol forms part of a given lipid membrane, 
phospholipid retain a considerable mobility even at the most packed states and phases are re-
defined being considered as liquid-ordered (Lo) and liquid-disordered (Ld) (20). For fluid 
membranes, the addition of cholesterol results in a condensing effect in such a way that 
phospholipids translational mobility and diffusion is restricted and order increments. For ordered 
states though, cholesterol alters molecular interactions of phospholipids with their surrounding 
neighbors leading to a reduction in order and that high mobility. 
A complex mixture of phospholipids responds to temperature depending on its composition, 
with those lipids with similar Tm and properties clustering together. This is further complicated by 
the presence of cholesterol, which finely modulates the phase behavior of a lipid mixture. The 
consequence is that lipids are not distributed uniformly throughout the membrane and clustering 
results in phase coexistence and the appearance of lipid domains, which affect membrane 
properties such as bending, permeability, compressibility and membrane protein distribution (20, 
21).   
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Because of its specific lipid composition, lung surfactant seems to exhibit phase coexistence at 
physiological temperatures (Tm=37oC) as observed in Fig. 6a (22, 23). Membranes made of the 
organic extract of surfactant (depleted of hydrophilic components), with or without the 
hydrophobic proteins SP-B and SP-C, display the same phase behavior when compared to native 
membranes, which confirms that lipid composition is the main responsible for surfactant phase 
segregation(23). Both hydrophobic proteins, SP-B and SP-C, have been shown to preferentially 
partition in disordered domains (23), frequently associated with membrane folds that may lead to 
3D-structural reorganizations (23, 24). Besides, SP-C has been demonstrated to localize at the 
boundary between phases in membranes (25), and monolayers (26). In the context of the interfacial 
film, both proteins are  excluded from condensed DPPC enriched domains upon compression, 
concentrating in those regions connecting condensed and expanded phases (27).  
 
Figure 6. Phase behavior of giant unilamellar vesicles made of lung surfactant. (a) Domains observed 
in yellow (labelled with the fluorophore Bodipy-PC) correspond to disordered regions, whereas 
those marked in red (DiIC18) match ordered regions, likely enriched in DPPC. Domain coexistence 
depends on the melting temperature of the mixture as observed (Tm surfactant ≈ 370C). Scale bar = 
20 µm. (b) From left to right, surfactant membranes exhibit different domain coexistence 
depending on cholesterol content (10, 15, 18, 21 and 30 mol %). Scale bar = 10 µm.  Adapted from 
(23). 
 
Cholesterol depletion leads to the generation of markedly different lipid phases in comparison 
to native surfactant (Fig. 6b), highlighting cholesterol as a crucial element to modulate lipid domain 
segregation at the micron- and nano-scale (23). Lipid composition is therefore critical to promote a 
high dynamic character to surfactant membranes, right at the edge of physiological temperatures. 
This could be important in the context of lungs, where the large fluctuations in area can require the 
interplay of surfactant fluid states to adapt surfactant structures and properly fulfil surfactant 
function.   
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Surfactant proteins 
Surfactant associated proteins (SP-A, SP-B, SP-C and SP-D) represent an important fraction of 
lung surfactant mass and are crucial actors sustaining surfactant biophysical and immunological 
roles. Typically, they can be divided in two groups based on protein nature, solubility and associated 
function.  
 
Surfactant and lung immunity: hydrophilic proteins SP-A and SP-D 
SP-A and SP-D belong to a family of proteins related to innate immunity, termed collectins (1). 
SP-A is the most abundant protein in surfactant (6% by mass), and as in the case of  SP-D (0.5%), 
can adopt different oligomeric states as illustrated in Fig. 7 (28). SP-A (monomers of 28-36 kDa) is 
typically found in bronchoalveolar fluid (BALF) forming part of a bouquet-like structure formed by 
six trimers (630 kDa) (29), whereas SP-D (monomers of 43 kDa) is usually present in a trimeric form 
that can further oligomerize generating dodecamers (520 kDa) and even larger structures (8x12, 
~4,2 MDa) (30, 31). 
Surfactant SP-A and D are produced both by alveolar type II cells (32) and club cells, previously 
known as Clara cells (33, 34), and their biosynthesis and secretion seem to be independent of 
pathways involving lamellar bodies (35). However, newly synthesized SP-A can ultimately be 
targeted to lamellar bodies (36), suggesting that SP-A association to surfactant does not depend on 
a unique mechanism. 
 
Figure 7. Lung collectins at the air-liquid interface. SP-D dodecamers (green) and SP-A octadecamers 
(pink)  associated to DPPC are shown in the hypophase (modified from (37)). 
 
SP-A and SP-D provide surfactant with a protective role against infection. They act as 
antimicrobial proteins by recognizing non-host oligosaccharides through their carbohydrate 
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recognition domain (CRD). Upon recognition, they opsonize and agglutinate pathogens in a process 
that facilitates their phagocytosis by macrophages and monocytes (28). They also show an intrinsic 
antimicrobial activity by increasing pathogen membrane permeability (38). These collectins act as 
immunomodulators by controlling the inflammatory response thought their interaction with 
immune cells such as macrophages (28, 39). 
Besides, they are also involved in surfactant homeostasis and possess a structural function 
shaping surfactant membranes and multilayers.  SP-A avidly binds DPPC (40, 41), reason why it is 
co-isolated with surfactant complexes (42). It is essential for the generation of tubular myelin in a 
calcium dependent manner (43, 44) and contributes to the surface activity of surfactant, enhancing 
the adsorption of lipids into the interface (45) and generating surface-associated surfactant 
structures with optimal biophysical properties (46). SP-D binds to certain lipid species such as PI 
and glucosylceramide, both minor components of surfactant (47, 48), but it is not strongly 
associated to surfactant membranes (42). Both proteins are involved in surfactant homeostasis and 
recycling (49), being SP-D important to modulate surfactant pools  (50, 51). 
 
Surfactant biophysics: Hydrophobic proteins SP-B and SP-C 
In contrast to lung collectins, SP-B and SP-C are small hydrophobic proteins strictly required for 
the air-breathing mode of life in mammals (Fig. 8) (52). They are mainly responsible for the 
biophysical function of lung surfactant including the efficient stabilization of an open air-liquid 
interface.  
 
Figure 8. Hydrophobic surfactant proteins associated to a surfactant interfacial monolayer. SP-B is 
shown in a dimeric form (orange) while SP-C appears as a monomer (blue) (modified from (37)). 
 
It has been already pointed out that lipids provide the tension reduction properties required for 
ensuring breathing, but hydrophobic surfactant proteins are the key to understand the mechanisms 
sustaining respiratory mechanics. For surfactant films to achieve the surface tension reduction, 
especially upon compression (exhalation), the surfactant active species must first experiment a fast 
interfacial adsorption into the air-liquid interface and, during expansion (inhalation), they have 
efficiently re-spread (53, 54). Those dynamic properties mobilizing surfactant lipids along 
respiratory mechanics are critically dependent on the presence of SP-B and SP-C, whose 
perturbations on lipid assemblies allow for the generation of an extremely dynamic lipid matrix able 
to adapt to the continuously changing alveolar context (Fig. 9). 
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Figure 9. Proposed model of how SP-B and SP-C could sustain the generation of a surfactant 
reservoir during compression and assist surfactant spreading upon expansion. SP-B and SP-C 
promote compression-driven membrane protrusions (1) that would be stabilized by SP-B-induced 
bilayer-bilayer contacts (3) and SP-C-promoted anchoring by its palmitic chains (4). Both SP-B and 
SP-C could facilitate membrane insertion (5) and re-spreading of lipid assemblies from the aqueous 
hypophase to the interface upon expansion (adapted from (55)). 
 
In order to understand how these proteins function, it is important to consider the current 
models proposed for the lung surfactant system. Experiments performed during the late 60s and 
70s leaded to the proposal of the “squeeze-out model” (56–58), which estates that upon 
compression, the composition of the interfacial film would be selectively refined to a pure DPPC 
monolayer, which is the only lipid competent to achieve a solid state leading to the low surface 
tension required for breathing (< 2 mN/m). Thus, other lipid species that would be required to 
fluidize DPPC and facilitate its adsorption, would be excluded from the interface at the time it must 
reach the lowest tensions. Years later, it was proposed that material excluded from the interface 
during compression would constitute a surfactant reservoir, promoted by the action of the 
hydrophobic proteins. From this reservoir, surfactant could be re-spread during expansion by 
transferring lipids into the interface. The proteins could be responsible of establishing the bilayer-
bilayer and monolayer-bilayer contacts through which the lipids could be mobilized in and out of 
the interface. The presence of stacked multilayers is supported by in vitro observations (59, 60), but 
in which direction they form (air or hypophase) or whether they occur also in vivo is still under 
discussion (61). Another model propose that no reservoir is required since surfactant could behave 
as a super-compressed monolayer. This means that surfactant can possess the high fluidity 
required for adsorption and still reach the high rigidity that avoids alveolar collapse when it is 
compressed to the high rate imposed by breathing dynamics (62, 63). Technical limitations have 
prevented the validation of this model to date.  
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According to bibliography, the “squeeze-out” theory is still widely accepted and the following 
sections will refer to this model as the one ruling surfactant function. SP-B and SP-C are thus 
important to define the mechanical properties of surfactant membranes, which must display proper 
behavior in terms of elasticity, stability and remodeling. The relevance of SP-B and SP-C is 
highlighted by what occurs when protein levels are reduced or absent.  SP-B deficiency is life 
threatening; the complete lack of the protein results in respiratory failure leading to death after 
birth (64–66). SP-C effects though, seem to be more subtle, and although early in life does not seem 
to be so critical, SP-C deficiency results in unstable lungs that ultimately develop interstitial lung 
disease.  
Both proteins seem to act in a coordinate manner to sustain breathing and sometimes they 
apparently exhibit redundant functions. However, they also display characteristic and independent 
actions that are addressed in the following section.  
 
SP-B 
SP-B (8,7 kDa) is usually purified from BALF as a covalent homodimer (17,4 kDa) and belongs to 
the saposine-like protein family (SAPLIP), a group of amphipathic polypeptides involved in the 
mobilization of lipids (67). Approximately half of the SP-B sequence is constituted by hydrophobic 
amino acids and a fair number of residues are remarkably conserved along evolution. Seven 
cysteines are essential to maintain protein structure and dimerization ability (through 3 
intramolecular and 1 intermolecular disulfide bonds) and 9 charged residues, 8 cationic and 1 
anionic, confer the protein a net positive charge (67, 68). Despite widespread efforts, the high 
resolution 3D structure of SP-B has remained elusive so far. Some information has been inferred 
from circular dichroism and infrared spectroscopy experiments, which showed results consistent 
with an average of 40-50% α-helical content (69, 70). 
SP-B adopts a superficial orientation in phospholipid membranes, with the protein oriented in-
plane with the bilayer (71–75). This configuration is supported by the interactions of amphipathic 
helical segments of the protein and the headgroup region of membranes. Besides, electrostatic 
interactions involving acidic phospholipids present in surfactant and the positive charges of SP-B 
play an important role.  
SP-B on its own is able to provide to surfactant phospholipids the most important properties of 
surfactant surface activity, facilitating lipid adsorption and re-spreading of the lipid films during 
inhalation (76–78). SP-B causes extensive membrane rearrangements with marked changes in 
membrane curvature leading to membrane fusion and lysis (79–81). These effects could be the 
basis sustaining SP-B-promoted connection and transfer of lipids from the surfactant reservoir into 
the interfacial film (82, 83). Together with SP-A, SP-B shapes surfactant membranes into tubular 
myelin, a highly ordered network of membranes, in the presence of calcium (43, 44) and it has been 
observed to generate highly cohesive multilamellar arrays (22). SP-B activity also results in an 
increase in membrane permeability through the generation of proteolipid pores and 
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supramolecular complexes (84–86), an effect that can be somehow connected with the SP-B-
mediated increase in oxygen diffusion through surfactant multilayers (87).  
SP-B is involved in surfactant biogenesis, participating in SP-C processing and in promoting the 
lipid packing to generate lamellar bodies (88, 89). SP-B has been also proposed as the key anchor 
triggering the unraveling of secreted surfactant into extracellular forms in a process that seems to 
involve a coordinate action of SP-B and SP-C (90). 
 
SP-C 
SP-C is the smallest (4,2 kDa) and most hydrophobic protein forming part of surfactant. It 
accounts for ~1% of surfactant mass, becoming the most abundant protein in molar terms. SP-C 
appeared relatively late in evolution and its sequence has remained highly conserved among 
species (Fig. 10a) (91). This, coupled to the lack of any known homologous protein and its confined 
expression (92), transforms it into a specific marker associated with the differentiation of lung 
tissue.  
SP-C exists as a 35 amino acid transmembrane protein expressed as a larger precursor (21 kDa) 
in AT2 cells, where it follows several proteolytic cleavages and some posttranslational modifications 
(detailed in following sections). Structurally, it adopts a metastable α-helical structure comprising 
residues 9-34 (Fig. 10b) (93), although its high proportion of branched residues (valine, leucine and 
isoleucine) are typically associated to β-sheet structures (94). For this reason, under certain 
pathologic circumstances SP-C turns into β-sheet strands ultimately leading to the formation of 
fibrillogenic amyloid-like aggregates (95, 96). SP-C misfolded forms are cytotoxic and they are 
associated to several interstitial lung diseases including pulmonary fibrosis and pulmonary alveolar 
Proteinosis (97). The N-terminal segment of SP-C (residues 1-8) is the only region of the protein that 
projects out from the membrane and does not have a reported defined structure. Predictive 
studies, though, have suggested that it adopts β-turn configuration giving rise to a hairpin-like 
amphipathic structure allowing it to strongly perturb phospholipid bi- and monolayers (98, 99).  
Figure 10. Sequence and structure surfactant protein SP-C. (a) A sequence aligment (Clustal Omega) 
is shown highlighting conserved residues (*), cysteines in the palmitoylation site (orange), and 
positively charged amino acids (blue) at physiological pH. (b) Structure of porcine SP-C determined 
by NMR (PDB 1SPF) in organic solvents without displaying the palmitoyl chains.  
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In vitro, SP-C displays several functions related to the biophysical behavior of surfactant. SP-C 
greatly alters lipid packing in membranes influencing lipid motion and lateral distribution (100, 
101). It also increases membrane permeability (84, 85, 99) and promotes interfacial lipid 
adsorption and lipid transfer among different lipid structures (102–104). SP-C is responsible for the 
reversible formation of multilayered stacks connected to the interfacial monolayer (60, 103). Doing 
so, it allows for the capture of surfactant material presumably squeezed out during exhalation (area 
compression) and surfactant re-spreading upon inhalation (area expansion). In this process protein 
palmitoylation seems to be relevant in order to sustain protein association to the highly compressed 
interfacial films reached during exhalation (105, 106).  The activity of SP-C mainly relies on its rigid 
transmembrane helix, which mediates protein-induced lipid alterations through hydrophobic 
interactions. The N-terminal segment, though, has been also reported to interact with membranes 
inducing packing defects that lead to vesicle aggregation and leakage in vitro (99). The cationic 
charges of the N-terminal segment establish electrostatic interactions with acidic phospholipids 
such as phosphatidyl glycerol (99). Besides, it has been proposed that palmitic chains couple protein 
motion to those occurring in the membrane (107).  
Mice models for SP-C deficiency exhibit different phenotypes depending on the genetic 
background. This seems to be consistent with patients suffering from SP-C deficiency either caused 
by the complete absence of the protein and its precursor, or due to mutations that prevent a proper 
protein processing and maturation  (97, 108, 109). In some cases, no pathology is apparently 
associated to SP-C absence in SP-C KO mice, although surfactant is observed to be less stable at low 
volumes (110). In other genetic backgrounds, SP-C deficiency results in an increase in phospholipid 
pools and significant lung remodeling (111). These lungs displayed an increased susceptibility to 
challenging conditions such as infection (112, 113), inflammation (114) and fibrosis inducting 
elements (115). Nonetheless, mutations in SP-C exhibit a dominant effect when inherited in 
heterozygosity, and they lead to much severe phenotypes than SP-C genetic ablation resulting in 
several forms of interstitial lung disease as a consequence of accumulation of aberrantly processed 
precursors (97). Thus, SP-C seems to be important for stabilizing the lungs, especially when they 
are exposed to challenging conditions. 
The particular relationship between SP-C and cholesterol, both constituting important 
surfactant modulators, is an important feature that has attracted the attention of researchers over 
the last years. As discussed previously, cholesterol modulates membrane properties, and 
depending on its proportion and the overall composition of lipid films and membranes, both 
beneficial and adverse effects on surfactant behavior have been reported (23, 116–119). However, 
in vitro studies have demonstrated that in cases in which cholesterol impaired the function of 
surfactant mimicking mixtures, SP-C restored surfactant properties depending on SP-C 
palmitoylation state (120, 121). Besides, cholesterol miscibility in surfactant-mimicking membranes 
improves upon addition of SP-C (120) and SP-C configuration in bilayers has been reported to be 
affected by the presence of cholesterol (122). This evidence strongly suggests that SP-C and 
cholesterol functions are connected in the lung and could somehow cooperate to modulate 
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surfactant activity, although the molecular mechanisms sustaining their relationship are still 
unknown.  
Finally, SP-C is not only important for the biophysical function of surfactant, but also possesses 
immunomodulatory properties in the lung (123). SP-C binds bacterial lipopolysaccharide, 
mediating its interaction with the membrane receptor CD14 (124). 
 
Lipid synthesis 
AT2 cells are in charge of synthetizing and secreting surfactant to the alveolar hypophase. 
Phospholipids and proteins follow different biosynthesis pathways that converge into lamellar 
bodies, the highly packed lysosomal-derived organelles in which surfactant is stored until secretion.  
De novo synthesis in the endoplasmic reticulum or recycling/remodeling are the two possible 
sources for surfactant phospholipids (125). In the case of DPPC, the major surfactant phospholipid, 
both pathways contribute significantly, with a 45% newly synthetized DPPC (via the Kennedy 
pathway) and the rest from the remodeling pathway (126). PCs are synthetized de novo in several 
steps that combine the action of a choline kinase (CK), a CTP:phosphocholine cytidyl transferase 
(CCT) and a phosphotransferase (CPT). A tight regulation of these enzymes, especially CCT, 
modulates the amount of lipid synthesis in order to keep lung homeostasis. In the remodeling 
pathway phospholipase A2 (PLA2) and lysophosphatidylcholine acyltransferase 1 (LPCAT1) are 
crucial enzymes (127).  
Other phospholipids, such as PG, can also be produced either way, with some species being 
reported as coming from de novo synthesis, and others such as DPPG, from the remodeling pathway 
(125). In any case, to maintain surfactant pools and functionality, a cross-talk between pathways 
that responds to surfactant demands is necessary. In the case of DPPC, LPCAT1 is the enzyme 
responsible for coupling both pathways (127), whereas it also plays a role in the production of 
surfactant PG (128).  
Surfactant cholesterol represents a paradox regarding its origin (129). Some works have 
suggested that it is supplied by the low and high-density lipoproteins present in blood circulation 
(125). However, other studies have failed to prove that circulating cholesterol ends up forming part 
of surfactant complexes (129, 130), suggesting that other possible sources must be taken into 
account. It is remarkable that cholesterol levels in surfactant are tightly regulated to ensure a 
proper breathing function, and they are able to increase and decrease extremely fast in response 
to changes in temperature or breathing rate (13, 131). This seems to imply that a cholesterol 
reservoir might exist in order to provide cholesterol at fast rates when an increase is required. A 
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specific cell type, the lipofibroblast, has been suggested as a reservoir of cholesterol (132, 133), 
although further validation is required to confirm whether it is present in all organisms and if it 
really constitutes a cholesterol storage. AT2 cells are able of producing cholesterol in peroxisomes 
(134), but also alveolar macrophages exhibit enzymes involved in cholesterol synthesis (135). Even 
though it is not known how cholesterol incorporates into lamellar bodies, the Niemann-Pick C 
pathway appears as a suitable candidate, through the cholesterol transporters Niemann-Pick C1 
and C2 (NPC1 and C2) present in the lamellar body proteome (136). Elucidating how cholesterol 
levels are regulated in the context of surfactant physiology is key to understand responses 
associated with several respiratory pathologies characterized by the incorporation in surfactant of 
abnormal cholesterol amounts such as the acute respiratory distress syndrome (ARDS) (137) or 
pulmonary alveolar proteinosis (PAP).  
 
Protein synthesis 
Synthesis and processing of SP-A and SP-D is not specific of AT2 cells and their secretion has 
been observed to occur through pathways not involving lamellar bodies. In the case of SP-A, a small 
protein fraction seems to be secreted actually associated to lamellar bodies (36) although the 
molecular mechanisms guiding this process are still unknown.  
In contrast, SP-B is essential for surfactant biogenesis participating in the maturation of lamellar 
bodies (138) and the processing of SP-C (89). SP-B is produced as a 381 amino acid precursor (40-
42 kDa) in which N-terminal (proSP-B1-200) and C-terminal (proSP-B280-381) propeptides flank mature 
SP-B domain (proSP-B201-279) protecting it from the polar cellular environment until it is assembled 
into lamellar bodies (139–141). proSP-B is translocated to the endoplasmic reticulum via a signal 
peptide and it is subsequently cleaved in different steps along the trafficking pathway (Fig. 11). The 
first proteolytic cleavage is mediated by napsin A, an aspartil protease, which removes most of the 
N-terminal propeptide of the protein (142). The resulting intermediate proSP-B travels through the 
Golgi apparatus reaching the acidic multivesicular bodies and composites bodies.  
 
Figure 11. Schematic representation 
of proSP-B processing in a type II 
pneumocyte. proSP-B is sequentially 
cleaved along the exocytic pathway 
(ER, endoplasmic reticulum; MVB, 
multivesicular bodies; CB, composite 
bodies; LB, lamellar bodies) until it is 
assembled into lamellar bodies for 
its secretion. Figure adapted from 
(42). 
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Along trafficking, the remaining N-terminal residues of the propeptide and the whole C-terminal 
region is cleaved and removed by the action of cathepsin H (cystin protease) and pepsinogen C 
(aspartil protease), resulting in the 79 amino acid mature protein (143) that is finally transferred to 
lamellar bodies. 
SP-C processing converges with SP-B in lamellar bodies. The gene encoding SP-C is structured 
into 6 exons and 5 introns located in the short arm of chromosome 8 (8p21) and its expression is 
orchestrated by TTF1 (thyroid transcription factor 1), as well as that of SP-B and SP-A (144).  Human 
SP-C mRNA is translated into a proprotein consisting of 191 or 197 amino acid residues depending 
on alternate splicing in AT2 cells. Most studies have reported that proSP-C (21 kDa) is inserted in 
the endoplasmic reticulum (ER) with a type II configuration, with the C-terminal end facing the ER 
luminal cavity (145, 146), although a type III configuration has also been suggested (147).  
 
Figure 12. Schematic representation of proSP-C processing in type II pneumocytes. proSP-C is 
sequentially cleaved along the exocytic pathway (ER, endoplasmic reticulum; MVB, multivesicular 
bodies; CB, composite bodies; LB, lamellar bodies) until it is assembled into lamellar bodies for its 
secretion. Figure adapted from (42, 146, 151). 
 
The sequence corresponding to mature SP-C (Phe24-Leu58) acts as a membrane anchor and 
comprises the only transmembrane segment (148). This region also serves as a dimerization motif 
required for SP-C sorting along the regulated secretory pathway (149). proSP-C is dually 
palmitoylated after its insertion in the ER (150) by a yet unknown palmitoyl transferase. The two 
palmitoylcysteines correspond to positions 5 and 6 in the mature SP-C sequence, and in some 
mammals, a phenylalanine substitutes one of those residues (91). For the acylation to occur, not 
only the N-terminal segment must be close to the membrane but also lysine and arginine residues 
occupying positions 11 and 12 in the mature protein are essential (146, 151, 152), since their 
mutation leads to defects in protein sorting preventing SP-C palmitoylation (150). After acylation, 
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proSP-C leaves the ER toward the trans-Golgi to initiate the proteolytic process (153, 154).  Both 
the N-terminal and C-terminal segments are removed sequentially completing four proteolytic 
steps (Fig. 12). The C-terminal region (proSP-C59-197) contains a chaperone domain termed BRICHOS 
(from Bri protein associated with familial British dementia, chondromodulin, and proSP-C; residues 
94-197) (155), which facilitates the formation of SP-C α-helix (156) and stabilizes it until 
palmitoylation occurs (157). A 30-residue C-terminal segment is firstly removed in the medial Golgi 
resulting in a 16 kDa protein. This step is followed by the subsequent cleavage of the remaining C-
terminal propeptide occurring along proSP-C trafficking through multivesicular and composite 
bodies (158). The N-terminal segment (proSP-C1-23) is essential for protein sorting, and it is also 
processed and removed in two steps (159). From the 7 kDa proprotein generated after C-terminal 
cleavage, a 6 kDa peptide corresponding to proSP-C10-58 is produced in multivesicular bodies by the 
action of cathepsin H (160). This peptide has been observed both in composite bodies and lamellar 
bodies, whereas mature SP-C is mainly present in lamellar bodies (159, 160). This suggest that the 
last step of processing takes place in the lumen of those lysosome-related organelles right before 
secretion, in a process that has been shown to be dependent on SP-B presence (88, 89).  
 
Lamellar bodies assembly and secretion 
Once synthetized, lipids and proteins have to be transferred to lamellar bodies in order to be 
secreted. How hydrophobic proteins reach these organelles coupled to their maturation has been 
detailed before. On the contrary, lipid transport is not completely understood and may involve 
vesicular and non-vesicular transport (125). Lipids coming from the recycling pathway reach 
lamellar bodies through the multivesicular bodies (MVB), but newly synthetized lipids seem to 
bypass those organelles. Non-vesicular transport of PC is supported by the finding that a 
dysfunctional Golgi do not affect lipid secretion (127, 161) and experimental observations suggest 
that DPPC and PG can be transferred directly from ER to MVB together with the ATP-binding 
cassette A3 (ABCA3) (162, 163), a protein absolutely required for lamellar bodies generation.  
ABCA3 is localized at the limiting membrane of lamellar bodies and is responsible for the transfer 
of lipids to the lumen of those organelles with ATP cost. Thus, the energy provided by ATP could be 
used to assemble the extremely highly packed lipid-protein organizations in which surfactant is 
stored (11). Due to the high packing state achieved, structural transitions  can lead to the generation 
of highly dehydrated states and non-lamellar phases (164, 165).  Upon secretion and depacking 
once at the air liquid interface, this accumulated energy may constitute the driving force for 
achieving an efficient and fast spreading of the interfacial film. 
The AT2 cell secretes surfactant in the form of lamellar bodies by exocytosis. Stretching forces 
are the most physiologically relevant inducer of surfactant exocytosis as observed experimentally, 
but many other agents are able to stimulate exocytosis such as  ATP and other purinergic receptor 
agonists and β2-mimetic drugs (166). Secretion starts with the fusion of the limiting membrane of 
the lamellar body with the plasma membrane in order to release surfactant to the medium, a 
process in which Ca2+ is the major second messenger triggering the fusion event (166).
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Figure 13. Electron transmission micrographs of surfactant extracellular and intracellular forms. 
Once secreted, surfactant is observed as lamellar body like particles (LBPs) (a,c), tubular myelin 
(TM) (a,c,d) and membrane multilayers (ML), which presumably are associated to the interfacial 
film (e,f). A lamellar body (LB) is also shown in the process of fusing to a multivesicular body (MVB) 
within a type II pneumocyte (b). Figures taken from (7, 12, 88, 167, 168). Scale bars correspond to 
(a) 0.1 µm (lower left), 1 µm (lower right); (b) 1 µm; (c) 1 µm; (d) 0.2 µm; (e) 0.3 µm; (f) 0.1 µm. 
 
When lamellar bodies are released, they maintain a packed state in the alveolar fluid as lamellar 
body like particles. These organizations retain characteristics of lamellar bodies and, by the 
coordinate action of SP-B and SP-C (90), unravel in a cooperative and efficient manner once 
touching the air-liquid interface. In some cases, unraveling of the LBPs leads to the generation of 
different structures including a lattice-like ordered network of membranes defined as tubular 
myelin (Fig. 13) (166). Tubular myelin has been considered as an intermediate state between the 
lamellar bodies and the interfacial film, being associated with, but not strictly necessary for, a 
proper biophysical surfactant function in vivo (166). For tubular myelin to form, SP-A, SP-B and Ca+2 
are essential elements (43). Although its specific function is still unknown, it has been proposed 
that it can serve a defensive purpose functioning as a scaffold for SP-A, SP-C, lysozyme and other 
molecules with a role in host-defense (169). Several studies have reported that tubular myelin is 
not essential for producing the interfacial film, suggesting that other mechanisms are responsible 
for triggering the adsorption of surfactant material to the air-liquid interface. Those mechanisms 
would rely either on the direct adsorption of the lamellar body like particles or on the formation of 
other intermediate structures (large vesicles or lipid aggregates) which could also promote 
surfactant adsorption.   
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Once surfactant is secreted, its constituents, both lipid and proteins, are long-lived molecules 
with a half-life going from 10 to several tens of hours. This is consequence of a slow clearance from 
alveoli to upper airways and from continuous recycling/re-secretion of material by AT2 cells (166). 
Surfactant turnover then becomes the most informative parameter, which measures the time 
required for surfactant pools to be replenished by newly secreted surfactant. In alveolar fluid, the 
turnover rate goes from 4 to 11h (32).  
When surfactant reaches the interface, it suffers several compression/expansion cycles along 
breathing leading to compositional and structural reorganizations, after which it is considered 
“used” surfactant (170). This material is released from the interfacial film in the form of small 
aggregates and cleared by AT2 cells and alveolar macrophages.  
 
AT2 cells 
AT2 cells are responsible for a 65% of surfactant clearance (171), leading to lipid catabolism and 
recycling. The recycling pathway depends on the protein SP-A (127), which upon interaction with a 
specific receptor on the AT2 cell plasma membrane (172), promotes the combined internalization 
of lipids and SP-A by a clathrin-dependent pathway (172, 173). Lipids are sorted to early endosomes 
and transferred to lamellar bodies in a calmodulin-dependent mechanism (49). However, not all SP-
A is rapidly recycled and secreted again to the alveolar space, with a protein fraction following an 
actin-dependent degradation route (127). Clathrin-dependent endocytosis is not the only pathway 
guiding surfactant recycling but it becomes the main recycling mechanism  in the absence of SP-A 
(173).  
SP-D deficiency results in the accumulation of lipids in the alveolar spaces (174, 175). However, 
rather than a direct activity on surfactant uptake and degradation (174), SP-D effect seems to be 
caused by the structural transformation of large surfactant aggregates into small, less functional, 
ones, which are preferentially taken up by AT2 cells (51, 176).  
Non-recycled phospholipids are mainly degraded by the action of PLA2 in both AT2 cells and 
macrophages (125). Besides, AT2 cells have mechanisms to eliminate excess PC such as the 
basolateral transport of lipids via the ATP-binding cassette transporter A1, ABCA1 (177, 178). 
 
Alveolar macrophages 
Although surfactant clearance mainly occurs through AT2 cells activity, alveolar macrophages 
metabolize a significant fraction (20%-30%) (9, 32, 125, 171). This cell type is critical to maintain 
alveolar homeostasis as illustrated by the pathologies derived from a deficient alveolar macrophage 
(AMϕ) function, such as pulmonary alveolar proteinosis (PAP) (179). 
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Alveolar macrophages are equipped with a set of enzymes and regulators of lipid catabolism and 
transport whose alteration results in impaired lipid degradation and accumulation in the alveolar 
fluid (135, 180–183), leading in some instances to the generation of “foamy macrophages” showing 
lipid accumulation in “lipid droplets”. GMCSF (granulocyte-macrophage colony stimulating factor) 
is the master modulator of surfactant clearance by AMϕ (179). This growth factor mediates the 
differentiation of monocytes into macrophages and is crucial for the activation of the lipid 
degradation and transport machinery (179). Neutralizing GMCSF autoantibodies (184, 185) and 
defective GMCSF receptor versions (186) result in PAP phenotype, which can be relieved upon 
macrophage lentiviral transduction and expression of genes downstream GMCSF such as pparγ 
(peroxisome proliferator-activated receptor gamma) or abcg1 (ATP-binding cassette transporter 
G1) (181, 187). GMCSF regulates the transcription of the transcription factor PU.1 through the 
JAK/STAT signaling pathway, and therefore, PU.1 dependent genes (179). Among them, scavenger 
receptors class II (CD36 and SR-BI) and lysosomal enzymes (lysozyme or lysosomal phospholipase 
A2; LPLA2; (188)) can be associated to lipid homeostasis in the lung (179). 
PPARγ, a central piece in lipid catabolism, is also under the regulation of GMCSF, and its 
deficiency leads to lipid accumulation in the lung. It controls the expression of ABC transporters, 
such as ABCG1 and scavenger receptors class II, such as CD36 (135). Additionally, it directly 
regulates the levels of lysosomal acid lipase (LAL or LIPA), sterol-27-hydrolase (CYP27A1 and 
CYP27A6) (135, 189) and acylcholesterol acyltransferase 1 (ACAT1), all enzymes involved in lipid 
and cholesterol metabolism linked to PAP (190).  
The role of ABCA1 and ABCG1 seems to be especially important. Both proteins participate in 
cholesterol efflux to LDL and HDL respectively (191), and mice models have proved that their 
deficiency in the lung is sufficient to lead to the PAP phenotype (192–194). Both transporters are 
regulated by LXR (nuclear oxysterol receptors) (195, 196) and their expression responds to 
cholesterol uptake (135). AMϕ also possess other cholesterol transporters, NPC1 and C2, in some 
instances related to patients suffering from PAP (197).  
Lipid clearance by AMϕ is also influenced by surfactant proteins since deficiency in SP-C (110–
113) and SP-D (50, 174) leads to the accumulation of lipids in the alveolar fluid. SP-D for instance is 
able to regulate alveolar macrophage number and therefore surfactant pool size (51), although in 
general, the mechanisms by which surfactant proteins influence lipid homeostasis are still a matter 
of study.  It seems particularly interesting how the small lipopeptide SP-C is able of interfering with 
AMϕ function especially concerning cholesterol metabolism (198). It has been previously 
mentioned that SP-C establishes a relationship with cholesterol that seems to be relevant in the 
regulation of surfactant function. Animals deficient in SP-C exhibit foamy alveolar macrophages, in 
which crystals with similar characteristics to those generated in atherosclerosis accumulate (111). 
This suggests that SP-C might somehow be involved in surfactant homeostasis regarding cholesterol 
regulation. Besides, SP-C is an immunomodulator (123), as it interacts with the AMϕ CD14 
regulating the recognition of lipopolysaccharide (124) by binding LPS itself, thus regulating the 
immune response in the lung. Hence, SP-C could play a pivotal role linking surfactant homeostasis 
and immunity in alveoli, a potential integrative role that requires further exploration.  
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Surfactant homeostasis is tightly regulated at several levels in order to maintain surfactant pools 
without altering film composition at the alveolar air-liquid interface. This is crucial for a proper 
respiratory function, and any imbalance in surfactant secretion/uptake or alterations in surfactant 
composition, results in severe respiratory disorders.  
Surfactant absence was the first cause of neonatal mortality in premature babies until the 
achievemnt of surfactant replacement therapy (199). These newborns developed neonatal 
respiratory distress syndrome (NRDS) at birth as a consequence of having immature lungs, unable 
of secreting surfactant since the first inhalation (200). Nowadays, intratracheal administration of 
surfactant clinical preparations aid to support the first breathing cycles, stabilizing the lungs and 
promoting surfactant secretion by the baby.   
The acute respiratory distress syndrome (ARDS) in adults is a far more complex pathology. It is 
characterized by an exacerbated inflammatory process that damages alveolar structure and causes 
severe hypoxemia (201). One of ARDS hallmarks is the leakage of serum proteins to the alveolar 
spaces as a consequence of the alteration of the alveolar-capillary barrier. Leaked proteins compete 
with surfactant complexes for the air-liquid interface, leading to surfactant inhibition. Besides, 
compositional and structural alterations of surfactant as a consequence of lung injury, result in a 
decrease in DPPC content and an increment in surfactant inactive forms (202), which coupled to 
the deficiency in surfactant proteins, such as SP-A and SP-B, contributes to an impaired biophysical 
function. This situation is accentuated by an abnormal increase in neutral lipids, mainly cholesterol 
(203), promoting surfactant dysfunction and leading to cellular damage. 
Pulmonary alveolar Proteinosis (PAP) is a good example of a respiratory pathology caused by 
an impaired surfactant homeostasis (204). As previously described, PAP is characterized by a 
pathological accumulation of surfactant complexes in alveolar spaces due to alterations in 
surfactant clearance by AMϕ. To date, the treatment is purely symptomatic and involves 
bronchoalveolar lavage to eliminate lipid excess from alveoli (205). However, cell therapy is 
emerging as a promising alternative for PAP patients and so far, AMϕ transplantation has been 
successful to revert the PAP phenotype in mice models (206) .  
Congenital alterations in surfactant proteins can also lead to several pathologies. Mutations in 
the SP-B, SP-C or ABCA3 genes disturb surfactant homeostasis causing different interstitial lung 
diseases (204). SP-B deficiency impairs lamellar body formation and SP-C processing causing 
respiratory failure (88).  In the case of SP-C, 14 different mutations in its precursor have been 
associated with the development of diffuse parenchymal lung disease (97). Heterozygous 
mutations of SP-C are sufficient to cause lung pathologies as it occurs in some neurodegenerative 
disorders such as Alzheimer’s or Huntington’s disease. Typically, proSP-C mutations generate 
aberrant protein isoforms that are misfolded or abnormally trafficked leading to conformational 
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disease. Aggregated protein forms trigger the unfolded protein response which ultimately cause 
endoplasmic reticulum stress and apoptosis (97). SP-C-induced cellular stress has been related to 
several pathologies including interstitial lung diseases such as pulmonary fibrosis.  
Mutations in ABCA3 result in AT2 cells failing to properly produce and secrete lamellar bodies. 
As a result, SP-B and SP-C processing are also altered and the phenotype of these mutations results 
in lethal respiratory failure (204).   
Many other mutations and disorders can affect surfactant homeostasis leading to respiratory 
associated diseases, highlighting the central role of surfactant in lung health and disease. 
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Lung surfactant biophysical function critically depends of the activity of the hydrophobic 
surfactant proteins SP-B and SP-C. Nevertheless, whereas SP-B absence is life-threatening, 
supporting its essential role for the breathing function, the specific role of SP-C is still a matter of 
debate. SP-C becomes functionally relevant when cholesterol is incorporated into surfactant 
mimicking preparations, and the presence of cholesterol modulates SP-C orientation in 
membranes. In addition, SP-C palmitoylation appears as an essential element to sustain the 
dynamic behavior of surfactant membranes and films. Considering the role of cholesterol in rapidly 
adapting surfactant structures to different environmental conditions, and the long-term 
stabilization of the lung associated to the presence of SP-C, it could be suggested that SP-C and 
cholesterol are somehow related in the modulation of surfactant structures to sustain respiratory 
dynamics. Indeed, according to previous evidence, SP-C activity could depend on the palmitoylation 
of its N-terminal segment, which might play a role in defining SP-C-induced effects on membrane 
structure. Taking this into consideration, the general objective of the present Thesis has been the 
characterization in detail of the behavior of surfactant protein SP-C in lung surfactant membrane 
contexts, with particular interest in its potential role to modulate the structure and properties of 
surfactant membranes in the presence of cholesterol. This general objective has been approached 
through the following specific objectives:  
1. Examination of the role of SP-C palmitoylation on SP-C structure and lipid-protein 
interactions in membrane multilayers.  
To identify lipid components specifically involved in defining SP-C configuration in lipid 
bilayers, SP-C orientation has been analyzed in membranes with different composition by 
Attenuated Total Reflectance- Fourier Transformed Infrared spectroscopy (ATR-FTIR). 
(Results. Chapter 1).  
 
2. Analysis of the effect of SP-C on cholesterol dynamics in native surfactant-derived and 
surfactant-mimicking membranes. 
SP-B and SP-C combined activities have been assessed with respect to protein-induced 
membrane reorganization activities and their effect on cholesterol distribution. (Results. 
Chapter 2).  
 
3. Evaluation of the effect of SP-C and cholesterol on membrane structure and lateral phase 
segregation. 
Each lipid component of model surfactant membranes (DPPC, POPC, POPG and cholesterol) 
has been assessed independently to analyze specific SP-C/lipid interactions. The effect of 
SP-C palmitoylation has been also investigated concerning the generation of lipid phase 
segregation. (Results. Chapter 3). 
 
4. Validation of selective SP-C/lipid interactions in membranes concerning SP-
C/phospholipid, SP-C/cholesterol and protein palmitoylation. 
A new method to assess specific protein/lipid interactions based on Thin Layer 
Chromatography (TLC) has been described.  (Results. Chapter 4) 
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5. Study of the effect of SP-C and cholesterol on surfactant homeostasis regarding lipid 
endocytosis and metabolism by alveolar macrophages. (Results. Chapter 5).  
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In the context of lung surfactant bilayers, SP-C adopts a transmembrane configuration with 
its N-terminal segment closely associated with the membrane by cysteine-attached palmitic 
chains (207, 208). However,  SP-C N-terminal segment has proven its ability to perturb and 
interact with membranes regardless of its acylation state (99), suggesting that palmitoylation 
may have other role in SP-C function than merely anchoring the N-terminal segment to the 
membrane.  
Palmitoylation seems to be involved in stabilizing SP-C α-helical conformation (208–210), 
although some studies have suggested that the presence of palmitoylated cysteines does not 
affect protein structure (211, 212). Besides, SP-C is known to promote the formation and 
stabilization of an interconnected multilayer meshwork associated to interfacial films (60, 213), 
a function that is thought to depend on protein palmitoylation. According to surfactant most 
accepted models (42, 54, 214), SP-C palmitic chains would facilitate the establishment of 
monolayer/bilayer and bilayer/bilayer contacts by inserting into lipid structures ahead of those 
in which the α-helical region is embedded. This mechanism could also explain how SP-C 
palmitoylation sustains proper surfactant dynamics, especially in the presence of cholesterol 
(215). Therefore, palmitoylation appears as a key factor modulating SP-C function, although the 
limited experimental information available so far has prevented the elucidation of its specific 
role in SP-C-associated activities. 
The aim of the research summarized in this chapter is to analyze the nature of palmitoylation-
mediated effects on SP-C-lipid interactions in the lung surfactant context, also considering 
effects on protein structure. With this purpose, Attenuated Total Reflectance-Fourier Transform 
Infrared (ATR-FTIR) spectroscopy has been employed, since it allows the simultaneous analysis 
of lipid and protein characteristic absorption bands. One of the  most powerful applications of 
this technique is the study of oriented lipid-protein multilayers, providing information not only 
on the state of lipids and proteins regarding structure and hydration, but also on the average 
configurational orientation of molecules by using polarized infrared light (for a review see (216)). 
This is particularly interesting in the case of surfactant, since the oriented multilayers studied 
here resemble the structure of those stacked membranes occurring naturally as part of the so-
called surfactant reservoir, and thus, our approximation allows the study of SP-C simulating the 
environment close to the air-liquid interface. 
Here we describe the analysis by ATR-FTIR of lipid-protein films containing either native 
palmitoylated SP-C or a recombinant non-palmitoylated SP-C version (rSP-C), in lipid systems 
designed to mimic the different properties of lung surfactant membranes. Our results suggest 
that palmitoylation is involved in defining SP-C configuration in membranes, and also in 
modulating lipid-protein interactions at the polar region of lipid bilayers. Nevertheless, protein 
acylation did not seem to affect protein structure. This information is relevant from a structural 
point of view, considering that SP-C palmitoylation could favor certain protein-lipid interactions 
promoting lipid structures optimized for an efficient surfactant interfacial activity.   
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Protein structure 
To analyze whether protein structure was altered by the lipid environment or palmitoylation, 
the ATR-FTIR spectra of palmitoylated and non-palmitoylated SP-C were obtained in films 
prepared from suspensions of the proteins in different phospholipid mixtures. Membranes 
composed of DPPC/POPC/POPG (50:25:15, w/w/w) were used as a model capturing the main 
features of lung surfactant in terms of the combination of saturated/unsaturated and 
zwitterionic/anionic phospholipid species. The other two lipid systems tested were DPPC/POPC 
(50:40, w/w) and POPC:POPG (75:15, w/w) in order to define the importance of electrostatic 
charge and lipid phase coexistence on protein-lipid interactions, respectively.  
 
Figure 1.1. SP-C and rSPC structure in DPPC/POPC/POPG membranes. ATR-FTIR spectra of SP-C 
and rSP-C reconstituted in DPPC/POPC/POPG (50:25:15, w/w/w) multilayers, at 210C, 250C and 
370C.  Frequency maxima for amide I (1700-1600 cm-1) and amide II (1600-1500 cm-1) bands are 
shown. Differences between the two proteins are illustrated in the subtraction spectra SP-C – 
rSP-C below, with the main difference marked by an arrow. Both spectra were scaled to the 
same intensity for the amide I band (1700-1600 cm-1). 
 
The ATR-FTIR spectra of SP-C and rSP-C inserted into DPPC/POPC/POPG membranes are 
illustrated in Fig. 1.1.  The difference spectrum, ΔSP-C-rSP-C, reveals an apparent shift of the 
amide I contribution of native SP-C with respect to the non-palmitoylated form. Amide I and II 
bands of SP-C and rSP-C appeared centered around 1657 cm-1 and 1543 cm-1, respectively. The 
narrow shape of these bands and their frequencies are consistent with a predominantly α-helical 
structure, as previously described for these proteins (93, 217). Secondary structure 
determinations for the two proteins estimated more than 80% α-helical content with no 
significant differences between them. However, the SP-C – rSP-C difference spectrum revealed 
an upward band deviation in the amide I wavenumbers, which increased in intensity and 
decreased in frequency with temperature. 
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Figure 1.2. Structure of SP-C and rSPC in different lipid environments. (a) ATR-FTIR spectra of 
proteins SP-C and rSP-C reconstituted in DPPC/POPC (50:40, w/w) or POPC/POPG (75:15, w/w) 
membrane multilayers, at 370C. Frequency maxima for amide I (1700-1600 cm-1) and amide II 
(1600-1500 cm-1) bands are shown. ΔSP-C – rSP-C represents the subtraction spectra. (b) 
Subtraction spectra ΔSP-C – rSP-C at 210C (blue), 250C (grey) and 370C (light blue), for each of 
the two lipid compositions. All spectra were scaled to the same intensity. 
 
The amide I contribution in the other two lipid environments assessed, DPPC/POPC and 
POPC/POPG, at three different temperatures is illustrated in Fig. 1.2. The shift in amide I 
wavenumber in palmitoylated vs. non-palmitoylated protein was also apparent in DPPC/POPC 
multilayers but not so much in the purely unsaturated phospholipid films. The consistent finding 
of this feature could be explained by slightly lower vibration frequencies for amides 
corresponding to the palmitoylated protein.  
As it will be discussed later, our results indicate that palmitoylation increased SP-C tilt-angle 
resulting in a more pronounced perturbation on membrane polar region. Thus, palmitoylation 
indirectly promotes water penetration at the membrane surface by influencing protein 
embedment in lipid bilayers. Higher penetration of atmospheric water, and thus higher polarity, 
could result in a reduction of SP-C amide I stretching frequency as a consequence of hydrogen-
bonding (218), an effect consistent with our findings. 
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Lipid-protein interactions 
To assess whether SP-C and rSP-C could perturb the lipid systems studied in a different 
manner, we have monitored the thermotropic profile of phospholipids by following the shift of 
the frequency associated with CH2 stretching vibrations. These bands are sensitive to the lipid 
chain trans/gauche isomerizations leading to temperature-dependent frequency changes. An 
increase in temperature generates vibrational bands towards higher wavenumbers, which can 
be used to compare the thermotropic profiles of phospholipid layers in the absence or presence 
of either palmitoylated or non-palmitoylated protein.  
 
Figure 1.3. Effect of SP-C and rSP-C on the thermotropic profile of different membrane multilayer 
systems. Thermotropic profiles of the three different lipid systems assessed, in the absence or 
in the presence of proteins SP-C or rSP-C, as monitored by the position of the CH2-asymmetric 
vibration absorption band. The profiles show the effect attributable to protein insertion into the 
membrane for each temperature studied. 
 
The thermotropic behavior of the three lipid systems studied, in the absence and in the 
presence of the native or the recombinant SP-C variants, is shown in Fig. 1.3. In none of the lipid 
compositions studied there is a clear effect attributable to the protein insertion into membranes 
in the range of temperatures analyzed. Methylene asymmetric stretching frequencies (2900-
2950 cm-1) overlap for samples containing or not SP-C or rSP-C at the temperatures tested, 
suggesting that neither lipid composition nor palmitoylation are critical factors to modulate 
lipid-protein interactions at the multilayer membrane films, at least as sensed by acyl chain 
vibrations under the conditions used for this study. 
To gain further insight into the characterization of SP-C-lipid interactions, we focused on the 
differences observed in the polar region of lipid spectra. Phosphate-associated vibration bands 
can provide information about superficial interactions in the membrane that modulate both 
their intensity and frequency (219). Fig. 1.4a illustrates the effect of the palmitoylated and non-
palmitoylated SP-C on the phosphate-associated vibration bands for the three different lipid 
systems studied. The largest differences are observed in the phosphate asymmetric and 
symmetric stretching region in the presence of the palmitoylated SP-C protein compared to non-
palmitoylated SP-C. For the surfactant mimicking synthetic mixture, DPPC/POPC/POPG 50:25:15 
w/w/w, the differences are mainly observed on peak intensity, which decreases when the 
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incorporated protein is non-palmitoylated SP-C. For the other two lipid systems, differences are 
also more conspicuous in the presence of the palmitoylated protein, although there are also 
some variations on the frequency of the vibrations. These alterations could be associated with 
a different extent of perturbation of the headgroup region of the membrane multilayers by the 
N-terminal segment of the protein.  
 
Figure 1.4. Effect of SP-C on phosphate vibrations in different lipid systems. (a) Spectra 
corresponding to the phosphate vibration region (1400-900 cm-1) are shown for the three 
different lipid systems assessed, in the absence or in the presence of proteins SP-C or rSP-C, at 
37oC. (b) Subtraction spectra of pure lipid – lipid-SP-C (black line) and lipid – lipid/rSP-C (dashed 
line). The main difference, introduced mainly by palmitoylated SP-C, is marked with a black 
arrow. 
 
Molecular orientation  
The molecular orientation of SP-C and rSP-C in the three lipid systems studied, as estimated 
by the dichroic absorption ratio of polarized IR, is summarized in Table 4.1. Different effects can 
be observed on protein tilting depending on temperature, palmitoylation or lipid composition. 
A slight increase in the tilt angle was found at higher temperatures for both proteins and all 
compositions tested, consistent with the assumption that disordering on lipid membranes at 
higher temperatures decreases membrane thickness, and thus results in hydrophobic mismatch 
that is resolved by the tilting of the helix.  
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Table 4.1. Tilting angles for SP-C and rSP-C proteins in the different lipid environments.  
 
 
On the other hand, palmitoylation seems to induce a consistent trend towards higher protein 
tilt angles in most of the cases analyzed. Palmitoylation-induced anchoring of SP-C to the 
membrane may induce a deeper embedment of the N-terminal end of the protein into the polar 
region of the bilayer, thus pulling out the helix that would form a wider angle with respect to 
the membrane normal. This is consistent with the fact that depalmitoylation induced a more 
perpendicular orientation of the protein when it is reconstituted in lipid bilayers as reviewed in 
(220). Nevertheless, the effect of palmitoylation cannot be analyzed independently of lipid 
composition. POPG-containing systems induced a more tilted protein configuration for both SP-
C and rSP-C at 21oC than estimated for the purely zwitterionic system. This could indicate again 
a closer association of the N-terminal segment with the membrane, in this case due to 
electrostatic interactions, as it has been previously described (99). The positively charged N-
terminal end of both proteins would be then interacting with the negative charge of POPG 
forcing again the helix to adopt a less perpendicular orientation.   
 
Palmitoylation is thought to be one of the main features associated with the functional 
activity of surfactant protein SP-C (209, 215), contributing to define the optimal conditions for 
the re-spreading ability of lung surfactant during inspiration (221, 222). In the current study, we 
have studied the structure, lipid-protein interactions and orientation of palmitoylated and non-
palmitoylated versions of SP-C in partly dehydrated multilayer films, which could somehow 
mimic the organization of lipids and proteins at the multilayer reservoir of surfactant. Our results 
suggest that palmitoylation is important to modulate the proper configuration of the protein in 
these lung surfactant-mimicking multilayers, however, how this configuration could be related 
to the function of the protein has to be analyzed carefully. 
In terms of protein structure, several studies have previously addressed the effect of SP-C 
palmitoylation with controversial results. Some of them have suggested that depalmitoylation 
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induce a loss of alpha helical structure increasing the chance of protein aggregation (208–210), 
whereas others have pointed out that lack of acylation does not alter protein α-helical structure 
and even may favor it, at least with respect to the length of the helical segment (211, 212). SP-
C has a strong tendency to aggregate even in non-polar solvents (223), particularly when it is 
free of lipids. For this reason, some of the chemical treatments used in those previous studies 
to add or remove the acyl chains could be the indirect or direct cause of the alteration in the 
protein structure, rather than the absence or presence of the chains themselves. Our study 
suggests that palmitoylation does not affect much the secondary structure of the protein as the 
infrared difference spectrum do not show large variations in amide I and II line shape and 
frequencies between SP-C and rSP-C proteins in the different lipid systems analyzed, which is 
consistent with the results found in a previous study (211). It could well be that the structure of 
the protein is particularly stabilized at its maximal α-helical conformation in the partly 
dehydrated, possibly highly packed, multilayered films, and this could be the reason why our 
estimations of that secondary structure yield at least 80% α–helical content, for the two proteins 
in all the lipid environments. However, a subtle but consistent difference was revealed as a shift 
of the α-helical wavenumbers from the difference spectra in the amide I region of palmitoylated 
and non-palmitoylated SP-C. Stretching vibrations are influenced by the polarity of the 
environment of any defined IR chromophore. Thus, differences in the presence of water 
molecules that could form hydrogen bonds with our molecule of study could explain such a 
decrease of the frequency of stretching vibrations. Taking into account that the energy of amide 
I band comes principally from vibrations of the C=O bond (224), a change of environmental 
polarity could be behind the shift in the vibration frequency.  
Protein-promoted perturbations may be also important to facilitate intermembrane 
topological connections and efficient transfer of surface-active lipid molecules through the 
whole surface film. From our results, we speculate that palmitoylation could generate a deeper 
insertion of the N-terminal segment of SP-C into the headgroup region of the lipid layers, 
producing larger packing defects and a local polarity increase in the membrane. In this sense, 
and considering that palmitoylated SP-C is also on average more tilted into membranes than the 
non-palmitoylated form, the more external N-terminal end of the α-helix would sense this 
change of polarity varying its frequency of vibration to lower wavenumbers. This effect is 
particularly observed when the lipid composition includes saturated phospholipids, suggesting 
a modulating effect of membrane composition. SP-C has been found to locate preferentially into 
liquid-disordered phases in membranes (23) and liquid-expanded regions in interfacial films (27, 
225), but accumulating at the boundaries between ordered and disordered regions in 
membranes and monolayers exhibiting phase coexistence (25, 226). We propose that SP-C, or 
at least its palmitoylated N-terminal segment, could be located at the edge of the domains 
formed by DPPC, where SP-C-induced perturbation could be maximal. In our experiments the 
difference in the amide I spectra of palmitoylated and non-palmitoylated SP-C increase while 
approaching to 37oC in those systems whose melting temperature is in the range of 
physiological temperatures. With increasing temperature, membranes reach a higher dynamic 
character, including more frequent and larger molecular fluctuations, deeper water penetration 
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and a possibly larger difference in water accessibility of the N-terminal end of SP-C helix. If 
palmitoylation were at least in part responsible for the association of SP-C with the boundaries 
of DPPC-enriched ordered lipid domains, differences in perturbations induced between 
palmitoylated and non-palmitoylated SP-C would be further accentuated, as observed in our 
experiments.  
The stronger effect of the palmitoylated protein to perturb the contribution of phosphates 
to the IR spectra would be consistent with changes promoted by the acylated segment of the 
protein on the organization, packing and polarity of the headgroup region of the lipid/protein 
multilayers. This is also consistent with the thermotropic profiles registered for these samples, 
which suggest that the effect of the proteins (both palmitoylated and non-palmitoylated) is 
limited as sensed by the acyl chains. Altogether these results indicate that the effect of 
palmitoylation is somehow focused to that headgroup level, in agreement with previous studies 
such as the one by Morrow et al (100).  
The study of SP-C orientation in membranes has been addressed before (122, 207, 208). Most 
of these studies have indicated an orientation for the alpha helix almost parallel to the acyl 
chains. In the present work we have observed differences on protein tilting depending on the 
lipid system studied and palmitoylation state. Discrepancies between previous values and those 
obtained in the current study could come from the assumption of an order parameter (S) of 1 
for our determinations, which was compatible with our results and theoretical values. 
Therefore, the angles discussed here correspond to maximum tilts, although it is not possible to 
discard the existence of disorder sources that could shift the values to more perpendicular 
orientations. 
Temperature seemed to have some effect on protein orientation, increasing slightly tilt 
angles toward higher values. This effect could be originated in a more pronounced hydrophobic 
mismatch when membrane thickness decreases at higher temperature, particularly when values 
above the melting temperature are reached and the phase transition occurs, as it may be the 
case for the lipid mixtures containing DPPC.  
The results presented here have shown that palmitoylated SP-C may alter the polar region of 
the membranes to larger extent than rSP-C. Consequently, for the acylated protein, the α-helix 
may be suffering the effect of a more polar environment caused by a deeper embedment of the 
N-terminal segment into the headgroup region of the phospholipid layers. These observations 
are consistent with our findings on protein orientation. When SP-C is inserted into multilayered 
films made of DPPC/POPC/POPG, palmitoylation seems to roughly induce a 5o more 
pronounced tilting angle with respect to the membrane normal. We are aware that the 
magnitude of this increase in the tilting angle is close to the limit of significance defined by the 
calculation method, but we still see it as relevant considering that in most experiments this trend 
is maintained in the same direction. Such palmitoylation-promoted increase on helical tilting is 
not so clear in the system containing no DPPC, suggesting that for palmitoylation to cause a 
more pronounced tilt a context of thicker membranes or membranes sustaining phase 
coexistence could be required.  It is important to mention that for systems containing POPG, the 
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calculated tilt angles were higher for both proteins when compared to those in the purely 
zwitterionic DPPC/POPC system, supporting the idea that electrostatic interactions between the 
N-terminal segment of the proteins and the anionic phospholipid also contribute to restrict SP-
C mobility and modulate its orientation.  
 
Figure 1.5. Model for the role of palmitoylation of SP-C and the presence of anionic 
phospholipids in lipid bilayers and multilayers. 
 
Finally, one has to consider the particular context imposed by the insertion of the protein 
into the partly dehydrated multilayer phospholipid films studied here. The cartoon in Fig. 1.5 
presents a model illustrating how selective protein-lipid interactions and differential tilting could 
define the configuration of SP-C in single membrane and in multilayer membrane arrangements. 
That configuration could be relevant for the efficient generation of the surface-associated 
surfactant reservoir, in which palmitoylation-promoted intermembrane contacts might facilitate 
re-spreading of surfactant membranes during inspiration. 
As a whole, the results obtained in this chapter allow to delimit the effects of protein 
palmitoylation to the membrane polar region, barely affecting lipid hydrophobic core as noticed 
by acyl chain motion over a range of temperatures. Palmitoylation has also been shown to be 
important to maintain a close association of SP-C N-terminal segment with the membrane, 
affecting protein tilting and polarity. Our results suggest that, together with SP-C palmitoylation, 
lipid composition is involved in modulating SP-C orientation in bilayers, promoting certain 
configurations that could be related to defined surfactant structures optimized for an efficient 
interfacial activity.  
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Cholesterol is a controversial molecule in the context of lung surfactant function. Although its 
presence in surfactant complexes has been extensively demonstrated, little is known about its 
origin or regulation (129, 227).  Cholesterol defines the complex lateral structure of surfactant 
membranes and monolayers, including the segregation into ordered (Lo) and disordered (Ld) 
fluid phases (23). This was confirmed by cholesterol depletion experiments, which revealed a 
markedly different phase segregation upon cholesterol removal by the solubilizing agent 
methyl-β-cyclodextrin (mβCD) (23).  Proteins SP-B and SP-C do not appear to contribute to 
lateral phase segregation (23) but rather to the formation of highly cohesive multilayer 
assemblies (228); whereas cholesterol has been shown to be essential especially at the edge of 
physiological temperatures (23, 227).  
From a functional point of view, the incorporation of cholesterol above a certain threshold has 
been reported to be deleterious for the proper surface activity of clinical surfactant preparations 
(199), and abnormally high cholesterol levels are associated to surfactant dysfunction in some 
respiratory disorders (203, 229). However, it has also been shown that cholesterol improves the 
spreading capability of model surfactant lipids (116) and as mentioned before, cholesterol is 
critical to maintain surfactant lateral structure especially at physiological temperatures (23). 
These contradictory findings suggest that the role of cholesterol is subtly related to the 
architecture and properties of lung surfactant at the air-water interface, and that it could 
critically depend on the presence of other surfactant components and/or structures as 
assembled in native complexes.  
To sustain the presence of cholesterol in surfactant without functional impairment, protein SP-
C has been suggested as an essential element (120, 121). Besides, SP-C has been shown to 
modulate cholesterol miscibility in surfactant-mimicking membranes (120), whereas protein 
configuration in bilayers is affected by the presence of cholesterol in a way that suggests it is not 
merely an consequence of the general effects derived from cholesterol incorporation into lipid 
bilayers (122). SP-C might therefore be an important factor regarding cholesterol modulation in 
the surfactant context, although the molecular mechanisms connecting SP-C and cholesterol 
remain unclear.  
The aim of the work presented in this chapter was to obtain further information about the role 
of the hydrophobic surfactant proteins, and particularly SP-C, in cholesterol distribution in 
surfactant membranes. With that purpose, a recently developed fluorescent sterol-partitioning 
assay was employed (230). With this technique, the partitioning of a fluorescent analogue of 
cholesterol (cholesta-5,7,9(11)-trien-3-β-ol, CTL) between membranes and a solubilizing agent, 
such as cyclodextrin, can be followed by measuring the anisotropy of the fluorophore. These 
measurements yield the determination of a partition coefficient, Kx, which indicates the affinity 
of the sterol for a given membrane. Thus, using the CTL partitioning assay, model and native 
surfactant membranes were assessed to detect whether the proteins SP-C and/or SP-B are 
involved in regulating cholesterol distribution in the surfactant context.   
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CTL partitioning between mβCD and Lung Surfactant-derived Membranes 
As an indirect measurement of CTL distribution in lung surfactant membranes, we measured CTL 
affinity for lung surfactant-derived membranes using large unilamellar vesicles (LUVs) made of 
the most physiologically relevant lipid mixtures. The organic extract (OE) of surfactant 
constituted the most representative surfactant sample, since it contained all the hydrophobic 
components of surfactant in their native proportion. These components were first separated 
into protein (Prot), phospholipid (PL) and neutral lipid fraction (N) and later recombined for 
testing by the CTL partitioning assay. In this assay, the concentration of CTL can be calculated 
from its anisotropy for each sample (see Materials and Methods). Those values are plotted 
against the concentration of mβCD, allowing the determination of the partitioning coefficient 
into membranes, Kx, as observed in Fig. 2.1.  
 
Figure 2.1. Representative fittings of calculated CTL concentrations for surfactant-derived 
membranes to equation (2) allows the calculation of Kx (see Materials and Methods). 
Experimental data points are represented by empty circles and the fitting, by a solid line. 
 
Fig. 2.2a shows CTL anisotropy for each combination as a function of the concentration of mβCD, 
and Fig.5.2b, the corresponding partitioning coefficient Kx. Higher anisotropy values indicate less 
motion for CTL, meaning it is in a more rigid environment, whereas higher Kx values indicate 
higher affinity of CTL for that particular membrane.  For no mβCD and every mβCD concentration 
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added, the anisotropy achieved in the presence of the hydrophobic surfactant proteins (PL+Prot) 
was below the anisotropy reached for samples containing only surfactant phospholipids (PL). 
This tendency was maintained when the neutral lipid fraction was added (PL+Prot+N versus 
PL+N). Lastly, the organic extract (OE) behaved similarly to those samples containing all the 
components of surfactant (PL+Prot+N) as expected. Thus, the anisotropy data suggest an 
alteration on CTL distribution to a more fluid environment (lower anisotropy) depending on the 
presence of the proteins.  
 
Figure 2.2. CTL anisotropy and partitioning into lung surfactant-derived membranes 
incorporating surfactant phospholipids (PL) to which either surfactant neutral lipid fraction 
(PL+N), protein fraction (PL+Prot) or both (PL+Prot+N) was added. OE represents the organic 
extract of native lung surfactant membranes. (a) CTL anisotropy is shown as a function of mβCD 
concentration at 37oC. (b) The partition coefficients are computed from the CTL anisotropy 
values for each lung surfactant combination. Average ± s.d. of n=3, *p < 0.05, **p < 0.01, ***p 
<0.001. 
 
A significant decrease in Kx values was also observed in the presence of the proteins (PL+Prot 
versus PL and PL+Prot+N versus PL+N), suggesting that the proteins increase cholesterol 
susceptibility to be removed from the membrane by mβCD (Fig. 2.2b).  
From these results, it is clear that in the presence of surfactant proteins, CTL acquires increased 
motion and a decreased affinity for lung surfactant-derived membranes. SP-B and SP-C have 
been widely reported to perturb lipid membranes (85, 231, 232), and their effect on cholesterol-
induced membrane phases has been also assessed (23, 233). The effect we observed could be 
explained by an indirect consequence of the membrane perturbation induced by SP-B and SP-C, 
or by a direct alteration of the sterol partitioning mediated by the proteins. 
Regarding the effect of the neutral lipid fraction, slightly higher anisotropy values were found 
when it was included in the vesicle composition (PL+N versus PL) even in the presence of the 
proteins (PL+Prot+N versus PL+Prot), especially for mβCD  concentrations beyond 0.15 mM (Fig 
5.2a). This is reflected by the observed increase in Kx for samples including the neutral lipid 
fraction (PL+N versus PL) (Fig. 2.2b). As can be deduced from the graph in Fig. 2.1a, the same 
thing occurred when Kx was calculated in the presence of the proteins (PL+Prot+N versus 
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PL+Prot). It is important to note that CTL and cholesterol compete for mβCD, and that could be 
the reason for these apparently higher Kx values.   
Cholesterol apparently partitions into ordered domains in lung surfactant membranes at 
physiological temperatures (23). We assumed that CTL partitions analogously as cholesterol in 
different lipid environments within the membrane given previous evidence (234, 235), although 
its lateral distribution is difficult to predict in these complex membranes. To better picture the 
effect of proteins or cholesterol (N) addition to each lipid system regarding CTL motions, we 
analyzed CTL anisotropy in the absence of cyclodextrin (Fig. 2.3a). Again, our results indicate 
that the effect of the proteins is to increase CTL motion, as detected by the decrease in 
anisotropy (PL+Prot vs PL, Fig 5.3a), which could be accomplished by favoring CTL distribution 
to a more fluid environment. The addition of neutral lipids (PL+N) did not significantly change 
the apparent anisotropy of CTL in the pure lipid system (PL), as seen from the anisotropy data 
(Fig. 2.3). This could be interpreted as indicating that CTL environment was not disturbed by 
solely cholesterol addition. In membranes perturbed by the action of SP-B and SP-C (PL+Prot), 
the presence of cholesterol partially counteracted the decrease on CTL anisotropy induced by 
the proteins (PL+Prot+N). A possible explanation for this could be a cholesterol-induced 
membrane reorganization, which could modify proteins’ density and distribution. In this sense, 
the motion of CTL would be more restricted, as indicated by its higher anisotropy.   
   
Figure 2.3. CTL and DPH-PC anisotropy in LS-derived membranes. Anisotropy measurements are 
shown for CTL (left panel) and DPH-PC (right panel) in membranes prepared from each indicated 
combination of LS fractions including LS organic extract, in the absence of mβCD, and measured 
at 37oC.  Average ± s.d. of n=3, *p < 0.05, **p < 0.01, ***p <0.001. 
To determine whether the effect on CTL anisotropy was mediated directly by the proteins, the 
anisotropy of another fluorescent lipid probe, DPH-PC, was measured in the same samples. The 
measurements were conducted at 37oC, a temperature at the end of native surfactant phase 
transition (23, 236), where surfactant membranes are extremely dynamic. DPH-PC partitions 
preferentially into liquid-disordered phases (237), where both SP-B and SP-C are also 
preferentially located, while CTL would be likely distributed into Lo domains. It is expected that 
a non-selective perturbation of the membrane by the proteins would affect both probes in a 
similar magnitude, and therefore, the changes observed for CTL anisotropy could be mirrored 
by the effects on DPH-PC. Fig. 2.3 compares the anisotropy of DPH-PC with that of CTL in the 
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same samples. We observed that there were no significant differences in the anisotropy of DPH-
PC in lipid systems alone compared with the same combinations in the presence of the proteins 
(PL versus PL+Prot, PL+N versus PL+Prot+N). However, as described above, the presence of the 
proteins caused a significant decrease in CTL anisotropy. This supports the idea that the 
presence of SP-B and SP-C alters the behavior of CTL in a yet unknown specific manner. Thus, 
we can conclude that the combined action of SP-B and SP-C results in an increase in CTL motion 
and a decrease in CTL affinity for lung surfactant-derived membranes.  
 
Effect of SP-C and SP-B on CTL distribution 
Once we confirmed that the hydrophobic protein fraction could be directly responsible for the 
alteration in CTL motion and its affinity for lung surfactant-derived membranes, the effect of SP-
C on CTL distribution became of special interest because of previous evidence connecting SP-C 
with the structure and activity of surfactant preparations in the presence of cholesterol (120–
122). To assess the specific action of SP-C on CTL affinity for membranes, we tested 200 nm LUVs 
of different compositions in the absence or presence of equimolar proportions of SP-C and CTL. 
Fig. 2.4 summarizes the effect of SP-C on CTL anisotropy in the pure lipid system (in the absence 
of mβCD) and Kx for two of the lipid systems analyzed.  
 
Figure 2.4. CTL anisotropy and partitioning into SP-C-containing membranes.(a) Comparison of 
CTL anisotropy in 200 nm vesicles made of POPC or DPPC/POPC/POPG (50:25:15 w/w/w), in the 
absence (control) or presence of SP-C, with no mβCD in the medium. (b) Kx calculated from the 
anisotropy values applied to the model explained in Methods. Average ± s.d. of n=3, *p < 0.05, 
**p < 0.01, ***p <0.001. 
The protein caused a substantial reduction in CTL anisotropy for POPC membranes, suggesting 
again an increase in CTL motion. No significant differences were found for CTL anisotropy in the 
surfactant-mimicking mixture DPPC/POPC/POPG (50:25:15 w/w/w) in the presence of SP-C. A 
significant decrease in Kx for both POPC and DPPC/POPC/POPG membranes was observed, 
suggesting that CTL had a reduced affinity for the two types of membranes in the presence of 
SP-C.  
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It was previously reported that SP-C could cause membrane blebbing in giant unilamellar POPC 
vesicles (GUVs) (85).  The increase in the dynamic character of those vesicles caused by the 
protein, with membranes showing more frequent undulations of higher amplitude, occasionally 
resulted in the formation of smaller liposomes. Taking into account this previous observation, 
we checked the size of the vesicles including SP-C by dynamic light scattering (DLS). Remarkably, 
the diameters obtained for the population of liposomes were greatly reduced compared to the 
200 nm pore vesicles that were originally formed by extrusion (Fig. 2.5).  This SP-C-induced 
fragmenting effect was also confirmed by cryo-electron microscopy (Cryo-EM). A high 
proportion of very small and highly curved vesicles was observed in the presence of the protein 
(Fig. 2.6a) whereas vesicles with no protein showed a size distribution centered around 130 nm, 
which followed the typical Gaussian distribution obtained upon vesicle extrusion (Fig. 2.6b). This 
effect was comparable in the two lipid systems studied. 
 
Figure 2.5. Effect of surfactant proteins on the size of lipid vesicles as measured by DLS. Right 
panel displays a representative DLS measurement from POPC and POPC+SP-C LUVs extruded 
through 200 nm pores. Left panel shows a table summarizing DLS measurements for vesicles 
with different compositions. Values are presented as means ± s.d. of n=3. 
 
In an attempt to prevent the breaking effect of SP-C, we assayed stiffer membranes. 
Interestingly, POPC/PSM (80:20 mol/mol) vesicles showed the same fragmentation as those 
prepared from POPC and 30 mol% cholesterol (Fig. 2.5). These results suggest that, under the 
conditions tested, the high ability of SP-C to fragment large membranes into small nanovesicles 
is independent on the lipid composition.  
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Figure 2.6. Effect of the presence of SP-C on the fragmentation of LUVs as observed by Cryo-EM. 
(a) Representative Cryo-EM micrographs illustrating differences in vesicle sizes in samples of 
LUVs reconstituted in the absence (left panels) or presence (right panels) of SP-C. Scale bars are 
100nm. (b) Size distribution of vesicles obtained by quantification of the diameter of the vesicles 
in the absence (left panel) or presence (lower panel) of SP-C. n= 389 for pure lipid LUVs and n= 
422 for SP-C-containing LUVs. 
A recombinant version of SP-C lacking the two palmitic chains at the N-terminal segment was 
also incorporated into POPC vesicles. Preliminary results showed that this recombinant version 
of the protein also produced the conversion of large membranes into small vesicles (~40 nm 
diameter). Consequently, it seems that the fission activity of SP-C was independent of the 
palmitoylation state.  
The effect of SP-B on membranes was different to that observed for SP-C. DLS measurements 
indicated an extremely high polydispersity index for the samples. For this reason, although CTL 
anisotropy seemed to be reduced when compared to pure POPC membranes (from 0.28 to 0.24 
both at 23oC and 37oC in the absence of cyclodextrin), data could not be fitted to obtain a Kx 
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within an acceptable error caused by sample scattering. This result is consistent with previous 
studies that reported a fusogenic activity of SP-B (79, 238), which could generate different 
vesicle entities in the sample.  
Lastly, we wanted to analyze the effect of the simultaneous presence of the two hydrophobic 
surfactant proteins, SP-B and SP-C. The hydrophobic protein fraction isolated from lung 
surfactant, includes the precise relative proportion SP-B/SP-C encountered in native surfactant 
membranes (~1:1 by weight). For this reason, samples including this fraction were assayed. The 
simultaneous presence of the two proteins reduced both the anisotropy and the calculated Kx 
(Fig. 2.7). However, the size of these vesicles was maintained at the same diameter of the 
extrusion membrane pores, as confirmed by DLS measurements (Fig. 2.5). This indicates that the 
fission/fusion activities of both proteins are canceled out when they are together.  
 
Figure 2.7. CTL anisotropy and partitioning into DPPC/POPC/POPG membranes incorporating 
the native fraction of surfactant hydrophobic proteins (+SP-B/C). (a) CTL anisotropy at 37oC of 
vesicles made of DPPC/POPC/POPG. (b) Partition coefficients calculated for the two lipid systems 
at 23oC and 37oC. Error bars represent the standard deviation of three independent 
experiments. 
 
There is evidence supporting that in highly curved vesicles, the looser packing of lipids increases 
cholesterol exchange from SUVs towards other SUVs or LUVs (239). Thus, it is very likely that 
CTL experiences a similar effect; however, the influence of membrane curvature in CTL 
partitioning has not been reported. Taking this into account, we cannot discard the possibility 
that the observed effect of SP-C on CTL partitioning could be due to the formation of highly 
curved membranes. For this reason, we also analyzed the influence of membrane curvature in 
CTL partitioning.     
 
Effect of membrane curvature in CTL partitioning 
To gain insights into how cholesterol distribution is affected by membrane curvature, we 
performed a CTL partitioning assay using vesicles of increasing diameters (30, 50, 100, 200 nm), 
and two different lipid systems. As shown in Fig. 2.8a, the lowest anisotropy values were found 
for the smallest vesicles. This was observed for the two lipid systems tested at the temperatures 
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measured. The Kx values also correlated with the anisotropy decrease for the more curved 
membranes (Fig. 2.8b). A more pronounced membrane curvature seemed to facilitate CTL 
extraction from the membrane by mβCD. This might be explained by an increase in CTL exposure 
to the media, which would improve its accessibility to mβCD, or by a weakening in CTL 
interactions with surrounding lipids, resulting in higher off-rates. Thus, it is possible that the 
conformational freedom of this molecule is intrinsically increased in more curved membrane 
environments.  
Taken together, our results suggest that membrane curvature significantly alters the distribution 
and diffusion of CTL in model membranes. This finding could be extrapolated to cholesterol, with 
important physiological consequences. 
Figure 2.8. CTL anisotropy and partition coefficient as a function of membrane curvature. (a) CTL 
anisotropy in POPC membrane vesicles of increasing diameters measured at 23oC. (b) Partition 
coefficients calculated for the two lipid systems in vesicles of different diameters. Actual vesicle 
size values are presented as means (n=3). Standard deviations were 5.8, 6.9, 18.4 and 29.7 
respectively. 
 
In this chapter, we used a cholesterol fluorescent analog, CTL, to examine how the hydrophobic 
proteins of lung surfactant influence cholesterol distribution in membranes. According to our 
results, the hydrophobic proteins SP-B and SP-C increased CTL mobility in surfactant-derived 
membranes as detected by a decrease in anisotropy, which suggests a protein-induced change 
in CTL distribution toward more fluid phases. We are aware that the application of the CTL 
mβCD-partitioning model to membranes with phase coexistence might be controversial if CTL is 
segregated differently between phases.  However, we think that our observation that proteins 
SP-B and SP-C alter mobility and partitioning of CTL is consistent because: 1) it was previously 
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reported that the proteins do not alter the lateral structure of surfactant membranes (23), and 
2) the proteins caused a consistent reduction in anisotropy and CTL partition coefficient both in 
simple membrane systems and in the complex lung surfactant-derived membranes, which could 
exhibit marginal segregation of ordered and disordered phases.  
We have observed that SP-B and SP-C are efficient in facilitating the CTL mobility within the 
membrane, a property that was also exhibited for other lipid probes such as spin-labelled lipids 
(231).  The increase in motion for CTL seems to be related to lower Kx values, reflecting a higher 
susceptibility of CTL to be removed from the membrane. This increment in mobility could be 
particularly important at the interfacial film, where cholesterol has to be squeezed-out during 
compression for the film to reach the minimum tension required to sustain breathing (58, 59). 
The protein-promoted increase in CTL motion and diminished affinity for the membrane support 
the notion that SP-B and SP-C play a major role in modulating the dynamic properties of 
surfactant lipids. Given the similarities between CTL and cholesterol (234), our findings could be 
extrapolated to the behavior of cholesterol in the presence of the proteins. 
Considering vesicle size, SP-C presence leaded to vesicle fragmentation, whereas SP-B 
incorporation resulted in the generation of a diverse population of vesicles with different 
diameters, an effect consistent with SP-B-induced membrane fusion (79, 238). However, when 
both proteins were included together in the native hydrophobic protein fraction, vesicle 
behavior differed greatly to that of each independent protein, resulting in vesicles that were 
stable in size. This study confirms that SP-B and SP-C have a carefully balanced combined action 
that can be relevant in the regulation of surfactant dynamic structure.  
In the absence of any surfactant protein, we observed that in small and highly curved vesicles, 
CTL anisotropy was decreased and the partitioning towards cyclodextrin was favored (reduced 
Kx) when compared to larger vesicles. The SP-C-fragmenting effect leaded to the formation of 
very small and highly curved vesicles, also resulting in lower anisotropy and Kx values. These data 
suggests that CTL formed part of the SP-C-generated vesicles, and thus, a possible mechanism 
guiding the selective CTL mobilization observed here might be SP-C-induced membrane 
curvature.  
At a molecular level, the effect of SP-C to promote surfactant membrane curvature, and 
ultimately membrane fission, should be related with the simple but particular structure of this 
lipopeptide. Here, we observed a membrane-fragmenting effect that seems to be independent 
of the lipid composition or palmitoylation state of SP-C.  
In Chapter 1, we have observed that both palmitoylated and non-palmitoylated SP-C forms are 
tilted in membranes. It has also been proposed that SP-C contains a dimerization motif (212, 
240, 241), and there is some evidence supporting the importance of SP-C oligomerization along 
intracellular pathways of SP-C sorting and trafficking (149). The dimerization of SP-C through its 
AxxxG motif at its C-terminal segment could generate a dimer with a conical configuration as 
illustrated in Fig. 2.9, which is consistent with the findings for SP-C tilting.  
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Transmembrane proteins with conical shape have been shown to generate membrane stress 
that can be relieved upon induction of curvature (242). Such a process would be consistent with 
our results for SP-C and the non-palmitoylated recombinant version, which share the same rigid 
α-helical structure supported by an unusual and highly conserved polyVal-like sequence (243). 
That particular rigidity might be required to force changes in membrane curvature, explaining 
why an α-helical protein such as SP-C is constituted by amino acids prone to generate β–sheet 
structures.  
It was previously proposed that the N-terminal segment of SP-C is also able to promote protein-
protein interactions (99, 244), which could progressively induce the accumulation of SP-C at high 
densities, an increase in curvature, and ultimately the segregation of small fissioned vesicles. 
The invariant size of small vesicles induced by SP-C in all the lipid systems assayed in this work 
could be a mere consequence of the geometry imposed by protein-lipid segregation. 
Furthermore, our results support that CTL/cholesterol formed part of these SP-C-promoted 
highly curved structures. This could be the basis for a selective refinement of surfactant; 
however, the functional or regulatory role played by SP-C in this process remains to be explored.  
Here, we observed that when SP-B is present in membranes, the SP-C membrane fragmentation 
activity was no longer detected, at least with the same efficiency. This could be explained by 
differences in membrane curvature. The effects of SP-B and SP-C (fusion and budding 
respectively) would involve the concurrence of opposite curvatures, which would balance out in 
the membrane. SP-B may therefore counteract the SP-C effect, such that an increase in SP-C 
levels could be needed, at least locally, to achieve the same behavior as observed when no SP-
B is present. Alternatively, it could be possible that a direct SP-B/SP-C interaction is required to 
prevent fusion/fission activities, a possibility that should be investigated. 
In this study, we used an amount of SP-C that is beyond its natural abundance in surfactant. On 
average, SP-C represents 1 wt% of surfactant mass. However, SP-C is not distributed uniformly 
along the lung surfactant structure. SP-C has been shown to be located at the boundaries of 
liquid-ordered regions (25) and liquid-condensed phases in DPPC monolayers (105, 226), 
although it is also present throughout the liquid-disordered and liquid-expanded phases (23, 
105). Our experimental conditions would therefore resemble what happens in membrane 
regions where SP-C is locally confined. In such situation, the association of several dimers could 
end up with the formation of highly curved structures, which might bud from the membranes 
or interfacial films with different consequences (Fig. 2.9). A possible trigger for this local increase 
in SP-C levels is the compression of the interfacial film during exhalation. In this scenario, SP-C 
could be transiently concentrated until it becomes excluded from the monolayer, when it would 
transfer either to the bilayers forming part of the surfactant reservoir or to the subphase, where 
small SP-C-containing vesicles would be prone to recapture by pneumocytes or macrophages. 
The ability of SP-C to mobilize lipids out from the compressed interfaces has been reported 
(105). 
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Figure 2.9. Model of the potential mechanism of membrane curvature and budding induced by 
SP-C in lipid bilayers. 
 
Our results also highlight the importance of membrane curvature for CTL, and by extension, 
cholesterol distribution and diffusion. This has implications that go beyond the lung surfactant 
system, being especially relevant for membrane trafficking and mechanical events in which 
marked changes in curvature take place, such as those occurring during membrane fission and 
fusion (endo- and exocytosis), lamellipodia formation and cell migration. In this sense, 
membrane curvature may constitute a factor that is capable of modulating cholesterol 
distribution and mobilization, and consequently membrane viscoelastic behavior, with potential 
significance for the different mechanisms that regulate crucial cell processes.  
Taken altogether, our data suggest that in the lung surfactant context, the combined action of 
SP-B and SP-C appears to facilitate cholesterol dynamics through protein-mediated changes in 
membrane curvature. Sterol partition was observed to be sensitive to the bending of bilayers, 
indicating that the effect of SP-C to mobilize cholesterol could be indirectly associated with SP-
C-mediated membrane remodeling. Our results suggest a potential role for SP-C in generating 
small surfactant structures that may participate in cholesterol mobilization and pulmonary 
surfactant homeostasis at the alveolar interfaces. 
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“Divide and conquer: Phase segregation in Lung Surfactant 
is modulated by Surfactant Protein SP-C and Cholesterol” 
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The role of cholesterol in lung surfactant has been addressed in previous sections. Both 
beneficial and impairing effects have been attributed to its presence regarding surfactant 
function (116, 117, 120, 121), in which SP-C appears as a modulating molecule (120, 215, 245). 
Cholesterol presence defines surfactant lateral structure, and as previously discussed, 
hydrophobic surfactant proteins have been excluded from playing a role in surfactant phase 
segregation (23). However, there is evidence suggesting that SP-C influences the size of ordered 
domains in a surfactant-mimicking model (25). This, together with the membrane structural 
changes attributed to the N-terminal segment of SP-C (244), the effects of SP-C on membrane 
permeability (84, 85) and the SP-C membrane-fragmenting behavior observed in Chapter 2, 
highlights the ability of this protein to cause deep membrane alterations, which likely reflect 
how SP-C adapts lipid assemblies in response to different physiological demands. 
In the previous chapter, we have also demonstrated that the effect of SP-C on cholesterol 
distribution seemed to be mediated by the generation of highly curved structures, and 
therefore, that alterations in membrane architecture could constitute the missing link between 
SP-C and cholesterol in lung surfactant.  
Hence, the objective of the work presented in this chapter was to analyze the combined effect 
of SP-C and cholesterol on a lung surfactant-mimicking system in terms of membrane structure 
and dynamics. The effects of SP-C palmitoylation have been also considered, given that this 
feature appears to be key in the SP-C/Cholesterol relationship (215). To investigate membrane 
structure, lipid vesicles were examined by means of two powerful techniques, 2H-NMR 
(Deuterium Nuclear Magnetic Resonance) and ESR (Electron Spin Resonance). These two 
spectroscopic methods have been extensively used to evaluate SP-C effect on membranes (100, 
244, 246–248), although SP-C behavior was always assessed in lipid systems with disaturated 
phospholipids as only constituents. For this reason, to better simulate lung surfactant 
composition, we have used here membranes incorporating saturated and unsaturated 
phospholipids, with cholesterol amounts resembling those occurring in surfactant. Independent 
labeling of lipids allowed the determination of direct effects of SP-C on each membrane 
constituent (DPPC, POPC, POPG or cholesterol) by 2H-NMR, whereas average effects on 
membrane structure were determined by ESR.  
This work provides proof of SP-C-induced alterations in membrane structure, which can be 
relevant to explain SP-C-related functions to sustain lung surfactant functionality at the air-liquid 
interface. 
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2H-NMR spectroscopy 
As a lung surfactant model system, membranes of DPPC/POPC/POPG (50:25:15 w/w/w) were 
employed. For 2H-NMR experiments, deuterated lipids were used to label three equivalent lipid 
systems: DPPC-d62/POPC/POPG, DPPC/POPC-d31/POPG and DPPC/POPC/POPG-d31. Comparing 
observations on these systems allowed us to analyze the behavior of each component 
independently either in the pure lipid system or in the presence of SP-C or rSP-C and/or 
cholesterol.  
Powder spectra obtained at 37oC from samples with different deuterated lipid components are 
shown in Fig. 3.1. Each deuteron contributes a doublet with prominent edges arising from 
molecules reorienting about symmetry axes that are perpendicular to the applied magnetic 
field. The splitting (Δν) of the prominent edges for a given deuteron is proportional to the 
orientational order parameter for that CD bond, 𝑆CD = 〈3 cos
2 𝜃CD − 1〉/2, where 𝜃CD is the 
angle between the CD bond and the symmetry axis and the average is over motions that 
modulate the orientation-dependent quadrupole interaction on the time scale of the NMR 
experiment. Thus, for a perdeuterated phospholipid chain, the resulting spectrum is a 
superposition of doublets reflecting the orientational order for every position along the chain. 
A less restricted, more isotropic reorientation correlates with smaller splittings, as occurs for 
those deuterons located at the highly mobile methyl end of the acyl chain. More restricted 
motions, such as those of acyl chain methylene groups closer to the phospholipid polar 
headgroup, result in larger quadrupole splittings.  
In the absence of cholesterol, spectra corresponding to pure lipid systems exhibit sharp Pake 
doublet features (bottom spectra in Fig. 3.1a, b and c) with splittings characteristic of 
perdeuterated acyl chains undergoing axially symmetric reorientation about randomly oriented 
lipid bilayer normals. Thus, these spectra represent multilamellar membrane suspensions in the 
liquid-crystalline phase. The prominent edges at about +/- 15 kHz reflect the existence of a 
plateau in the orientational order parameter profile of the saturated acyl chain on each 
deuterated lipid species (249).  For DPPC-d62/POPC/POPG (Fig. 3.1a), the addition of 5 wt% SP-C 
resulted in a relative decrease in the intensity of the Pake doublet spectral components 
corresponding to liquid crystalline phase bilayers. The appearance of broad spectral wings with 
peak intensities at ~±24 kHz, can be associated to highly ordered lipid chains undergoing 
reorientation that is not axially symmetric over the NMR timescale (~10-5 s). The superposition 
of spectral components corresponding to a liquid crystalline phase and a highly ordered phase 
for this sample, is indicative of a SP-C-induced phase separation.  Spectra similar to the highly 
ordered phase component have been attributed to interdigitated lipid bilayers at high pressures 
(250–252), but the interpretation of the broad spectral component should be approached 
cautiously since other bilayer phases can produce a comparably high orientational order. 
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DPPC-d62 was not the only lipid involved in the SP-C-induced ordered phase, since the analysis 
of POPC-d31 and POPG-d31-containing vesicles demonstrated that these lipids were also affected 
by the ordering capacity of SP-C (Fig. 3.1b and c).  Thus, the comparisons illustrated in Figs. 3.1a, 
b, and c indicated that at 37oC, the addition of SP-C to DPPC/POPC/POPG mixed lipid bilayers 
induced separation into a highly ordered, possibly interdigitated, phase enriched in SP-C and a 
liquid crystalline phase. However, the latter appeared to differ only slightly from the 
corresponding lipid-only DPPC/POPC/POPG phase in terms of average chain order and 
dynamics.   
Incorporation of rSP-C also promoted the appearance of a component corresponding to highly 
ordered lipid in the spectra for all three deuterated lipids, but the fraction of each lipid in the 
highly ordered phase was smaller. However, a DPPC-d62 labeled lipid preparation incorporating 
another batch of rSP-C, showed a behavior similar to SP-C-containing samples (Fig. 3.2). SP-C 
palmitoylation stabilizes protein α-helical structure preventing its aggregation (157), thus, non-
acylated SP-C versions are more prone to aggregate and that can result in significant differences 
from stock to stock in terms of protein structure. The effect observed here (Fig.6. 1a) could then 
be an indirect consequence of protein acylation state. A non-acylated, partially aggregated stock 
would result in a less effective protein, given that aggregated rSP-C could not incorporate 
completely into membranes.  Thus, the absence of SP-C palmitoylation may not preclude the 
formation of a highly ordered phase, but did indirectly reduce the fraction of lipid that partitions 
into that ordered phase.   
 
Figure 3.2. Powder spectra of DPPC-
d62/POPC/POPG at 37oC incorporating 
different protein stocks. Top spectra 
represent the difference between two 
rSP-C batches, in particular the one 
presented in Fig. 3.1 (rSP-C, blue line), 
and an alternative one (rSP-C2, black 
line). Bottom spectra illustrate the 
similarities between the spectra 
containing native SP-C presented in Fig. 
3.1 (SP-C, blue line) and the second 
batch of rSP-C tested (rSP-C2, black 
line). 
 
 
 
The partitioning of deuterated lipids between different phases can be quantified; however, 
possible differences in quadrupole echo decay time between phases have to be considered. 
Using the same number of scans, unnormalized spectra registered for the lipid-only and lipid/SP-
C samples both containing nominally identical amounts of DPPC-d62, integrated to areas that 
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differed by only 4%.  This suggests that quadrupole echo decay times for the two phases were 
similar and thus, spectral subtraction could provide an estimate of DPPC-d62 partitioning 
between the coexisting liquid crystal and highly ordered phases. For the DPPC-d62 spectra in Fig. 
3.1a, it was found that subtracting 0.65 times the lipid-only spectrum from the lipid/SP-C 
spectrum eliminated most of the liquid crystalline spectral intensity from the lipid/SP-C 
spectrum. Even though the difference spectrum still contained some sharp features, due to 
slight differences in liquid crystal phase splittings between the two phases, these results suggest 
that about 35% of the DPPC-d62 was in the highly ordered phase in the lipid/SP-C sample. The 
same procedure was applied to samples containing POPC-d31 and POPG-d31, indicating that 20%-
25% of the POPC-d31 and about 25%-30% of the POPG-d31 in lipid/SP-C samples, partition into 
the highly ordered phase.  Therefore, according to these estimates the SP-C-induced ordered 
phase would be slightly enriched in DPPC-d62 and POPG-d31, and slightly depleted in POPC-d31. 
When the non-palmitoylated protein was added, the partitioning of the three lipids into the 
small fraction of ordered phase was not as differentiated, suggesting that palmitoylation might 
amplify differences in the capacity of the SP-C-induced ordered phase to accommodate different 
lipids.  
The spectra in Figs. 3.1d, e and f show that when cholesterol is incorporated into the lipid phase, 
the effect of SP-C on the mixture exhibited different features. Addition of 10 wt% cholesterol to 
the DPPC/POPC/POPG lipid mixtures resulted in an increase in quadrupole splittings for 
deuterons on each of the deuterated lipids (Fig. 3.1d, e, f, bottom spectra). Such cholesterol-
induced ordering of lipid acyl chains is typical of the liquid-ordered phase observed in a number 
of lipid-cholesterol mixtures (21, 253, 254).  In contrast to the situation in the absence of 
cholesterol, where SP-C induced the separation of a highly ordered phase from a largely 
unperturbed lipid phase at 37oC, the effects of adding SP-C to the cholesterol-containing lipid 
mixtures appeared to be more subtle, possibly because of the high degree of orientational order 
already imposed by the presence of the sterol.    
The middle spectra of Figs. 3.1d, e and f show how the combination of cholesterol and SP-C 
affect each lipid component in the mixture. The DPPC-d62 spectrum for lipid/cholesterol/SP-C 
(Fig. 3.1d, middle spectrum) still displays a clear vertical edge, corresponding to the orientational 
order parameter plateau at ~ +/- 20 kHz. This suggests that the DPPC-d62 acyl chain reorientation 
in the mixture with cholesterol and SP-C is still axially symmetric. Pake doublets corresponding 
to individual methylene deuterons, however, are less sharply resolved in this spectrum. This 
broadening indicates that the correlation time for reorientation is larger than in the absence of 
SP-C, and is approaching the upper threshold for fast motions on the 2H-NMR timescale. In the 
spectra for POPC-d31 and POPG-d31 for the corresponding mixtures (middle spectra in Figs. 3.1e 
and f), methylene doublets are unresolved.   
The loss of resolution in the POPC-d31 and POPG-d31 spectra for the lipid/cholesterol/SP-C 
mixtures could reflect two situations, either acyl chain reorientation is too slow to be axially 
symmetric on the 2H- NMR time scale, or an intermediate rate exchange between domains with 
slightly different acyl chain order occurred (21). In the POPG-d31 spectrum for this mixture (Fig. 
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3.1.f, middle spectrum), there is a small spectral edge with a splitting similar to the one observed 
for the plateau in the corresponding lipid-only spectrum (bottom spectrum of Fig. 3.1e), and 
evidence of a narrower methyl doublet. At 30oC, the POPC-d31 spectrum for the 
lipid/cholesterol/SP-C mixture is a superposition of two components, indicating separation into 
a more ordered and a liquid crystalline phase (Fig. 3.3 a, b). For the corresponding mixture 
containing DPPC-d62, however, the spectrum at 30oC (Fig. 3.3c) shows no evidence of phase 
separation and is characteristic of reorientation that is not axially symmetric on the 2H NMR 
timescale.  
 
 
Figure 3.3. (a, b) 2H-NMR spectra of multilamellar vesicles made of DPPC/POPC-d31/POPG + 10 
wt% Cholesterol and 5 wt% SP-C. Each panel represents an independent experiment performed 
with a newly prepared sample incorporating different stocks of SP-C. Spectra at 30ºC are 
characteristic of a two-component phase segregation that is not observed in the same manner 
in spectra at 37ºC. Differences found between replicates are likely due to slight different 
cholesterol concentrations found between the lipid batches used to prepare these samples. (c) 
Powder spectra of DPPC-d62/POPC/POPG incorporating 10 wt% cholesterol and 5 wt% SP-C at 
30ºC. The spectra show lipid reorientations too slow to be axially symmetric on the experiment 
timescale. No phase separation is observed. This sample was prepared with different lipid stocks 
compared to the one presented in Fig. 3.1a.  
 
The spectra shown in Figs. 3.1d, e and f suggest that in DPPC/POPC/POPG (50:25:15 w/w/w) 
mixtures containing 10 wt% cholesterol, addition of 5 wt% SP-C affects the dynamics of all three 
lipid components but not necessarily in the same ways.  In order to gain more insight into the 
dynamics of bilayer components in the lipid/cholesterol/SP-C bilayers, 2H-NMR spectra were 
obtained from a series of bilayer mixtures containing cholesterol-d6. Fig. 3.4a shows the 
structure of cholesterol including the deuteron locations.  The bottom spectrum of Fig. 3.4b is 
obtained from DPPC/POPC/POPG (50:25:15 w/w/w) containing 10 wt% cholesterol-d6 at 37oC. 
By comparison with previously reported spectra for cholesterol-d6 in DMPC membranes (255), 
the doublet with the largest splitting can be assigned to the deuteron on carbon 3 and to the 
axial deuterons on carbons 2 and 4.  The doublet with a splitting of ~ +/-15 kHz can be assigned 
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to the equatorial deuterons on carbons 2 and 4, and the central doublet with a very small 
splitting, to the deuteron on carbon 6 (Fig. 3.4a).  
 
Figure 3.4. (a) Structure of Chol-d6. Deuterated positions are numbered. (b) Powder spectra of 
DPPC/POPC/POPG (50:25:15 w/w/w) +10 wt% Chol-d6 measured at 37ºC. The different proteins 
incorporated (5 wt%) did not alter the spectra substantially.  
The addition of SP-C had little effect on the doublet splittings; however, it leaded to some 
broadening of the lineshape and an overall reduction in area of the unnormalized spectrum by 
about a half.  This appeared as a decrease in the signal-to-noise ratio of the normalized spectra 
shown in Fig. 3.4.  Addition of rSP-C, SP-B, or the hydrophobic protein fraction of native lung 
surfactant, SP-B/SP-C, had a similar effect on the cholesterol-d6 spectrum.  Comparison of the 
lipid/cholesterol-d6 and lipid/cholesterol-d6/protein spectra indicated that the orientational 
order of the rigid portion of cholesterol-d6 was not affected by the addition of SP-C or any of the 
proteins.  The insensitivity of the observed splittings to the addition of SP-C suggests that the 
observed line broadening and loss of intensity cannot be due to intermediate rate exchange 
between environments in which the deuterons have different splittings.  It would thus appear 
that the addition of SP-C to the lipid/cholesterol-d6 mixture resulted in an increase in the 
correlation time for reorientation of the rigid portion of the cholesterol-d6.  
 
ESR spectroscopy 
To confirm our results on SP-C-induced increase in lipid order, we performed ESR experiments 
using the lipid system previously mentioned. Spin-labelled lipids can be incorporated into lipid 
bilayers in a low proportion without perturbing membrane behavior. Besides, different positions 
along the acyl chain and the phospholipid headgroup can be labeled, and thus it is possible to 
obtain information on the dynamics and conformational order of lipids at different levels within 
the membrane. Measurements were carried out at different temperatures and two different 
amounts of SP-C were tested, 5 wt% and 10 wt%. 
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Two spin-probes, 12PSCL and 5PCSL, were incorporated in multilamellar vesicles of 
DPPC/POPC/POPG 50:25:15 (w/w/w). Results for 12PCSL-containing samples are shown in Fig. 
3.5a . 12PCSL is labelled in n12 position, and therefore represents acyl chain mobility close to 
the hydrophobic core of the membrane. The increase in temperature resulted in line narrowing 
correlating with an increase in membrane fluidity. Samples incorporating SP-C showed broader 
spectra when compared with the lipid-alone one, especially above 25oC. Greater differences 
were observed in the range from 30-37oC, where the pure lipid exhibited a spectrum 
characteristic of a more fluid character than the SP-C-associated ones. The two amounts of SP-
C tested generated very similar spectra, although 10 wt% protein restricted lipid motion to a 
slightly higher extent. This is reflected in an increased outer hyperfine splitting, 2Amax, which was 
significantly higher for samples incorporating SP-C (Fig. 3.5b).  
 
Figure 3.5. (a) ESR spectra of DPPC/POPC/POPG membranes incorporating no protein (dotted 
line), 5 wt% (dark blue line) or 10 wt% SP-C (light blue line) labelled with 1 mol% of the probe 
12PSCL at different temperatures. The spectra to the left and right correspond to magnifications 
showing a detailed view of the low and high-field spectra for membranes containing no protein 
(black line), and samples containing either 5 wt% SP-C or 10 wt% SP-C (dark and light blue lines 
respectively). In the right panels, lines connecting consequent minimums have been added as a 
visual guide. The total scan range was 100G. (b) Outer hyperfine splittings (2Amax) of 12PCSL-
labeled samples containing no protein (full circles), 5 wt% SP-C (dark blue squares) or 10 wt% 
SP-C (light blue triangles) as a function of temperature. 
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However, even though SP-C induces restriction in lipid motion as observed for the “bulk” fluid 
phase, we cannot distinguish a second immobilized component, which is consistent with what 
was previously reported for this protein (231). These results are in agreement with our 
previously observed SP-C-induced immobilizing effect in the lipid system, and could support the 
proposed interdigitated structure. Furthermore, the induction of such structure would require 
that all positions along the acyl chain showed a restricted motion under the presence of SP-C. 
Our results for samples incorporating a probe positioned closer to the lipid headgroup, 5PCSL, 
suggest that SP-C also induced a trend towards higher splittings at this level (Fig 6.6).  Taken 
together, these results support the SP-C-induced restriction in the average lipid motion of the 
lipid system studied that could be mediated by the generation of an interdigitated structure. 
 
Figure 3.6. ESR spectra of DPPC/POPC/POPG vesicles incorporating no protein (black line), 5 wt% 
or 10 wt% SP-C (dark and light blue lines respectively) labelled with 1 mol% of the probe 5PSCL 
at different temperatures. Spectra to the left and right correspond to magnifications showing a 
detailed view of the low and high-field spectra for vesicles with no protein (black line), and 
samples containing either 5 wt% SP-C or 10 wt% SP-C (dark and light blue lines respectively). The 
total scan range was 100G.  
 
As in previous chapters, in this work lung surfactant-mimicking membranes comprising the most 
representative lipid components of surfactant, DPPC/POPC/POPG (50:25:15 w/w/w) were 
studied. According to our results, SP-C is able to induce lateral phase segregation in the absence 
of cholesterol in that lipid environment. Such phase segregation occurred at near-physiological 
conditions (37oC, pH 7) and resulted in an immobilized lipid fraction involving the three 
phospholipids analyzed here. These results agree with those of other works, in which the 
generation of lipid nanodomains (25) or even immobilized lipid phases (244) have been observed 
upon addition of SP-C or SP-C N-terminal peptides, stressing SP-C efficiency to alter lipid packing.  
Similar studies, though, reported little effect of SP-C observed on other lipid assemblies. This 
can be explained by differences in the lipid composition, since 2H-NMR and ESR studies of SP-C 
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have been classically approached employing membranes made of disaturated phospholipids 
(100, 244, 246–248), given that DPPC is the major surfactant lipid. However, under some 
circumstances, even in those environments SP-C has proven to increment lipid order 
substantially, resulting in the appearance of ordered striated domains (256) or immobilized 
phases (244). In these studies, effects associated with hydrophobic mismatch or SP-C/lipid 
electrostatic interactions have to be taken into account, which highlights the importance of 
providing a native-like lipid environment for SP-C to fulfil membrane rearrangements. The lipid 
system employed in this chapter incorporates an additional level of membrane complexity 
compared to the previous works, resembling more closely the native protein environment.   
In our experimental approach, the liquid crystalline phase observed in lipid/SP-C spectra (Fig. 
3.1a, b and c, middle) remained essentially unaltered compared to the lipid-only system, 
suggesting that either SP-C was concentrated in the ordered regions or its presence in the fluid 
regions caused no effect. SP-C could be locally concentrated through the establishment of 
protein-protein interactions (212, 240, 241), such as those occurring in protein dimerization. SP-
C dimers could precede a larger extent of oligomerization or clustering, a possibility already 
suggested as the cause of SP-C-induced packing defects or pores in membranes (84, 85). We 
propose a model in which an increased protein density in localized regions of the membrane 
could amplify the extent of those interactions, triggering the lateral segregation observed in our 
experiments (Fig. 3.7). This is supported by previous evidence showing SP-C confined 
localization, either at the boundaries of ordered/disordered domains in bilayers or 
condensed/expanded regions in monolayers (25–27). However, it must be noted that SP-C 
partitioning amongst domains cannot be directly deduced from the results shown in this 
chapter.  
In the absence of cholesterol, the SP-C-induced ordered phase exhibited spectral features 
consistent with interdigitated structures (250–252). Nevertheless, as previously mentioned, we 
cannot discard other lipid organizations that could result in spectra of similar characteristics. ESR 
experiments showed an average decrease in lipid mobility at levels close to the phospholipid 
headgroup (5PCSL, Fig. 3.6) but also at the hydrophobic core of the membrane (12PCSL, Fig. 3.5), 
supporting an SP-C-induced ordering effect that could be also related to an interdigitated phase, 
an activity previously attributed to the SP-C N-terminal segment (244). ESR spectra, though, do 
not show any features characteristic of a strongly immobilized lipid phase, in agreement with a 
previous study (231). It must be considered that upon phase separation, spin probes can 
partition unevenly among domains providing only partial information on the system. The probes 
used in our approach were PC-based nitroxide-labeled molecules and consequently, their 
behavior and partitioning might be more similar to that of POPC, a lipid that although was more 
ordered upon SP-C presence, seems to be the least SP-C-influenced one according to 2H-NMR 
results.  
In DPPC/POPC/POPG membranes, we have observed that the SP-C-induced ordered phase was 
slightly enriched in DPPC and POPG, and partially depleted in POPC. In the ordered phase, the 
stronger accommodation of POPG-d31 relative to POPC-d31 may reflect a balance between an 
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electrostatically favored compatibility with the positively charged SP-C-rich phase, and the 
mechanical mismatch between unsaturated chains and the SP-C-induced ordered environment. 
Thus, in line with 2H-NMR results, SP-C creates packing defects promoting phase segregation, 
which might facilitate the sorting of unsaturated phospholipids out of DPPC-enriched regions as 
proposed in the model in Fig. 3.7. Given that DPPC can be packed more tightly than unsaturated 
lipids, this could be relevant for reaching low surface tensions during exhalation. Another 
possible implication of the potential SP-C-induced interdigitated phase would be promoting the 
generation of curved structures. The interdigitated phase could then represent a possible 
intermediate state between the interfacial monolayer and the underlying bilayered reservoir. 
This would facilitate both adsorption and re-spreading of lung surfactant material, a  function 
already related to SP-C-induced interdigitation (244). Lipid interdigitation combines a high 
degree of tail ordering and a high level of hydration of the head groups, providing membrane 
characteristics between liquid crystalline and gel phases. Shifting that to the lung surfactant 
context, a potential SP-C-induced membrane-interdigitation could also generate highly 
condensed lipid patches to provide stability to the multilayered interfacial film. 
 
Figure 3.7. Model of the potential mechanism of SP-C-induced selective lipid interdigitation. 
The molecular basis supporting SP-C-promoted interdigitation is an intriguing matter. SP-C is 
reported to cause changes in the polarity of the membrane through its N-terminal segment, 
which alters the disposition of the phosphate moiety in DPPC membranes causing a “pulling” 
effect towards the aqueous medium  (100, 231). Additional perturbations in lipid packing include 
those derived from the potential SP-C oligomerizing capacity (212, 240, 241) and its tilted 
orientation in membranes (Chapter 1). Therefore, SP-C could nucleate packing defects that could 
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be relieved upon the adoption of a new lipid configuration, possibly representing the first steps 
towards protein-promoted interdigitation.  
Regarding the effects of protein acylation, SP-C palmitoylation seemed to enhance the extent of 
lipid perturbations. Conversely, non-palmitoylated SP-C showed a somewhat heterogeneous 
behavior depending on protein batches, some of them equaling the effects of the palmitoylated 
protein (Fig. 3.2). This highlights the importance of protein acylation in stabilizing protein 
structure and accordingly, protein functionality. Palmitoylation of SP-C N-terminal peptides 
appeared to be determinant for promoting the membrane-ordering effect interpreted as 
interdigitation (244), however, those peptides bound and disturbed phospholipid packing 
independently of their acylation state (99, 257). Considering that full-length SP-C anchors the N-
terminal segment to the membrane through the transmembrane α-helix, acylation of the full-
length protein might not be so critical compared to its importance for N-terminal peptides as 
already reported (25). Thus, according to our results, the main role of SP-C palmitoylation seems 
to be the magnification of differences between the lipids involved in SP-C-induced phase 
separation, suggesting that a non-palmitoylated protein could be less effective in sorting out 
lipids properly.  
To provide further insight into the cholesterol/SP-C relationship, the combined effect of SP-C 
and cholesterol on membranes mimicking surfactant composition was assessed. In 
DPPC/POPC/POPG membranes, cholesterol increased lipid order as described for many other 
lipid-cholesterol combinations. However, the presence of SP-C resulted in a more subtle effect 
when compared to the cholesterol-free system, where there was a marked phase separation 
into a highly immobilized phase and a liquid crystalline phase. For lipid/chol/SP-C samples, all 
phospholipids seemed to be more immobilized than in lipid/chol membranes, displaying slower 
reorientations especially in the case of POPC and POPG (Fig. 3.1e, f). Their broadened spectra 
were indicative of reorientations that were too slow to be axially symmetric on the 2H-NMR time 
scale or an intermediate rate exchange between domains with slightly different chain order (21). 
Cholesterol was oriented along the bilayer normal in all samples with an almost unaltered 
motion (Fig. 3.4b). For a rigid and planar structure such as cholesterol, only motion involving the 
whole molecule with respect to the bilayer normal could modify its order parameter and 
consequently, its splittings. Different proteins were tested in an attempt to detect any 
protein/cholesterol specific interaction.  Cholesterol deuteron splittings did not change 
substantially in the presence of SP-C, rSP-C or SP-B, nor when the native hydrophobic protein 
fraction of surfactant (SP-B+SP-C) was included, so specific perturbations on cholesterol 
behavior could be discarded. The presence of the proteins, though, slowed slightly cholesterol 
reorientation about its molecular axis, likely resulting from the overall increase in lipid order. 
Even though in the presence of cholesterol no phase segregation was clearly evident at 37oC for 
any of the preparations tested, DPPC/POPC-d31/POPG exhibited phase separation at 30oC when 
SP-C and cholesterol were combined (Fig. 3.3a, b). DPPC did not show any signs of phase 
separation in those conditions (Fig. 3.3c), although possible differences in membrane fluidity 
between systems due to deuteration could explain this difference. Nonetheless, the effects 
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observed here suggest that SP-C and cholesterol are subtly related in modulating membrane 
architecture, also responding to changes in temperature in a coordinate manner. Besides, the 
higher ordering induced by cholesterol/SP-C for POPC and POPG compared to DPPC, together 
with the phase separation observed for POPC at 30oC could suggest that cholesterol might be 
unequally distributed, with a higher proportion being localized together with unsaturated 
phospholipids. Such an effect might be in line with SP-C promoting a compositional refinement 
in the lung surfactant system as previously proposed in Chapter 2.  
Taken altogether, 2H-NMR and ESR results support that SP-C restricts lipid mobility as previously 
reported (231, 233), both in the absence and in the presence of cholesterol. SP-C is able to 
induce a highly ordered, possibly interdigitated, phase, which provides some insights into how 
SP-C-induced membrane rearrangements could participate in processes such as lipid adsorption 
or DPPC enrichment at the interfacial film.   
The combination of SP-C and cholesterol resulted in an increase in lipid chain order compared 
to cholesterol alone, suggesting that although SP-C induces an ordering effect in both cases, it 
also depended on the presence of the sterol.  These results complement the information 
obtained in Chapter 2, highlighting the importance of the SP-C/cholesterol relationship in 
modulating surfactant architecture with potential functional consequences.  
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From all surfactant-associated proteins, SP-C is regarded as a lipopeptide because of its high 
hydrophobicity and its “hybrid” protein and lipid character conferred by palmitoylation. In some 
instances, SP-C has been considered as the most hydrophobic protein in the global proteome 
(258, 259). Very frequently, this protein exhibits lipid-like characteristics resulting from this 
extremely hydrophobic character. Because of these characteristics, as we have observed 
through previous chapters, SP-C establishes strong lipid-protein interactions mainly mediated 
by its hydrophobic α-helical transmembrane segment, although in terms of lipid selectivity, 
additional efforts are required to define SP-C affinity for certain type of lipids.  
We have previously observed how SP-C modulates membrane structure by inducing 
curvature and perturbing lipid packing (Chapters 1, 2 and 3). From these results, specific lipid-
protein interactions could be inferred, since DPPC and POPG, for instance, seemed to be altered 
by SP-C to a higher extent than POPC. Nevertheless, whether those interactions rely directly on 
SP-C features or they are a consequence of specific membrane structural constraints, requires 
further study.  This makes necessary alternative approximations to assess SP-C-lipid interactions. 
From a lipid point of view, thin layer chromatography (TLC) emerges as a simple and fast 
technique to analyze lipid behavior in terms of partition between polar and non-polar phases 
and the resulting migration through the silica plate. 
TLC is a classical procedure employed to analyze the lipid composition of a complex mixture, and 
has been broadly used to assess the lipid profile of different tissues (260–264) and membrane 
complexes such as lung surfactant (265–272). Since one of the main purposes of TLC has been 
phospholipid characterization, native samples of membranes or lipids have been typically 
subjected to organic extraction and then applied as organic solutions. Thus, water-soluble 
molecules such as hydrophilic proteins and polar interactions between lipids and proteins were 
systematically skipped. 
Given the particular behavior of SP-C in membranes, in this chapter we aimed to further 
characterize protein-lipid interactions established in lung surfactant, particularly those 
concerning SP-C. In a TLC, we hypothesize that tight lipid-protein interactions might influence 
the running pattern of different phospholipid species, so these lipids interacting closely with 
proteins might be identified by altered lipid migration profiles. To identify these potential 
interactions, in this study native surfactant membranes were applied on TLC plates avoiding 
organic extraction procedures and thus, preserving polar interactions. To have a closer look on 
SP-C-specific effects, we made use of surfactant-mimicking membranes configuring different 
lipid systems to which SP-C might preferentially bind. The role of cholesterol was also analyzed 
and the possible contribution of SP-C palmitoylation was taken into account. 
The results derived from this study stress the strong character of SP-C-lipid interactions and 
the highly hydrophobic nature of this protein, which are important characteristics to define SP-
C function at the air-liquid interface. These features need to be further explored and 
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undoubtedly considered for the development of SP-C mimicking peptides with application in 
lung surfactant replacement therapy.   
Analysis of surfactant membranes   
Lung surfactant was isolated from porcine lungs and applied as a whole aqueous suspension 
on a TLC plate. The developing phase employed, Chl/MeOH/water 65:25:4 v/v/v, has been 
classically used for resolving polar lipids such as phospholipids, which run along the plate 
generating differentiated bands depending on their headgroup. Molecules with a higher polarity 
interact strongly with the silica-plate over the organic solvent, so that their migration is delayed 
and appear as bands located closer to the application point (AP). In contrast, more hydrophobic 
and less polar molecules interact preferentially with the developing phase, being observed at 
the top of the plate with larger distances from the application point (larger Rfs).  
To differentiate bands occurring in native surfactant (NS) potentially associated to specific 
lipid-protein interactions, organic extracted surfactant (OE) was applied in organic solvent for 
comparison. Fig. 4.1 illustrates iodine-stained lipid bands of a TLC run with native and organic 
extracted surfactant as well as lipid references: phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS), 
sphingomyelin (SM), lysophosphatidylcholine (LPC) and cholesterol (Chol). Lipid bands did not 
show appreciable differences between native and organic extracted complexes, which mainly 
comprised PC, and less abundantly, PG, PE and neutral lipids such as cholesterol (NL). 
Nevertheless, given their polarity, surfactant-associated proteins presumably remained at the 
application point, so that strong-lipid protein interactions might retain interacting phospholipid 
molecules within protein bands. Organic phosphorus determination assays yielded no 
phospholipid detection in the application point, but interestingly, the analysis of the protein 
profile shed interesting results (Fig. 4.2).   
 
Figure 4.1. Iodine-stained TLC of surfactant complexes applied as native membranes (NS) or 
organic extracted (OE). Specific lipid bands can be identified by comparison with lipid references: 
PC, PE, PI, PS, SM, LPC and Chol, and the application point (AP) is indicated. 
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Specific bands were scratched out from the silica and subjected to SDS-PAGE and western 
blot analysis (Fig. 4.2). SP-A was exclusively found in native surfactant membranes, since the 
organic extraction procedure removes hydrophilic components from surfactant (Fig. 4.2). As 
expected, upon examination of the organic extract the only proteins observed were SP-B and 
SP-C as previously reported (273), which remained at the application point. Nevertheless, a 
parallel analysis for native surfactant membranes revealed several protein bands in the 
application but total absence of SP-C (Fig. 4.2a). A thorough analysis of the TLC plate revealed 
that, far from staying at the application point like most proteins, SP-C run along with lipids 
localizing close to the PC band. This particular behavior was only exhibited when membranes 
were applied as aqueous suspensions, and therefore when polar interactions were somehow 
preserved on the silica plate. The migration pattern of SP-C might be interpreted as a result of 
strong SP-C-lipid interactions that pull the protein within the developing organic phase. This 
unexpected finding suggests that this technique could be useful for the study of specific lipid-
protein interactions.  
 
Figure 4.2. (a) Silver staining of a 13% polyacrylamide gel with the material scratched from AP 
(application point) and PC (phosphatidylcholine) TLC-bands from NS or OE. (b) Immunodetection 
of surfactant associated proteins in the different TLC regions and samples by western blot.  
 
Effect of SP-C palmitoylation and membrane composition in SP-C-lipid interactions    
Several features of SP-C structure could be crucial for the particular behavior exhibited by 
the protein in the TLCs. The particular sequence of SP-C and its dually palmitoylated cysteines 
contribute to its hydrophobic character, which together with SP-C small size (35 amino acids, 4.2 
kDa), might explain why a peptide is competent to migrate in a phospholipid TLC.  To test if 
protein acylation could be a factor worth considering, both native SP-C (palmitoylated) and 
recombinant SP-C (rSP-C, non-palmitoylated) were assembled into membranes of different 
compositions and analyzed. This experimental design allowed us to test simultaneously whether 
membrane composition and protein palmitoylation defined SP-C migration pattern. As observed 
in Fig. 4.3, iodine-stained lipid bands could be unequivocally associated to each lipid component 
in the different mixtures, whereas SP-C was localized in a unique fluorescent band detected by 
fluorescamine staining. Fluorescamine binds covalently to the amine groups present in the 
5. RESULTS. Chapter 4 
106 
 
protein but not to the lipid components of these samples. No differences in the protein 
migration pattern were observed associated to SP-C palmitoylation state nor lipid composition. 
It is remarkable that both SP-C and rSP-C migrated exactly to the same region, generating a band 
located below the one displayed by PC species (DPPC or POPC). No protein was observed in 
association to POPG as revealed by fluorescamine staining. Nevertheless, POPG only 
represented a minor portion of the membranes employed here, so that possible SP-C-POPG 
migrating complexes might pass unnoticed in this type of lipid samples.  
 
Figure 4.3. Migration pattern in a TLC of SP-C and rSP-C incorporated in membranes of different 
compositions. (a) Iodine staining of a TLC showing lipid bands corresponding to DPPC, POPC, 
POPG and a small SP-C-associated lipid band (black arrow). The application point is marked as 
AP. (b) Fluorescamine staining showing protein localization in the TLC plate. It is possible to 
observe how the protein is concentrated in the small band beneath the PC band observed in (a) 
(white arrow). 1,2 and 3 correspond to samples with different lipid compositions: 
DPPC/POPC/POPG (50:25:15 w/w/w); DPPC/POPC (50:40 w/w) and POPC/POPG (75:15 w/w).  
  
Once observed that SP-C palmitoylation did not affect the SP-C-lipid interaction detected in 
TLCs, we wanted to examine whether PG could influence protein migration. Given that lung 
surfactant is mainly composed of PC species and a fair proportion of anionic phospholipids, 
mainly PG, for the next set of experiments, lipid vesicles included a higher amount of PG to 
detect specific PG-SP-C interactions. Membranes of pure POPG and POPC/POPG (1:1 w/w) were 
used as illustrated in Fig. 4.4.  
Figure 4.4. TLC of PG containing 
vesicles in the presence of SP-C. (a) 
Iodine staining showing lipid bands 
corresponding to POPC, POPG and 
SP-C-associated bands (black 
arrows). (b) Fluorescamine staining 
showing protein localization in the 
TLC plate (white arrows). 
Membrane composition was POPG 
and POPC/POPG (1:1 w/w).  
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Even in pure POPG membranes, the SP-C-associated band was positioned close to the one 
configured by PC, revealing that this position was protein-specific and not due to the lipid used 
to generate the membranes. However, in those samples, besides the PC-like band, a small 
fraction of the protein was pulled up with POPG, reflecting a balance between specific and non-
specific interactions. 
 
SP-C- cholesterol interaction 
We have observed that SP-C behavior seemed to be independent on protein palmitoylation 
and depended only to some extent on lipid composition. POPG displayed a specific interaction 
with the protein, and thus, it seemed feasible to detect other specific SP-C-lipid interactions 
occurring in membranes. Due to the evidences connecting SP-C and cholesterol in lung 
surfactant (120, 121, 245), we extended our analysis to detect possible SP-C-cholesterol 
interactions. With this purpose, different membrane compositions with increasing amounts of 
cholesterol were used. Using this approach, if direct SP-C-cholesterol interactions are stablished, 
we would expect to detect SP-C associated to cholesterol bands. Membranes including POPC 
and POPG were assayed as observed in Fig. 4.5.  
 
Figure 4.5. TLC of POPC/POPG (7:3 w/w) membranes containing increasing amounts of 
cholesterol and SP-C. (Left panel) Iodine staining showing lipid bands corresponding to POPC, 
POPG, cholesterol. SP-C-associated bands are marked with black arrows. (Right panel) 
Fluorescamine staining showing protein localization in the TLC plate (white arrows).  
 
The results observed in Fig.4.5. show how SP-C preferentially located under the POPC band, 
although a slight proportion of the protein remained with POPG. Remarkably, no cholesterol-
associated protein band was observed, suggesting that if an interaction exists, it is not preserved 
under this conditions or it is not strong enough to be revealed by the TLC protein-fingerprinting 
assay. It is interesting to note, however, how the narrow POPC bands become more diffuse with 
increasing amounts of cholesterol in the absence of SP-C. When SP-C is added though, bands are 
diffuse even when no cholesterol was present, and no changes in shape are observed while 
cholesterol amount increased. This fact could mean that not only certain lipid-protein 
interactions observed in membranes are preserved, but also lipid-lipid interactions such as those 
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exhibited between phospholipids and cholesterol. Besides, the fact that the lipid mixture 
behaved invariably for membranes containing SP-C with and without cholesterol, suggests that 
the phospholipid-SP-C interactions detected here do not seem to be affected by the presence 
of cholesterol.  
 
Figure 4.6. (a) (i) Iodine-stained TLC of POPC vesicles incorporating 5 wt% cholesterol and 
increasing amounts of SP-C. PCCh and Ch correspond to lipid references, PC-cholesterol and 
cholesterol respectively. (ii) Fluorescamine-stained TLC showing bands corresponding to SP-C. 
(b) (i) Iodine-stained TLC of POPC vesicles including 5 wt% SP-C and different amounts of TFC 
(TopFluor-Cholesterol). PCTFC and TFC correspond to lipid references, PC-TFC and TFC 
respectively. (ii) Visualization of fluorescent TFC corresponding bands. After fluorescamine 
staining, both TFC and SP-C-containing bands are observable (iii).(iv) SDS-PAGE and silver 
staining from silica-scraped-bands numbered in (i).  
 
To discard that the interaction SP-C-cholesterol was not observed by an effect of detection 
limit, two different approaches were used. Firstly, the proportion of SP-C was incremented to 
observe if some of it appeared with cholesterol in the upper TLC band. As observed in Fig. 4.6a, 
the SP-C-associated band increased in intensity for higher protein concentrations, whereas no 
protein fluorescent band was again detected associated to cholesterol. In a second approach, a 
cholesterol fluorescent analog, TopFluor-cholesterol (TFC), was incorporated in PC membranes 
containing a fixed proportion of SP-C. As illustrated in Fig. 4.6b, before fluorescamine staining, 
fluorescent bands correlated with the migration pattern of cholesterol, but no fluorescence was 
detected for lower bands that could correlate with the one associated to SP-C. In order to 
observe if any protein remained in bands other than the SP-C-associated one, different regions 
of the TLC plate were scrapped from the silica for a SDS-PAGE analysis. Silver stained bands 
confirmed that the protein was only present at the TLC band stained with fluorescamine, thus 
discarding again any SP-C-cholesterol interaction.  
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Finally, since no cholesterol/SP-C interaction was detected in phospholipid systems, 
cholesterol/SP-C particles were generated to test whether they could be solubilized when they 
were combined in the absence of phospholipids. The particles obtained were non-soluble in an 
aqueous system as observed in Fig. 4.7. Upon centrifugation, they were detected in the pellet 
as demonstrated by the Coomassie staining of SP-C bands subjected to SDS-PAGE (Fig. 4.7a). 
Interestingly, the presence of increasing amounts of cholesterol resulted in deformed bands, 
indicating that cholesterol run though the gel disrupting SP-C running pattern. A TLC of these 
insoluble particles showed that SP-C migrated again in the TLC configuring a band comparable 
to those observed previously as SP-C-associated bands (Fig 4.7b). Besides, increasing amounts 
of cholesterol were translated into more protein detected in those bands, demonstrating that 
in aqueous solution, SP-C and cholesterol associate generating non-soluble particles.   
Figure 4.7. (a) 13% SDS-PAGE of 
Chol-SP-C samples. Numbered lanes 
correspond to particle composition 
shown in (b). Lane 1 corresponds to 
a SP-C reference. (b) Top panel, 
fluorescamine staining of a TLC of 
insoluble Chol-SP-C particles. SP-C 
and Chol references were also 
treated with aqueous buffer and 
applied. Particles contained 5 µg of 
SP-C and the amount of cholesterol 
indicated in molar proportions. 
Bottom panel. Phosphomolibdic 
acid staining of the TLC shown in top 
panel. Cholesterol bands are 
marked by a white arrow.  
SP-C is a transmembrane protein which strongly interacts with surrounding lipids modifying 
membrane properties. In this study, we have detected that from all SP-C-lipid interactions 
established in a membrane environment, some are resistant to organic solvents after being 
mostly depleted of water. Since the TLC developing phase is mainly composed of organic 
solvents (chloroform/MeOH/water 65:25:4, v/v/v), it is unlikely that intact membranes could be 
found, meaning that SP-C-lipid complexes in organic solvents exhibit this characteristic running 
pattern.  
SP-C alters lipid packing and mobility restricting lipid motion, effects that have been typically 
associated to hydrophobic SP-C-lipid interactions mediated by the α-helix. In Chapter 3 we have 
detected an immobilizing effect of SP-C towards DPPC, POPC and POPG that leaded to phase 
segregation and could involve an interdigitated-like state. Alternatively, SP-C N-terminal 
segment is also known to disturb lipid bilayers even in the absence of palmitoylation (99, 244) 
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and at high densities, it even restricts lipid motion generating packed structures such as those 
involved in the interdigitated phase (244). These findings imply that in a physiological context, 
SP-C establishes different types of protein-lipid interactions: labile interactions with surrounding 
lipids that might be exchanged with other lipids in a longer length-scale, and stronger 
interactions that lead possibly to the tight immobilization of certain lipids (231).  
In a bilayer, lipids can interact with a transmembrane protein either acting as a “hydrophobic 
solvent” forming rings around it (annular shell) or positioning in defined protein regions, such as 
those located in the middle of oligomeric structures, or protein clefts (non-annular sites) (274). 
Typically, lipids forming part of the annular shell are not very specific and adapt to match the 
protein surface. However, lipids forming part of non-annular sites exhibit a higher specificity as 
observed in crystallized proteins (274). Shifting this information to SP-C, we would expect that 
lipids interacting strongly with the protein would be the ones revealed by TLCs. According to 
previous evidence (231), the possibility that this protein is enclosed by an annular shell of lipids 
tightly interacting with it seemed unlikely. Conversely, considering the experiments shown in 
Chapter 3 and the confined localization of SP-C in membranes and monolayers (25, 27), specific 
protein-lipid interactions cannot be ruled out. According to our results though, SP-C displayed 
an almost invariable migrating pattern when embedded in either POPC or POPG membranes, 
although specific SP-C-POPG interactions were also detected. This indicates that although most 
of the interactions detected did not exhibit a strong specificity, this methodology could be useful 
to discriminate those less populated specific cases. This is consistent with previous results (231), 
which suggested that SP-C interacts with lipids in a very dynamic way, promoting fast and 
continuous lipid exchange. 
To understand SP-C/lipid interactions, it is necessary to consider SP-C amino acid composition 
and sequence. SP-C α-helix contains mainly Val, Leu and Ile, non-polar residues that 
preferentially interact with the hydrocarbon chains of phospholipids fatty acids. SP-C α-helical 
segment is well embedded in the lipid bilayer leaving unpaired charged residues (Arg and Lys) 
located close to the polar lipid headgroup. These amino acids are extremely conserved and 
required for the proper processing and trafficking of SP-C precursor (146, 150). Their long and 
flexible non-polar side chains keep them buried in the hydrophobic core of the membrane, 
whereas their charged groups lead to the “snorkeling” effect on the membrane surface (275, 
276). These groups could then be involved in hydrogen bonding to a phosphate and/or ester 
oxygen of the phospholipid molecule, or establish electrostatic interactions with the negatively 
charged phosphatidyl glycerol. However, for all those interactions to occur, a polar environment 
is required. Interestingly, the C-terminal end of SP-C is nearly depleted of polar groups, in which 
only the C-terminal carboxyl could be charged depending on its protonation state. Upon 
protonation, the C-terminal end of SP-C could easily dive into the hydrophobic core of the 
membrane. Therefore, it seems that the sequence and structure of SP-C could be particularly 
well suited for its function at the respiratory air-liquid interface. The hydrophobic C-terminal 
side of the protein can be projected towards the air while the N-terminal polar segment of SP-C 
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would remain anchored at the surface of the surface-active film that pulmonary surfactant 
establishes at the alveolar spaces.  
In a TLC performed as described here, membrane suspensions are applied and left to dryness, 
so that original polar interactions could be preserved thanks to residual solvation molecules. 
However, the contact with the developing phase would disrupt those membranes and most of 
these polar interactions. SP-C exhibits a deep membrane-disturbing character, and we have 
observed how it modulates membrane structure. We propose here that those membrane 
regions already disturbed by SP-C could be prone to adopt lipid configurations that resist the 
development with organic solvent. A suitable explanation is the transient generation of inverse 
micelles such as the subunits of a HII structure. In that way, lipid polar headgroups would keep 
the solvation water in the inner part of the micelle, whereas acyl chains and the hydrophobic 
SP-C helix could be exposed to the organic solvent from the TLC developing phase (Fig. 4.8). This 
would explain why protein palmitoylation does not affect SP-C migration pattern (Fig. 4.3). Thus, 
the interactions dominating here would be mainly those established by the α-helical region of 
the protein with little contribution of the N-terminal segment. 
 
 
 
 
 
 
 
 
Figure 4.8. Model for SP-C-lipid complexes migrating thought the TLC plate. Membranes in the 
form of vesicles are deposited as aqueous solutions in the application point and air-dried. When 
the developing phase reaches samples, membranes are dissolved forming inverse micelles with 
a core of water in which the hydrophobic regions would be exposed to the organic solvent.  
 
Regarding the SP-C/cholesterol relationship, the evidence provided by this work does not 
support the establishment of a direct specific interaction, in agreement with the results 
described in Chapters 2 and 3. The SP-C/phospholipid interaction observed here remained 
unaltered under the presence of cholesterol, and apparently, no SP-C-cholesterol association 
was detected in the TLCs. This was deduced from the experiments with increasing SP-C-content, 
in which no protein was detected in association with the sterol-containing band. Similarly, when 
the fluorescent cholesterol analog TFC was incorporated into SP-C-containing membranes, no 
TFC fluorescence was observed in association to SP-C. Thus, to explain how cholesterol and SP-
C participate in the modulation of surfactant properties, a membrane environment seems to be 
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required. Whether cholesterol could interact differently with phospholipids due to the presence 
of SP-C or whether minor amounts (not detected by the TLC-fingerprinting assay) are present at 
the SP-C-associated band, needs further exploration. 
 Surprisingly, the preparation of Chol/SP-C particles resulted in non-soluble complexes in 
which cholesterol altered the apparent electrophoretic mobility of SP-C. Moreover, the 
application of these insoluble particles on a TLC demonstrated that SP-C was also able of 
migrating through the plate associated to cholesterol. However, in this case, since both 
components are non-soluble in water, a certain type of complex might self-associate to prevent 
exposure to the aqueous environment, but this does not necessary involve the establishment of 
specific cholesterol/SP-C interactions. This hypothetical complex could also retain some 
solvation molecules and develop in the TLC plate in a similar way to the one proposed here.  
To conclude, the migration pattern of SP-C through a TLC seems to be a combination of SP-C 
properties: small size, extreme hydrophobicity and strong membrane association. All of this, 
together with residual solvation water coming from membrane assemblies, could promote the 
generation of small lipid/SP-C particles under organic solubilization, which might be the clue to 
understand how this protein interacts with lipids. This technique is therefore useful to identify 
those lipids interacting with SP-C, and thus provides a way to infer the local lipid composition in 
SP-C partitioning regions in surfactant membranes. 
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Lung surfactant synthesis and degradation are critical processes with a direct impact on lung 
homeostasis. Alveolar type 2 cells (AT2) play a central role in these processes, constituting the 
only cell type capable of producing and secreting surfactant (9, 125). These cells are also involved 
in surfactant uptake, recycling and degradation, and despite the fact that they have been 
considered as the main actor in charge of these functions, the implication of alveolar 
macrophages (AMϕ) has been gaining relevance during the last years (135, 180, 181). The 
importance of AMϕ in surfactant catabolism becomes especially apparent in patients of 
pulmonary alveolar proteinosis, a disease characterized by the accumulation of abnormally high 
amounts of surfactant material in the alveolar spaces due to AMϕ dysfunction (179, 184). 
Therefore, a balanced action of AT2 cells and AMϕ is crucial, in which crosstalk mechanisms 
might be key to maintain lung homeostasis (9).  
Recent studies have linked AMϕ with cholesterol degradation in surfactant, a mechanism 
that seems to rely on GM-CSF and PPARγ dependent genes (135, 179–181). Some of the proteins 
are transporters involved in cholesterol efflux, such as the ATP-binding cassette ABCA1 and 
ABCG1, and influx, as the LDL receptor (LDL-R), scavenger receptors as SR-AI and CD36, enzymes 
involved in cholesterol synthesis and metabolism, such as the hydroxymethyl-glutaryl-coenzyme 
A reductase (HMGCR) and the sterol 27-hydroxylase (CYP27A1), and nuclear receptors as the 
liver X receptors LXRα and β, which in turn regulate several other mediators and proteins (135, 
180, 181). This illustrate the complexity of AMϕ response to lipid uptake and degradation and 
definitely prove that AMϕ constitute an active agent in surfactant catabolism and homeostasis. 
This is particularly interesting considering the controversy in the regulation of cholesterol levels 
in surfactant membranes and films (116, 118, 129, 137, 227, 277), which must be 
compositionally optimized to support breathing according to different respiratory demands. To 
date, the origin of surfactant cholesterol and the molecular mechanisms by which it is sensed by 
alveolar cells remain unknown, but current models have started to consider AMϕ as a suitable 
switch involved in cholesterol regulatory mechanisms.  
In different pulmonary diseases, such as the Hermansky-Pudlack syndrome or different forms 
of pulmonary fibrosis, and animal models of respiratory pathologies, AMϕ develop 
dysfunctional phenotypes leading to the appearance of lipid, and particularly cholesterol 
accumulation in the so-called lipid droplets (278–280). In certain pathological conditions, due to 
this accumulation, these macrophages acquire an increased granularity and a peculiar shape, 
reason why they are also are termed lipid laden or “foamy” macrophages (281, 282). In some 
instances, highly ordered cytoplasmic structures have been observed (283, 284), resembling 
cholesterol crystals reported in atherosclerosis (282, 285). Remarkably, SP-C deficiency has also 
been reported to alter AMϕ function and lead to lipid accumulation, and in a study, crystalline 
structures were also detected in AMϕ cytoplasm of SP-C KO mice (111). Thus, taking into 
account the role of AMϕ, and considering the combined effects of SP-C and cholesterol on lung 
surfactant structure and dynamics, we could speculate that the SP-C-cholesterol relationship 
could contribute to a homeostatic purpose.  
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In this chapter, we have assessed the possible physiological consequences of SP-
C/cholesterol combinations regarding cellular surfactant homeostasis. To explore the effect of 
SP-C and cholesterol on lipid uptake by AMϕ, a flow cytometry-based engulfment assay was 
performed in a murine alveolar macrophage cell line, MH-S. MH-S treated with vesicles of 
different composition were also analyzed by fluorescence and transmission electron microscopy 
and the effects of SP-C and cholesterol on lipid metabolism and transport were studied using 
RT-PCR.   
Our results suggest that surfactant-derived vesicles containing certain SP-C/cholesterol 
proportions increase lipid uptake in AMϕ and regulate the expression of several genes involved 
in lipid metabolism and transport.  These results provide the first proof of the implication of SP-
C in surfactant lipid engulfment depending on cholesterol, representing a possible mechanism 
involved in cholesterol regulation to maintain compositionally optimized lung surfactant 
membranes and films fully competent to sustain the respiratory function.  
 
 
Lipid engulfment in AMϕ  
Lung surfactant engulfment by MH-S cells was evaluated by means of flow cytometry. A 
clinical surfactant preparation (Curosurf; Chiesi Farmaceutici, Parma, IT), was labelled with a 5 
wt% fluorescent cholesterol analog, TopFluorCholesterol (TFC). This surfactant preparation 
consists in an organic extraction of porcine lung surfactant depleted of neutral lipids and thus, 
cholesterol. Therefore, Curosurf comprises surfactant phospholipids and the hydrophobic 
surfactant proteins SP-B and SP-C in a near-physiological proportion (199). To determine the 
most effective times and lipid concentration for assessing effects on lipid engulfment, a time-
course experiment adding different surfactant concentrations to MH-S cells was performed. 
Results are expressed in terms of %engulfment, defined as the percentage of positive cells for 
TFC fluorescence (Fig. 5.1a,b). 
According to our results, lipid uptake consists in a very fast process at the temperatures 
assessed here (23oC), resulting in lipid incorporation even at the shortest times (t<5min) (Fig. 
5.1c). Regarding lipid concentration, surfactant administered above 0.5 μg /105 cells leaded to a 
saturation in the engulfment index reaching values close to 100% of positive events after 5 min 
of treatment. Thus, in order to detect differences based on cholesterol or SP-C concentration, 
0.25 μg /105 cells and times ranging from 30 min to 1 hour were selected for subsequent assays. 
The fluorophore used for labelling lipid vesicles was a cholesterol fluorescent analog, hence, to 
account for cholesterol effects on lipid uptake, a validation of its possible interference with the 
engulfment assay was required.  A fluorescent lipid molecule also detected with the FITC filters 
(Bodipy PC, BPC), was selected to discard any particular effects of TFC on lipid uptake. Our results 
suggest that no significant increment in the engulfment index was due to the use of TFC, 
confirming that TFC could be reliably used to analyze the effect of cholesterol on lipid 
engulfment by AMϕ (Fig. 5.1d). Additionally, to discriminate between the engulfment of 
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surfactant vesicles and possible unspecific interactions that could lead to the association of 
labelled vesicles to the plasma membrane, experiments quenching the external cell fluorescence 
with Trypan Blue confirmed that fluorescence was unaltered upon quenching, confirming that 
the detected signal was specific to lipid engulfment. 
 
 
Figure 5.1. (a) Density plots illustrating cells in the FITC channel (TFC). Upon the addition of 0.25 
μg /105 cells of Curosurf, cells incorporating the fluorescent lipids shifted towards higher 
fluorescence intensities increasing along time. (b) Representative histogram showing an overlay 
of the FITC (TFC) fluorescence intensity reached for no lipid (black), 0.25 μg /105 cells at 5 min 
(red) and 1h (green). (c) Time-course engulfment of different lung surfactant concentrations by 
MH-S cells. (d) Lipid engulfment assessed by BPC-labelled Curosurf. Cell viability was above 80%. 
 
MH-S cells treated with 0.25 μg /105 of Curosurf for 1 hour were centrifuged and cytospin 
slides were stained using the Diff-Quik kit to assess cell morphology. MH-S cells remained 
apparently unaltered after lipid engulfment under the bright field microscope (Fig. 5.2). 
However, a detailed characterization by TEM resulted in the detection of cytoplasmic lipid 
inclusions consistent with the appearance of lipid droplets that were larger and more abundant 
in treated cells compared to the control.  
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Figure 5.2. Diff-quik staining of untreated MH-S cells (top left) and treated with 0.25 μg /105 cells 
of Curosurf for 1h (top right). Scale bar=10 μm. TEM micrographs of sections from non-treated 
MH-S cells (left, bottom panels) and treated with Curosurf (right, bottom panels). Lipid inclusions 
are marked with arrows. Scale bar=2 μm. 
 
 
Engulfment mechanism  
Macrophages exhibit a broad capacity of endocytosis being capable of engulfing bacteria, 
apoptotic cells or nanoparticles by different mechanisms. Some of them are receptor-
dependent, whereas others, as in the case of lipid vesicles, have been explored to less detail. To 
investigate the possible mechanisms ruling surfactant engulfment, inhibitors of different 
endocytic pathways were used and MH-S cells were treated with Curosurf (Fig. 5.3).  
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Figure 5.3. Inhibition of endocytic pathways in MH-S cells. All the inhibitors were incubated for 
30 min and washed prior the engulfment assay. Cells were treated with 0.25 μg /105 cells TFC-
labelled Curosurf for 1h. Data are presented as means ± SEM. Cell viability was above 70% for 
every treatment.  
 
Most of the treatments analyzed reduced lipid engulfment to some extent in comparison to 
untreated control cells, which reached 70% of positive events.  Amantadine (2.5 mM, (286)), 
cytochalasine D (2 μM, (287)) and chlorpromazine (10 μM, (288)) are considered as inhibitors of 
the clathrin-dependent endocytosis. Cytochalasine D disrupts actin polimerization whereas 
chlorpromazine avoids chlatrin coating of the endocytic vesicle. Amantadine acts at a different 
level, stabilizing chlatrin-coated vesicles hindering its dissociation. Despite the different acting 
mechanisms, all inhibitors reduce engulfment to a 30%. Cholesterol depletion caused by 
cyclodextrin treatment (2 mM, (289)) resulted in a surprisingly high %engulfment index, which 
was above the control. This could be interpreted as an increment of cell avidity for the sterol in 
order to replace cholesterol levels at the plasma membrane, although there is no evidence of 
similar results for comparable treatments in alternative cell lines. This could also be an effect 
not directly related to endocytosis, by which the cell could transfer directly lipids from the vesicle 
to the plasma membrane.  
Genistein (15 μM, (287)) is a tyrosine kinase inhibitor that destabilizes the actin network 
avoiding the recruitment of dynamin II, which is indispensable for caveolae-mediated 
endocytosis. Baphylomicin (0.1 μM, (290)), however, perturbs the H+ gradient by blocking H+-
ATPases avoiding acidification of endocytic vesicles. Both treatments leaded to an engulfment 
inhibition similar to those related to chlatrin-mediated endocytosis.  
CD14 is a membrane receptor involved in the recognition of bacteria lipopolysaccharide (LPS) 
and its endocytosis. There is evidence relating SP-C with CD14, demonstrating that not only it is 
able to bind LPS in a competitive manner (291, 292), but also interacts with CD14 modulating 
LPS recognition (124). Given these observations, we analyzed whether surfactant engulfment 
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could be related to an SP-C/CD14 interaction. CD14 blocking with a specific antibody also 
reduced slightly surfactant engulfment, possibly representing a minor specific pathway.  
Lastly, as negative control we blocked CD45, a membrane phosphatase expressed by 
macrophages with no reported implication in endocytosis. As expected, CD45 blocking did not 
reduce lipid endocytosis when compared with the control.  
 
Effect of cholesterol in surfactant lipid engulfment  
AMϕ have been specifically related to cholesterol metabolism in the lung. Thus, to analyze 
whether cholesterol could play a role in lipid engulfment, Curosurf preparations were incubated 
with different cholesterol amounts and lipid uptake was validated in MH-S cells (Fig. 5.4).   
 
Figure 5.4. Effect of cholesterol in lipid engulfment of a lung surfactant preparation by MH-S 
cells. (a) Time-course of lipid engulfment using 0.25 μg /105 cells of Curosurf labelled with 5 wt% 
TFC incorporating different amounts of cholesterol. (b) Lipid engulfment assay performed for 1h 
and 0.25 μg/105 cells of Curosurf vesicles labelled with 5 wt% BPC incorporating increasing 
cholesterol content.  
 
Cholesterol content seemed to increase lipid uptake, revealing higher %engulfment indexes 
for larger cholesterol proportions using two types of labelling, TFC or BPC. Besides, for the 
highest amount of cholesterol tested, saturation was rapidly reached, suggesting that cells had 
a larger affinity for cholesterol-containing vesicles. 
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Effect of SP-C on lipid engulfment 
Cholesterol seemed to have an effect on lung surfactant uptake by alveolar macrophages. 
However, how SP-C could additionally modulate this engulfment cannot be directly inferred 
from these experiments. To properly evaluate SP-C effects, lung surfactant phospholipids were 
isolated and combined with different amounts of SP-C and cholesterol. Time-course 
experiments were performed to assess lipid uptake in response to different SP-C (0, 1%, 5%, 
10%) and cholesterol (0%, 5%, 10%, 20%) concentrations over time. Our results displayed a high 
variability depending on the experiment and batch of SP-C employed. To reduce disparity and 
combine all data in a same analysis, data were normalized according to the saturation point in 
every plate, which was reached after 30 min treatment (Fig. 5.5). Despite the variability, vesicles 
incorporating the lowest amounts of SP-C seemed to have a slight tendency towards higher 
engulfment indexes in comparison to the pure lipid, although the effect of cholesterol in SP-C 
containing vesicles was not that clear. In the absence of SP-C, cholesterol leaded to an increase 
in lipid uptake, whereas for 1% and 5% SP-C, its effect was somehow balanced by the presence 
of the protein. Apparently, the incorporation of 10% SP-C resulted in larger engulfment indexes, 
both in the absence and presence of cholesterol, yielding a maximum lipid uptake value when 
cholesterol was incorporated (5-20%). This reveals that the proper combination of SP-C and 
cholesterol might influence macrophage endocytic activity, with possible implications in 
surfactant compositional refinement and lung homeostasis.  
 
Figure 5.5. Effect of SP-C and cholesterol on lipid engulfment by MH-S cells. Lipid vesicles 
containing the phospholipid fraction of surfactant (PL) were supplemented with different SP-C 
and cholesterol amounts. The results presented here represent the exposure of cells to a lipid 
concentration of 0.25 μg/105 cells for 30 min.  
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To further evaluate SP-C effects, we hypothesized that when excess cholesterol needs to be 
depleted from surfactant to achieve a proper biophysical activity, SP-C/cholesterol-enriched 
vesicles might be released from the surface-active material and follow degradation routes that 
might involve AMϕ. Thus, the effect of the larger SP-C and cholesterol amounts employed, 10 
wt% SP-C and 20 wt% cholesterol, was analyzed in subsequent experiments. Results from 
separate engulfment assays showed that although the increase in lipid uptake associated to SP-
C and cholesterol independent effects was not significant, the combination of both elements (10 
wt% SP-C and 20 wt% cholesterol) ended up into a significant increase in lipid engulfment (Fig. 
5.6a). These results are in agreement with our hypothesis, which involves the modulation of lipid 
uptake by SP-C and cholesterol enriched vesicles in AMϕ. 
 
Fig 5.6. Effect of SP-C and cholesterol-enriched vesicles on lipid engulfment by MH-S cells. (a) 
Lipid vesicles containing the phospholipid fraction of surfactant (PL) including either 10 wt% SP-
C and/or 20 wt% chol were added at a final lipid concentration of 0.25 μg/105 cells and assessed 
for 30 min. Data are presented as means ± SEM. Differences between groups were evaluated by 
one-way ANOVA with a post-hoc Tukey test (*p< 0.05, **p<0.001). (b) Epifluorescence 
micrographs of MH-S cells treated with surfactant-derived lipid vesicles (PL) or vesicles 
incorporating 10 wt% TxR-SP-C. DAPI-stained nuclei are observed in blue and TxR-SP-C in red. 
Scale bar= 50 μm. 
 
To narrow down the possible mechanisms ruling SP-C and cholesterol combined action, the 
subcellular localization of SP-C was analyzed upon the engulfment assay. Texas Red was used to 
label SP-C molecules at the N-terminal end, generating fluorescently labelled SP-C (TxR-SP-C). 
To avoid problems of detection limit, the amount of lipid employed in the engulfment assay was 
increased substantially. SP-C seemed to be restricted to the plasma membrane, where the 
fluorescence was localized in defined regions. However, whether SP-C does not enter the cells 
or whether it is redirected to the plasma membrane after the engulfment process are questions 
yet to answer.  
 
5. RESULTS. Chapter 5 
125 
 
Metabolism and lipid transport 
We have observed how SP-C in combination with cholesterol is able to modulate lipid uptake 
by an alveolar macrophage cell line. However, we were also interested in analyzing how these 
cells would respond to the engulfment of lipid vesicles with different compositions. With this 
purpose, MH-S cells were treated with surfactant-derived liposomes and the expression of 
several genes related to lipid transport and metabolism was analyzed by real-time PCR.  
MH-S cells were treated for 1h with liposomes with different compositions. In one group, 
cells were administrated 0.25 μg/105 cell of Curosurf or Curosurf supplemented with 20% 
cholesterol for 1h (Fig. 5.7 and 5.8). 
  
 
 
 
Figure 5.7. Clustergram showing the 
expression of genes related with lipid 
transport and metabolism in response to 
Curosurf treatment with or without 20 wt% 
cholesterol. Minimum expression levels are 
shown in red whereas maximum levels are 
represented in green. Samples and target 
genes are clustered according to similitudes 
in the expression profile. 
 
  
 
 
 
 
In these preliminary experiments, Curosurf treatment altered gene expression in MH-S 
incrementing expression of most of the analyzed genes, except for Msr1, coding for the 
scavenger receptor SRAI, and Pparγ. Genes coding for several enzymes involved in lipid 
metabolism such as the lysosomal acid lipase (Lipa) or the lysosomal phospholipase 2 (Lpla2) 
and those participating in cholesterol metabolism, including the cholesterol hydroxylase CH25H, 
or the sterol 27 hydroxylase, CYP27A1, were overexpressed in Curosurf-treated cells in the 
absence of cholesterol. This indicates that upon lipid uptake, MH-S cells apparently upregulate 
genes involved in lipid metabolism, promoting the degradation of newly incorporated lipid 
material. Nr1h2, coding for the nuclear receptor LXRβ (an sterol sensor), also appears 
overexpressed, and similarly, targets of the LXR/Retinoid X receptor heterodimer were 
increased, including genes for cholesterol efflux transporters such as Abca1 or Abcg1 (Fig.5.8). 
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Other lipid transporters such as  Niemann Pick type C 1 and 2 proteins (Npc1 and Npc2) appear 
increased at the mRNA level (293). There is a trend towards higher expression of genes coding 
for receptors involved in cholesterol/lipid uptake, such as the LDL receptor (LDL-R) or CD36, 
which could facilitate lipid uptake for its degradation.  
Figure 5.8. Gene expression of lipid metabolism and transport genes induced in MH-S cells 
treated with Curosurf or Curosurf/20% cholesterol measured 1h after treatment. Results are 
expressed as fold change with respect to the control (untreated cells). Data are presented as 
means ± SEM. Differences between groups were evaluated by one-way ANOVA with a post-hoc 
Tukey test (*p< 0.05, **p<0.001). 
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Cd36 and Abcg1 expression are known to be regulated by Pparγ in macrophages (135, 182, 
294), but in our case, Pparγ mRNA levels remain unaltered in Curosurf-treated cells, suggesting 
that alternative mechanisms might be involved. It is remarkable, however, the trend observed 
for the hydroxymethyl-glutaryl-coenzyme A reductase (HMGCR) expression, an enzyme 
implicated in cholesterol de novo synthesis. How lipid uptake could increase HMGCR mRNA 
levels seems contradictory, which reveals the complexity of pathways connecting lipid 
engulfment and gene expression in AMϕ. Strikingly, the engulfment of Curosurf supplemented 
with 20 wt% cholesterol resulted in gene expression levels similar to control cells. It might be 
then possible that supraphysiological amounts of cholesterol (~20 wt%) could alter lipid 
metabolism in AMϕ leading to lipid accumulation.  
Curosurf includes physiological proportions of proteins SP-B and SP-C. However, it does not 
allow the evaluation of possible effects associated specifically to SP-C. In the previous section, 
treatment with surfactant-derived vesicles incorporating 10 wt% SP-C and 20 wt% cholesterol 
leaded to an increased lipid uptake by MH-S cells. Thus, gene expression was evaluated for cells 
treated with the deproteinized phospholipid surfactant fraction (PL) or lipids supplemented with 
20 wt% cholesterol, 10 wt% SP-C or both (Fig. 5.9 and 5.10). As can be deduced from Fig. 5.9, 
there are considerable variations from sample to sample, specially concerning those 
incorporating SP-C. In the previous section, we described how the engulfment assay showed 
variability issues, which could be related to several factors going from SP-C batches to a 
differential response of MH-S cells depending on cell passage or cell state. Despite this 
variability, it is still interesting how the enzymes associated to cholesterol metabolism, CH25H 
and CYP27A1, exhibited an increased gene expression upon lipid treatment with any of the 
preparations used, as occurred in genes coding for the scavenger receptors SRAI and CD36.  
ABCA1 levels were slightly decreased for samples not including cholesterol, suggesting that 
cholesterol efflux in these cases might be regulated depending on the lipid composition of 
engulfed vesicles.  
 
Figure 5.9. Clustergram showing the 
expression of genes related with lipid 
transport and metabolism in response 
to the administration of lipid vesicles 
incorporating lung surfactant 
phospholipids (PL) supplemented 
with 10 wt% SP-C, 20 wt% chol or 
both. Minimum expression levels are 
shown in red whereas maximum 
levels are represented in green. 
Samples and target genes are 
clustered according to similitudes in 
the expression profile. Some samples 
have been removed from the scheme 
for clarity. 
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Figure 5.10. Gene expression of lipid metabolism and transport genes in MH-S cells treated with 
lung surfactant-derived vesicles measured 1h after treatment. Lipid suspensions used included 
the phospholipid fraction (PL), and PL supplemented with either 10 wt% SP-C, 20wt% Chol or a 
combination of both. Results are expressed as fold change with respect to the control (untreated 
cells). Data are presented as means ± SEM. Differences between groups were evaluated by one-
way ANOVA with a post-hoc Tukey test (*p< 0.05,**p<0.001). 
 
However, in general terms, nor SP-C or cholesterol presence modified gene expression 
significantly, with levels remaining in the range of control cells. Two genes appeared to be 
significantly altered by SP-C presence, Lpla2 and Npc2, both encoding lysosomal-produced 
proteins. This suggests that SP-C may directly or indirectly act through the endosomal/lysosomal 
system once the engulfment event has taken place. NPC2 is involved in the intracellular 
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mobilization of exogenous cholesterol, transferring non-esterified cholesterol from the lumen 
of late endosomes/lysosomes to NPC1, located in the limiting membrane. From there, 
cholesterol is exported to reach different cellular compartments, such as the endoplasmic 
reticulum and plasma membrane, although the molecular mechanism has not been defined yet 
(295, 296). Lysosomal phospholipase A2 (LPLA2) is highly expressed in AMϕ, and it is involved in 
surfactant catabolism (188, 297). Deficiency in this enzyme results in phospholipidosis, leading 
to lipid accumulation in the alveolar spaces (188, 297).  According to our results, Npc2 mRNA 
was substantially incremented when SP-C-containing vesicles were used in the absence of 
cholesterol, whereas Lpla2 expression was decreased both compared to the control and to 
vesicles incorporating SP-C/Chol. Again, these results seem to be contradictory, since they 
suggest that SP-C could be involved in promoting cholesterol mobilization from the endocytic 
vesicle to other cells compartments when no cholesterol is being incorporated, an effect that is 
no longer observed when SP-C is combined with 20 wt% cholesterol. Similarly to 
Curosurf/cholesterol treatment, it is possible that the use of such a high concentration of 
cholesterol render cells insensitive to it, resulting in cholesterol accumulation in AMϕ. However, 
how SP-C could reduce LPLA2 expression is an intriguing matter. One would think that upon lipid 
uptake, LPLA2 levels would be increased to facilitate lipid catabolism, although it is possible that 
SP-C might somehow regulate this process favouring lipid degradation through alternative 
mechanisms.   
 
 
The relevance of cholesterol and SP-C in lung surfactant dynamics and structure has been 
described in the previous chapters. To highlight the importance of the cholesterol/SP-C 
relationship in surfactant lipid membranes physiologically, we have analyzed the effect of the 
different lipid, cholesterol and protein composition in a model of one of the cells involved in 
lung homeostasis. With the aim to establish a connection with the biophysical properties of 
cholesterol and SP-C lipid mixtures, we propose here a cellular mechanism with potential 
relevance in vivo. 
Lung homeostasis results from the balance between surfactant synthesis and 
degradation/recycling, but specific mechanisms are still being explored. AMϕ play an important 
role in surfactant catabolism, and although they might not account for most of surfactant 
degradation (30%), AMϕ dysfunction give rise to lipid/cholesterol accumulation resulting in 
severe pathologies. These findings suggests that AMϕ could modulate cholesterol metabolism 
in the lung and participate in the regulation of surfactant cholesterol levels. To test this 
hypothesis, we have conducted experiments evaluating vesicle engulfment of a clinical 
surfactant preparation, Curosurf, and of samples with different compositions including 
surfactant phospholipids supplemented with variable amounts of SP-C and cholesterol. We 
considered SP-C as an interesting element to assess given its reported involvement in lung 
homeostasis (97, 123), its interaction with the AMϕ receptor, CD14 (124), and the particular 
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relationship stablished with cholesterol in surfactant membranes (25, 120, 121, 245). Besides, 
SP-C has been proposed before to increment lipid uptake by alveolar cells (298). Our results 
show that MH-S cells, an AMϕ-like cell line, are capable of engulfing Curosurf complexes 
extremely fast below physiological temperatures, showing lipid incorporation at the shortest 
times tested. This effect was dose and time-dependent, which is consistent with a previous study 
(299). This reveals the high efficiency of AMϕ in uptaking lipid assemblies from the environment, 
a property that could be likely related to their ability in regulating lung surfactant pools at the 
alveolar spaces. In addition, although MH-S can exhibit some lipid droplets in the absence of any 
treatment, incubation with the lower lipid concentrations resulted in a qualitatively apparent 
increment in the number of droplets, which also occurred with higher frequency. This further 
supports the role of AMϕ in both uptaking and metabolizing lipids, stressing their importance 
for surfactant clearance and metabolism.  
The engulfment of lipid vesicles by AMϕ seems to be related with membrane properties such 
as charge and fluidity (300–302). Furthermore, it has been suggested that membrane lateral 
structure could be involved in a preferential engulfment by macrophages without the need of 
specific recognition by a cellular receptor (302). Cholesterol modulation of membrane fluidity 
and lipid packing has been studied thoroughly, and in previous chapters we have described how 
SP-C and cholesterol modulate membrane properties altering membrane lateral structure and 
lipid dynamics. Thus, the preferential engulfment of vesicles with a certain SP-C/Chol ratio 
observed here could be explained by the adoption of certain membrane properties, although 
possible receptor-mediated recognition cannot be ruled out. Similarly, cholesterol incorporation 
into Curosurf could enhance lipid engulfment by a similar process, since cholesterol 
incorporation in surfactant is reported to modulate membrane fluidity. Interestingly, although 
there is some controversy, some reports have pointed to preferential lipid uptake in the form of 
small vesicles rather than larger liposomes by macrophages (303, 304), an effect that translated 
to AMϕ, could be related to the degradation/recycling of surfactant in the form of the less 
surface-active small aggregates (SA), lipid assemblies derived from “exhausted” surfactant 
(305). Then, SP-C activity could influence macrophage engulfment by generating small vesicles 
that might be enriched in less active surfactant components, a feature we described in Results 
Chapter 2.  
Inhibition of clathrin-mediated (amantadine, cytochalasine D and chlorpromazine) and 
caveolae-dependent endocytosis (genistein) as well as the disruption of endocytic vesicle 
acidification process (baphylomycin) resulted in a similar reduction of the engulfment index, 
suggesting that lipid uptake does not occur through a single pathway and several mechanisms 
might be involved. Cholesterol depletion of the cell plasma membrane induced by cyclodextrin 
treatment resulted in a higher lipid uptake measured as %engulfment.  This could result from a 
compensatory mechanism, by which the cell could transfer directly lipids from the vesicles to 
the plasma membrane to quickly replace cholesterol levels. Surprisingly, CD14-blocking also 
resulted in a slight decrease in lipid uptake (~18%). Given SP-C/CD14 reported interaction (124), 
we could hypothesize that a minor part of surfactant vesicles could be engulfed in a CD14-
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mediated manner. Besides, an specific SP-C/receptor interaction could explain the observed 
characteristic SP-C localization in the plasma membrane, where its seems to be confined in 
defined regions. Nevertheless, studies specifically assessing the possible implication of CD14 in 
lipid endocytosis and whether SP-C could be involved are required to contrast this hypothesis.  
In this study, lipid uptake by MH-S cells seemed to be influenced by lipid composition and SP-
C content. To evaluate the effect of lipid engulfment, the expression of several genes involved 
in lipid transport and metabolism were analyzed. In AMϕ, PPARγ is the master element 
regulating lipid metabolism (135, 180, 181). PPARγ has been related to GM-CSF-induced 
signaling, and it coordinates with the sterol regulatory-element binding proteins (SREBPs) and 
the liver X receptors (LXRs) to regulate lipid metabolism in AMϕ. Several genes have been 
associated to PPARγ regulation in vivo, including ABCG1, SRA-I, CD36, LXRα, CYP27A1, SREBP2, 
HMGCR, and LDL-R (135). Therefore, we intended to analyze how these genes were altered by 
lipid engulfment specially observing effects focusing the effects on PPARγ mRNA levels. Our 
results suggest that lipid engulfment elicited a complex response according to changes in gene 
expression, in which both cholesterol and phospholipid metabolism genes seemed to be 
involved. Although no changes in PPARγ expression were observed in cells treated with Curosurf, 
they displayed an increased gene expression affecting cholesterol efflux transporters ABCA1 and 
ABCG1, enzymes implicated in cholesterol (CH25H and CYP27A1) and phospholipid metabolism 
(LAL, LPLA2). However, we have shown for the first time that receptors in charge or cholesterol 
uptake (CD36, LDL-R) and enzymes participating in cholesterol de novo synthesis (HMGCR) also 
showed increased expression levels. Hence, a possible explanation would be that macrophages 
could trigger a general response towards lipid degradation and efflux upon lipid engulfment and 
at the same time, they could sense cholesterol absence in the engulfed vesicles resulting in 
activation of cholesterol uptake and synthesis. Strikingly, the addition of supraphysiological 
cholesterol concentrations to Curosurf preparations resulted in gene expression levels similar to 
the control, indicating that high cholesterol concentrations might lead to cell desensitization 
after lipid engulfment resulting in lipid accumulation as occurs in some respiratory disorders. In 
the case of vesicles made of lung surfactant phospholipids (PL), results also showed some 
controversy. In general, there was a trend towards higher expression of the cholesterol 
metabolism enzymes CH25H and CYP27A1, as well as it occurs for scavenger receptors SRA-I and 
CD36, regardless of SP-C or cholesterol presence. SP-C incorporation seemed to increment 
specifically Npc2 and decrease LPLA2 mRNA levels in the absence of cholesterol. Thus, we show 
for the first time that SP-C could promote cholesterol intracellular mobilization from the 
endocytic vesicle to other compartments through Npc2, whereas it could reduce phospholipid 
metabolism by reducing LPLA2 mRNA levels. These effects seem to be contradictory, but 
pathways for cholesterol synthesis, degradation and mobilization in alveolar macrophages are 
still unknown. This means that further investigation is needed to understand lipid metabolism 
in these cells. 
The results obtained from gene expression analysis suggest that lipid uptake/engulfment by 
MH-S cell lead to complex changes in gene expression associated to lipid metabolism and 
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transport. These effects seemed to depend on lipid composition, including the presence or 
absence of SP-C and/or cholesterol. Nevertheless, the information obtained from these 
experiments should be considered cautiously. To properly understand the response of AMϕ to 
lipid uptake and interpret the implication of changes in gene expression, additional evidence 
concerning treatment time and lipid concentration must be collected. Besides, variability issues 
prevent us to clearly conclude  the effects of SP-C and cholesterol, in which cell compensatory 
mechanisms might also be involved. The use of intermediate amounts of SP-C and cholesterol 
could provide important information concerning whether a threshold must be reached to trigger 
changes in gene expression. 
We are aware that the use of an immortalized murine alveolar macrophage cell line, MH-S, 
presents some limitations. Although the phagocytic capacity of this cell line seems to resemble 
that of primary AMϕ, they differ in some features as in the expression of certain surface markers 
(306). For this reason, the extrapolation of these results to the behavior of primary AMϕ must 
be done carefully. The complementation of these results with experiments using primary AMϕ 
would provide a wider overview of how AMϕ respond to lipid engulfment validating the results 
obtained here.  
The evidence obtained in this chapter contributes to support the important role of AMϕ in 
lipid uptake and clearance, essential to maintain surfactant pools assuring a proper respiratory 
function. Lipid engulfment results in changes in gene expression with potential consequences in 
lipid mobilization and metabolism, and we have described a particular effect of SP-C and 
cholesterol on vesicle uptake. These encouraging results define a new line of research based on 
SP-C and cholesterol effects on lung homeostasis. Besides, plenty of different molecular 
metabolic pathways in macrophages need to be investigated in detail. Additional aspects, such 
as differential macrophage polarization, should be considered in the future experiments. This 
would contribute to the elucidation of the AMϕ role in integrating the immune response and 
the regulation of lung surfactant homeostasis, in which SP-C and cholesterol are promising 
candidates.   
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A proper respiratory function depends on the activity of lung surfactant, a lipid protein 
complex compositionally optimized to support breathing. From all surfactant components, the 
relevance of the hydrophobic surfactant proteins SP-B and SP-C becomes evident from 
respiratory pathologies resulting from their deficiency. SP-B absence renders surfactant 
dysfunctional, leading to respiratory failure upon birth (64–66). However, SP-C has been 
associated to the long-term stabilization of the lung (110). The lack of SP-C is related to 
pulmonary pathologies developed progressively with age and whose severity strongly depends 
on the genetic background (111–115). SP-C-related disorders are more often caused by mutant 
forms of the protein that fold improperly (307), generating protein structures that are cytotoxic 
for alveolar cells and result in conformational lung disease (97). SP-C-associated functions 
overlap in many cases with SP-B activity, at least when assayed in different in vitro models. This 
includes facilitating lipid adsorption (102–104) into the air-liquid interface or generating 3D 
structures that serve as a surfactant reservoir  (60, 103), which stores newly secreted surfactant 
complexes and surfactant molecules squeezed out from the interface upon compression. In this 
context, SP-C could be figured as a supporting molecule for SP-B function rather than an element 
competent by itself to assist specific features of the complex and dynamic surfactant 
functionality. Nevertheless, considering the extensive processing of SP-C to its mature form, its 
extremely conserved sequence and tissue-specific localization, and the difficulties that a cell 
must overcome to produce and store such a hydrophobic molecule, it is unlikely that this peptide 
appeared evolutionarily just as an alternative strategy to assist SP-B activities.  
With this in mind, in this Thesis we aimed to shed light on SP-C specific activities considering 
a relevant structure-function determinant, the palmitoylation of the protein. This covalent 
modification takes place early during SP-C processing (150), and it has been considered as an 
important element stabilizing SP-C α-helical structure (157, 210, 213). One of the main roles 
associated to SP-C acylation is its participation in monolayer/bilayer and bilayer/bilayer 
contacts, which could explain how such a small protein can lead to the generation of bilayer 
stacks associated to the interfacial surfactant film (60, 121). Thus, to deduce palmitoylation-
dependent SP-C features, we carried out an ATR-FTIR study on lipid-protein multilayered 
membranes in which protein structure, orientation and lipid-protein interactions could be 
analyzed (Chapter 1). According to our results, acylation did not affect α-helical content, since 
both native SP-C and non-palmitoylated rSP-C were determined as ~80% α-helical. However, 
although palmitoylation itself might not be involved in promoting the adoption of a certain 
protein structure, it could contribute to stabilize the SP-C α-helix (157, 210, 213). This effect is 
manifested in Chapter 3, in which the effects of different rSP-C variants could be explained in 
terms of protein structure, suggesting that non-palmitoylated protein forms are more prone to 
aggregation.  SP-C structure was neither dependent on the composition of the lipid systems used 
in Chapter 1, which were systematically varied to assess effects on lipid-protein interactions.  In 
these lipid systems, SP-C showed little effect on packing or mobility of lipid acyl chains as 
detected by the degree of trans-gauche isomerizations, which in average, were not indicative of 
any specific effects derived either of protein incorporation, or protein palmitoylation. In Chapter 
3, however, 2H-NMR experiments revealed that SP-C induced segregation into a highly ordered, 
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possibly interdigitated, phase and a liquid crystalline phase. Besides, according to our 
estimations, lipid species contributed unevenly to ordered domains, which were enriched in 
DPPC and POPG and partly depleted in POPC. In average, an increase in lipid order was also 
detected by ESR, involving acyl chains positions (n=12) close to the hydrophobic core of the 
membrane, and the polar headgroup (n=5). The discrepancy regarding lipid fluidity and order 
between ATR-FTIR results (Chapter 1) and the results obtained by 2H-NMR and ESR (Chapter 3), 
can be explained in terms of sample hydration. For ATR-FTIR experiments, lipid and lipid/protein 
films are prepared by deposition and partial drying on the ATR crystal, resulting in films retaining 
just solvation water molecules. 2H-NMR and ESR, though, require highly concentrated lipid 
suspensions in which the level of membrane hydration is substantially higher than for ATR-FTIR 
films. Therefore, partly dehydrated films such as those examined by ATR-FTIR would possibly 
remain in a more packed state, in which the ordering induced by SP-C or by the non-
palmitoylated rSP-C might pass undetected.  
Protein palmitoylation has been shown to be important to define SP-C configuration into 
lipid membranes and modulates lipid-protein interactions (Chapter 1). Regarding ATR-FTIR 
results, we have described that palmitoylated SP-C suffered a higher tilting degree that non-
palmitoylated rSP-C in the lipid systems studied. This is consistent with a deeper embedding in 
the membrane promoted by the palmitic chains, which could pull the protein towards more 
tilted configurations. In the same line of reasoning, we also observed that palmitoylation 
promoted a deeper water penetration on the membrane polar region, affecting phosphate 
vibrations to a wider extent. These effects can be related to the ability of the protein to induce 
lipid interdigitation (Chapter 3), characterized by a high hydration level at the polar headgroup 
and increased acyl chain order. We have proposed that SP-C mediated-lipid segregation could 
be triggered by the interaction of the N-terminal segment of the protein and the polar region of 
the membrane (Chapter 3), an effect that seems to depend on protein palmitoylation to 
maximize the differences between lipid species involved. In lung surfactant and surfactant-
mimicking membranes, SP-C is not randomly distributed and localizes specially at the boundaries 
between liquid-ordered and disordered domains in bilayers (25) and between liquid-expanded 
and condensed phases in monolayers (105, 226). In addition, SP-C palmitoylation has been 
described to couple N-terminal acyl motion to those of DPPC (308), and it has been suggested 
as a relevant element to generate interdigitated phases (244). This evidence is in agreement 
with the results from Chapters 1 and 3, indicating that protein palmitoylation is important to 
define a proper SP-C configuration in surfactant membranes and films, which assists protein-
induced interdigitation by maximizing the differences between the lipids species involved in SP-
C-induced lipid domains (Chapter 3).  
SP-C tilted configuration could be associated to the dimerization of the protein. As previously 
discussed, SP-C has been reported to dimerize during the processing of the proSP-C precursor 
along the exocytic pathway (149), and although proof of the functionality of SP-C dimers is still 
limited (240), some models have reported the potential dimerization of the protein though the 
AxxxG motif (212, 241).  Besides, this motif is extremely conserved through evolution, suggesting 
6. GENERAL DISCUSSION 
139 
 
it could be an important structural factor to account for SP-C function. As illustrated in Chapter 
2, for SP-C dimers to accommodate in a lipid bilayer, each monomer should be tilted with respect 
to membrane normal, adopting a conical configuration. Accordingly, the accumulation of several 
dimers in a certain region could alter membrane curvature, a process that could explain the SP-
C-induced fragmenting effect into small and highly curved vesicles (Chapter 2). We have 
detected that the non-palmitoylated protein form, rSP-C, also induced membrane 
fragmentation. Preliminary experiments, however, suggested that the vesicles generated were 
slightly larger (~40 nm) than those generated by SP-C activity (~20-30 nm). Differences in tilting 
regarding SP-C acylation state could be the reason behind this difference; however, further 
research is required to define the role of SP-C palmitoylation in the membrane fragmenting 
effect.  
We have discussed that the membrane fragmenting effect (Chapter 2) and lateral 
segregation (Chapter 3) induced by SP-C are consistent with SP-C tilted configuration (Chapter 
1). These lipid reorganizations could be viewed as different intermediary states of a same 
process. First, SP-C could promote phase segregation separating DPPC-enriched regions from 
unsaturated phospholipids, as depicted in the model suggested in Chapter 3. The packing 
defects generated between domains could be the first step towards curved structures 
facilitating membrane budding, a process that could depend on a certain amount of SP-C to be 
accumulated. Thus, the interdigitated phase promoted by SP-C could be an intermediate state 
between the interfacial monolayer and the underlying multilayered reservoir, stressing the 
importance of SP-C induced membrane reorganizations in the dynamic structure of lung 
surfactant.  SP-C induced interdigitation might also be involved in the final membrane fission 
producing the transformation of large membranes into small nanovesicles. These two SP-C 
effects, membrane-fragmenting and lipid interdigitation, could be somehow related to the 
selective protein/lipid interactions revealed by the TLC analysis performed in Chapter 4. Lipids 
enclosed by the SP-C or rSP-C dimeric configuration or those forming part of the protein-
promoted interdigitated regions would be tightly immobilized. As a result of these strongly 
stablished protein/lipid interactions, SP-C/lipid complexes appear after organic solubilization as 
detected by the TLC-based method described in this Thesis (Chapter 4). We propose that inverse 
micelles could explain the behavior of these protein/lipid complexes, which somehow simulate 
the air-liquid interface (apolar organic phase: air, micelle polar core: aqueous subphase).  
Shifting the individual observations based on SP-C analysis to surfactant behavior in the lung 
requires the consideration of additional important factors such as SP-B effects. SP-B presence 
counteracted the SP-C-induced membrane fragmentation, indicating a relevant SP-B/SP-C 
relationship. This has been manifested before, such as in the combined SP-B/SP-C effects on 
membrane permeability and stability (85) or even in lamellar bodies unfolding (90). It is also 
important to note that SP-B/SP-C complexes as assembled and secreted in lamellar bodies might 
differ from those established by the combination of independently isolated SP-B and SP-C. This 
suggests that SP-B/SP-C interactions could have a different nature depending on the particular 
stage of pulmonary surfactant metabolism, including surfactant biogenesis and secretion, the 
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generation of the different surfactant extracellular forms, surfactant interfacial activity and 
surfactant degradation and recycling.  Whether this relationship occurs though specific 
protein/protein interactions o indirectly through protein-induced membrane alterations 
requires further study, but it remains clear that both proteins regulate lung surfactant structures 
in a coordinate manner to support surfactant function.  
A second focus of this Thesis has been the analysis of SP-C and cholesterol relationships in 
the lung surfactant context. As we have extensively discussed, cholesterol is one of the most 
controversial elements of surfactant. Its origin has not been completely elucidated yet, even 
though several studies have been carried out to assess this issue (9). The presence of cholesterol 
establishes a marked segregation of fluid phases in surfactant (23, 119), and variations in 
cholesterol levels are known to adapt surfactant structures extremely fast to defined 
physiological situations (129, 131). This evidence highlights cholesterol as an structural 
modulator of surfactant membranes and films, and indicates that mechanisms involved in 
cholesterol sensing and mobilization may be evolutionary conserved to regulate cholesterol 
levels in surfactant. Considering this, recent evidences pointed to SP-C as a suitable molecule 
involved in cholesterol regulation (25, 120, 121, 245), which could also be linked to the role of 
SP-C in lung homeostasis. Therefore, we have analyzed the role of SP-C in cholesterol 
mobilization and dynamics considering also effects on membrane structure.  
The effect of SP-C in cholesterol mobilization was described in Chapter 2, which seemed to 
depend on protein-induced alterations in membrane structure. Cholesterol motion was higher 
upon incorporation of SP-C into vesicles, an effect potentially associated to the SP-C-promoted 
membrane-fragmenting effect. The increase in cholesterol motion was also observed in the 
most physiological system tested (surfactant-derived membranes), in which the coordinated 
effect of the native hydrophobic protein fraction of surfactant (SP-B and SP-C) was resulted in a 
significant increase of cholesterol motion. In Chapter 3, it has been described how SP-C and 
cholesterol are related in modulating membrane architecture, responding in a coordinate 
manner to temperature changes. Together with the observations made in Chapter 2, this 
evidence suggest that SP-C is involved in cholesterol mobilization by altering membrane 
structure. In addition, taking into account that SP-C supplementation restores the functionality 
of cholesterol-containing films in a dynamic context (120, 121), these results support the 
hypothesis that SP-C could be related to the compositional refinement of lung surfactant films 
from less surface-active molecules, involving cholesterol and other unsaturated phospholipids. 
Interestingly, observations made by Leonenko et al. (277) could support this hypothesis. The 
incorporation of increasing amounts of cholesterol in a surfactant clinical preparation resulted 
in structurally and functionally different interfacial films (118, 277). Compression-expansion 
isotherms allowed the determination of lipid loss from the interfacial film upon compression, 
which were considerably low for physiological cholesterol amounts, permitting the re-
establishment of a functional interfacial film (118, 277).  Shifting that to SP-C function, lipid loss 
occurring for physiological cholesterol levels could be associated with an SP-C-dependent 
cholesterol depuration, in which SP-C-induced lipid reorganizations could be involved. However, 
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lipid loss increased substantially upon cholesterol increase beyond physiological levels, showing 
a markedly different film structure and impaired functionality (118, 277). For these 
supraphysiological cholesterol levels, the SP-C amount present in a clinical surfactant 
preparation like the one tested in this study (~1 wt%), is likely insufficient to overcome 
cholesterol impairing effects and the irreversible film collapse. Supplementation of these films 
with different SP-C amounts would provide valuable information to confirm SP-C effects on 
cholesterol mobilization.    
To test the hypothesis that SP-C/Cholesterol relationships might be involved in surfactant 
refinement with a homeostatic purpose in the lung, we analyzed the effect of cholesterol- and 
SP-C-containing vesicles on one of the cell types involved in lung homeostasis, the alveolar 
macrophage (Chapter 5). Alveolar macrophages were chosen over type II epithelial cells given 
their implication in lipid and cholesterol transport and metabolism (135, 180, 181), which 
seemed to be altered in different respiratory pathologies due to macrophage dysfunction (179, 
186, 229). As a model, the murine AMϕ-like cell line MH-S was used. According to our results, 
although SP-C on its own did not elicited significant changes in lipid uptake, its combination with 
cholesterol apparently regulated lipid engulfment. Increased cholesterol content, however, 
seemed to increase lipid uptake by alveolar macrophages regardless of the presence of SP-C. 
Lipid engulfment did not seem to be restricted to a unique mechanism, and possible receptor-
mediated processes cannot be discarded. Vesicle size and membrane fluidity can affect lipid 
uptake by alveolar macrophages, and thus, the combined effect of cholesterol and SP-C on 
membrane structure and fluidity analyzed in previous chapters (2 and 3) is a factor that must be 
taken into account. The study of the transcriptional response of MH-S cells to lipid 
administration revealed that genes associated to lipid metabolism and cholesterol transport 
were altered upon lipid uptake. Changes in gene expression appear to depend on lipid 
composition, including the presence or absence of SP-C and/or cholesterol. However, specific 
effects of cholesterol and SP-C require a thorough and extensive analysis, which also require a 
deeper exploration of the poorly studied pathways for cholesterol synthesis, degradation and 
mobilization in alveolar macrophages. It must be considered that MH-S cells share several 
properties with AMϕ such as phagocytosis, although they differ in certain characteristics such 
as some surface markers (306, 309). For this reason, the complementation of these results with 
experiments using primary AMϕ would provide a way of validating the results obtained here, 
and contribute to the understanding of how AMϕ respond to lipid engulfment.  
The evidence presented in this Thesis illustrates how specific SP-C-induced membrane 
reorganizations support the complex and dynamic behavior of lung surfactant structures, 
providing proof of SP-C-induced membrane fragmentation and revealing SP-C-promoted lipid 
segregation in surfactant-mimicking membranes. The results introduced here constitute robust 
arguments supporting a physiological role for SP-C and cholesterol relationships in lung 
homeostasis involving alveolar macrophages, a hypothesis tested for the first time in this Thesis. 
SP-C could then be considered as a pivotal molecule linking cholesterol and lipid homeostasis, 
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lung immunity and lung surfactant biophysics, which would explain its particular features, lung 
tissue specific localization and sequence conservation along evolution.  
Several questions remain to be answered, including how SP-C effects are coordinated with 
SP-B function to modulate surfactant activity; which are the molecular mechanisms and SP-C 
structural determinants involved in membrane reorganizations; and how cholesterol levels in 
surfactant are sensed and regulated regarding SP-C function by both type II alveolar cells and 
alveolar macrophages.  Future research assessing these questions would constitute an essential 
piece to understand the molecular mechanisms ruling lung surfactant behavior and its 
implication in respiratory pathologies, generating valuable information useful to improve the 
current clinical preparations applied for surfactant replacement therapy. 
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The experimental work presented in this Thesis has revealed specific SP-C effects on 
membrane structure and lipid dynamics, which in combination with the role played by 
cholesterol, are important to understand the relevance of SP-C in the framework of lung 
surfactant function and homeostasis. In general terms we may conclude:   
1- SP-C palmitoylation does not affect protein structure incorporated in lipid membranes 
but contributes to SP-C α-helix stabilization. N-terminal acylation of SP-C leads to a 
greater protein tilting degree with respect to the membrane normal in most of the lipid 
systems studied, increasing the polarity at the phosphate region of the lipid bilayer and 
promoting  SP-C-lipid interactions at this level. Thus, it is confirmed that palmitoylation 
is an important feature to define a functionally optimal SP-C configuration in lipid bilayers 
and monolayers. 
 
2- SP-C and the native hydrophobic protein fraction of surfactant, incorporating SP-B and 
SP-C, affect specifically cholesterol mobilization in lipid bilayers. This was revealed by a 
decreased partition of the cholesterol fluorescent analog, cholestatrienol, in lipid 
membranes over the solubilizing agent methyl-β-cyclodextrin. The same behavior was 
observed for different lipid compositions including POPC model membranes, surfactant-
derived lipid vesicles or surfactant mimicking systems such as DPPC/POPC/POPG 
50:25:15 w/w/w. This effect suggests a role for SP-C in cholesterol mobilization and 
regulation in surfactant membranes with potential implications in lung homeostasis. 
 
3- SP-C-induced structural modifications in lipid bilayers results in liposome fragmentation 
into highly curved and small vesicles. Membrane composition did not affect this SP-C-
associated activity, which apparently was not dependent on SP-C palmitoylation. SP-B 
counteracted SP-C-induced effects, indicative of either a direct protein/protein 
interaction or balanced SP-B and SP-C modulating effects on membrane structure.  
 
4- 2H-NMR studies demonstrated that SP-C induces phase segregation in lung surfactant-
mimicking membranes in a cholesterol and temperature-dependent manner as shown in 
DPPC/POPC/POPG (50:25:15 w/w/w) membranes. In the absence of cholesterol, SP-C 
leads to the segregation of a highly ordered and a liquid crystalline phase at physiological 
temperatures, whereas upon cholesterol addition phase segregation occurred at 30oC. 
Cholesterol dynamics did not seem to be affected by SP-C, rSP-C, SP-B or the native SP-
B/SP-C protein fraction, at least in the microsecond time scale sampled by 2H-NMR 
experiments. However, SP-C and cholesterol combined effects on membrane structure 
and lateral segregation suggest a contribution of SP-C on cholesterol modulating activity 
on surfactant structures. 
 
5- The lipid ordered phase induced by SP-C in the absence of cholesterol is consistent with 
an interdigitated structure that accommodates DPPC, POPC and POPG to different 
extents. This differential accommodation seems to depend on protein palmitoylation. 
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The restriction in lipid mobility related to SP-C incorporation was confirmed by ESR 
experiments.  
 
6- The effects on membrane structure induced by SP-C are associated to strong 
protein/lipid interactions that can resist organic solvent solubilization. The TLC-based 
method developed here permits the identification of selective lipid/lipid and 
lipid/protein interactions such as those described for SP-C.  
 
7- SP-C and cholesterol increased lipid uptake by a murine alveolar macrophage cell line, 
MH-S. Several mechanisms appeared to be involved in lipid engulfment, including 
receptor-unspecific and receptor-specific pathways. After the engulfment process, SP-C 
was confined at defined regions in the plasma membrane suggesting a role for SP-C in 
lipid uptake and/or vesicle endocytic processing. Lipids were accumulated intracellularly 
in the form of lipid droplets. 
 
8- Lipid uptake elicits alterations in the transcriptional estate of alveolar macrophages. 
Genes coding lipid and cholesterol transporters, enzymes implicated in lipid metabolism 
or different transcription factors were affected depending on the composition of the 
vesicles engulfed. Additional experiments are required to define specific gene targets 
responding to SP-C and/or cholesterol incorporation.
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Synthetic lipids were purchased from Avanti Polar Lipids (Alabaster, AL) and chemicals and 
reagents were supplied by Sigma Aldrich (St. Louis, MO) unless otherwise stated.  Chloroform 
(Chl) and methanol (MeOH) were from LabScan (Gliwice, POL). 
 
Customized lipids and fluorescent probes were synthetized by Prof. Peter Slotte´s group in 
the department of Biosciences, Abo Akademi, Turku (Finland).    
Palmitoyl sphingomyelin (PSM) was purified from egg yolk sphingomyelin by reverse-phase 
high-performance liquid chromatography (HPLC) using MeOH/water (95:5, v/v) as the eluent. 
Δ5,7,9Cholestatrien-3β-ol (CTL) was synthesized from 7-dehydrocholesterol as described (310). 
Purified CTL was aliquoted and stored dessicated under N2 at -700C in light protected vials until 
used.  18:1-DPH-PC (1-oleoyl-2-propionyl-DPH-sn-glycero-3-phosphocholine) was prepared 
from 1-oleoyl-2-OH-sn-glycero-3-phosphocholine and DPH-propionic acid (Setareh Biotech, 
Eugene, OR) according to established methods (311, 312). The probe was purified by preparative 
HPLC (Discovery C18 column; Supelco, Bellefonte, PA) with methanol as the eluent. The purity 
and identity of DPH-PC were assessed by electrospray ionization mass spectrometry and 
analytical HPLC. The concentrations of the fluorophore stock solutions were determined based 
on their molar extinction coefficients (DPH-PC: 88,000 cm-1 M-1 at 350 nm in methanol; CTL: 
11,250 cm-1 M-1 at 324 nm in ethanol).  
Lung surfactant was isolated from bronchoalveolar lavage fluid (BALF) of slaughtered porcine 
adult fresh lungs and purified as described (313). Approximately a total of 2.5L of cold 0.9% NaCl 
per complete respiratory apparatus (lungs and trachea) was used (2-3 lavages were performed). 
The recovered bronchoalveolar fluid (BALF) was filtered through a gauze and centrifuged (1000g 
5min 4ºC) to eliminate cells and debris. Typically, BALF was stored at -20ºC until employed. To 
obtain the surfactant active fraction, constituted by surfactant large aggregates, BALF was 
thawed at 4ºC and centrifuged in a first step at 100000g for 1h at 4ºC. This step yielded the 
recovery of membranes in the pellet. A subsequent gradient centrifugation allowed the 
separation of lung surfactant complexes from other cell lipids and membranes based on their 
differential density. Pellets were thoroughly resuspended in a solution containing 16% NaBr 
0.9% NaCl and the discontinuous gradient was formed by slowly adding 13% NaBr 0.9%NaBr and 
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0.9%NaCl on top of the heavy solution. Tubes were centrifuged in a swinging angle rotor (SW40 
Ti, Beckman Coulter) at 120000g for 2h at 4oC. Surfactant complexes were concentrated 
between the lighter solution (0.9% NaCl) and the medium dense one, 13%NaCl 0.9%NaCl. After 
removing carefully the first solution, surfactant pellets were transferred to a homogenizer, 
diluted with 0.9% NaCl and aliquoted. This is the thereafter defined as native surfactant, and 
contained the lipid fraction of surfactant as well as surfactant associated proteins SP-A, SP-B and 
SP-C. Other proteins closely interacting with surfactant such as traces of immunoglobulins and 
hemoglobin are also co-isolated with surfactant complexes. Native surfactant was frozen in 
liquid N2 and stored at -80oC until employed.  
To obtain lung surfactant hydrophobic constituents, an organic extraction following the 
procedure established by Bligh and Dyer was performed (see Organic Extraction below) (314). 
The Chl/MeOH fraction was termed surfactant organic extract, called hereafter OE, and 
contained surfactant lipids and the hydrophobic proteins SP-B and SP-C. To allow the separation 
of lung surfactant constituents, the OE was concentrated using a rotary evaporator and 
chromatographed using a gel filtration resin (Sephadex LH-20, GE Healthcare; Little Chalfont, 
UK), with Chl/MeOH (1:1, v/v) acidified with 0.05% HCl (0.1N)  as the eluent in a 1000mm-SR25 
column (Ge Healthcare, Little Chalfont, UK). This column was operated by gravity and permitted 
the separation of proteins and lipids. Absorbance at 240 and 280 nm was measured to detect 
fractions containing either protein or lipids. The proteins eluted in the void volume given their 
large size compared to the lipids. Thus, the native hydrophobic protein fraction, containing SP-
B and SP-C in their natural protein/protein ratio, was obtained in the first peak and termed Prot. 
The second fraction corresponded to surfactant phospholipids and was designated as PL, and 
the third fraction, containing the neutral lipids, was named N. All fractions were preserved at -
20oC and recombined taking into account their volumetric proportions as eluted from the 
column.  
 
Native surfactant proteins SP-B and SP-C were isolated from porcine lungs as described (273). 
A complete respiratory apparatus was minced and lavaged with 1L 0.9% NaCl. Minced and 
lavaged lungs were extensively filtered and the resulting lavage was centrifuged in two steps. 
The first centrifugation (5min 1000g 4oC) yielded the elimination of cells and debris in the pellet. 
A second centrifugation (2h 3000g  4oC) allowed the recovery of protein-lipid complexes and 
membranes (pellet). Pellets corresponding to ~500 ml of lavage were transferred to B19 glass 
tubes and stored at -20ºC until used. Because of their highly hydrophobic character, SP-B and 
SP-C were co-isolated with lipids after performing an organic extraction. The Chl/MeOH fraction, 
containing SP-B/C and lipids, was concentrated in a rotary evaporator and loaded onto a 
Sephadex LH-20 gel filtration column equilibrated with Chl/MeOH 2:1 v/v. This step allowed the 
delipidation of the protein fraction. Tubes corresponding to the SP-B/C fraction were pooled and 
concentrated again using the system previously mentioned. To obtain each protein separately, 
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the protein fraction was again loaded on a second Sephadex LH-60 (GE, Healthcare) 
chromatography column equilibrated with Chl/MeOH 1:1 v/v 0.05% HCl (0.1 N). The acidification 
with HCl minimized protein/resin interaction and allowed an easier protein recovery. SP-B 
eluted in the first fraction resolved from SP-C eluted. Given the lack of aromatic amino acids in 
SP-C, whereas SP-B registered absorbance at 240nm and 280 nm, SP-C only did at 240 nm. Each 
fraction was pooled independently and kept in glass containers at -20oC.  
Samples purity and identity was confirmed by SDS-PAGE and amino acid analysis (detailed 
below in “Amino acid analysis”).  
Human recombinant rSP-C (sequence: GPFGIPCCPVHLKRLLIVVVVVVLIVVVIVGALLMGL) was 
purified according to the method of Lukovic and co-workers’ with modifications (217). Protein 
cloning and vector construction was conducted as described by Lukovic (217).  
rSP-C was overexpressed as a fusion protein in Escherichia Coli B21 (DE3) pLys. The 
construction is detailed in Fig. 14. The 6-His-Staphylococcal nuclease and rSP-C sequences were 
connected by a glycine linker and a thrombin cleavage site (LVPR|GP). The two additional amino 
acids remaining in the rSP-C sequence after thrombin cleavage (GP) do not interfere with protein 
interfacial activity. 
 
Figure 14. Schematic organization of the rSP-C-containing chimerical protein expressed in 
bacteria.  
Fusion protein overexpression was induced with 1mM isopropyl β-D-1-
thiogalactopyranoside at O.D.=0.4-0.5. After induction, the culture was grown for 3 h at 37 °C. 
Cells were recovered by centrifugation and the cell pellet was stored at -80ºC until used. Pellets 
were thawed on ice and re-suspended in lysis buffer (10 mM Tris pH 7.0 0.5% w/v N-
lauroylsarcosine, DNAse (Roche, Basel, CH) and lysozyme). After 30min-incubation at 4oC with 
stirring, 30s-sonication steps (0.5s on, 0.2s off) were performed on ice until the lysate was clear 
and non-viscous. A centrifugation step was carried out to eliminate the remaining membranes 
(18000g 30 min 4oC) and the supernatant was collected. The lysate was filtered through 0.2 μm 
polyethersulfone filters. A 5ml pre-packed nickel affinity chromatography column (Hi-Trap, GE 
Healthcare; Little Chalfont, UK) was equilibrated in equilibration buffer (50 mM Tris pH 7.0 150 
mM NaCl 0.5% N-lauroylsarcosine) using a peristaltic pump P1 (GE Healthcare; Little Chalfont, 
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UK). 10mM of imidazole was added to the lysate before loading to avoid nonspecific binding of 
proteins to the resin.  5-6 volumes of washing buffer (50 mM Tris pH 7.0 150 mM NaCl 0.2% N-
lauroylsarcosine 30 mM imidazole) were employed to eliminate proteins nonspecifically 
attached to the column. rSP-C was recovered with elution buffer (50 mM Tris pH 7.0 150 mM 
NaCl 0.2% N-lauroylsarcosine 500 mM imidazole). 1 ml fractions were collected and the 
absorbance at 280 nm was recorded. Fractions containing eluted protein were pooled and 
dialyzed using SnakeSkinTM dyalisis membranes with a 10K molecular weight cut-off (Thermo 
Scientific, Waltham, MA) against dialysis buffer (50 mM Tris pH 7.0 150 mM NaCl 0.2% N-
lauroylsarcosine). Dialysis was conducted o/n at 4°C to remove imidazole. To separate rSP-C 
from the nuclease, 0.5U of thrombin (Merck Millipore; Darmstad, DE) per mg of fusion protein 
were employed and incubated in cleavage buffer (20 mM Tris pH 8.4 150mM NaCl) at 4oC 
overnight. Cleavage was checked by SDS-PAGE and Coomassie-blue staining (detailed below). In 
order to obtain the cleaved SP-C polypeptide and to eliminate contaminant byproducts, an 
organic extract of the cleaved mixture was performed. During the organic extraction, the step 
of protein flocculation was avoided to increment the yield of the purification. The organic extract 
was concentrated in a rotary evaporator in the presence of lipid (PC 5:1 lipid/protein ratio w/w) 
to avoid irreversible protein precipitation and chromatographed through a gel-filtration LH-20 
column (1.5 cm x 100 cm; SpectrumLabs, Breda, NL)  eluted with Chl/MeOH 1:1 v/v HCl 0.05% 
(0.1N) v/v. rSP-C was obtained again free of lipid as it elutes from LH-20. Protein purity was 
assessed by SDS-PAGE and the concentration was determined by amino acid analysis.  
Fluorescently labeled SP-C was obtained as described (27, 315). The preparation was slightly 
alkalinized (pH 7.8) with the appropriate amounts of 50 mM Tris in methanol to allow the N-
terminal amine group of SP-C to be protonated. Texas Red (1 mg/ml) was added in methanol in 
a 3.5:1 molar probe/protein proportion. 
The reaction took place overnight at 4°C. The sample was then acidified to pH 2.0 to stop the 
reaction and after the addition of egg phosphatidylcholine to prevent protein aggregation, it 
was concentrated using a rotary evaporator. To separate labeled protein from the free probe, 
the sample was chromatographed through a column with LH-20 resin and Chl/MeOH 1:1 v/v 
0.05% HCl (0.1N) as the eluent. Protein identity was confirmed by SDS-PAGE, Western-Blotting 
and amino acid analysis.    
 
In this Thesis, as a model of murine alveolar macrophages, the cell line MH-S was employed 
(309). This cell line was purchased from Sigma Aldrich (St. Louis, MO) and cultured in Roswell 
Park Memorial Institute (RPMI) 1640 medium (Merck Millipore; Darmstad, DE) supplemented 
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with 10% heat-inactivated fetal bovine serum (FBS) (Gibco, Thermo Fischer Scientific; Waltham, 
MS) at 37ºC under a humidified 5% CO2 atmosphere. Cell passage was performed when 
confluence was 80-85% by trypsin treatment (Gibco, Thermo Fischer Scientific; Waltham, MS).  
 
To obtain hydrophobic constituents from different protein-lipid samples or lung tissue, the 
protocol of Bligh and Dyer was followed (314). A volume of sample in aqueous solution was 
mixed with two volumes of MeOH and one volume of Chl. This mixture was vortexed thoroughly 
for 30 s, and a single-phase solution was obtained. This mixture was incubated at 37-40°C for 30 
min to allow the flocculation of water-soluble proteins. The addition of one more volume of Chl 
and water yielded the formation of a biphasic solution upon thorough mixing. This solution was 
centrifuged at ~600g for 5 min at 4oC and the organic phase (lower fraction) was harvested 
carefully. Two volumes of Chl were added to the remaining aqueous fraction and vortexed, 
followed by another centrifugation step. This process increased the yield of hydrophobic 
material recovery. Again, the Chl/MeOH fraction was collected and the washing step was 
performed once more time. All hydrophobic fractions were pooled and kept at -20°C until used. 
Phospholipid concentration was determined by phosphorus quantification (316). Samples 
were dried out in clean glass tubes and lipid hydrolysis and phosphorus mineralization was 
achieved by incubation at 260 ºC for 30 min in a sand bath in the presence of 0.65 ml of 
perchloric acid (70%). To avoid acid evaporation, tubes were capped with marbles or glass 
ampoules. The acid solution was then diluted with 3.5 ml or miliQ water and 0.5ml of 2.5 % 
molybdate and 0.5ml of 10% ascorbic acid were added. After each addition, samples were 
thoroughly vortexed. The incubation at 100°C in boiling water allowed the colorimetric reaction 
in which ascorbic acid reduced the phosphomolibdic complexes formed, resulting in a blueish 
color. Samples were measured in a spectrophotometer to obtain absorbance at 820 nm. A 
calibration curve made with known amounts of phosphate was included in each set of 
measurements to properly calculate the concentration of phospholipid phosphorus in the 
samples of interest.  
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To determine protein concentration in SP-B, SP-C and rSP-C samples, the lack of aromatic 
amino acids (SP-C) and the highly hydrophobic character of these proteins (SP-B and SP-C) 
prevented the use of conventional techniques such as the Bradford or Lowry assay. For that 
reason, approximately 100-200 μl of isolated protein (typically 10-20 μg) was dried under a N2 
stream and subjected to an acid hydrolysis for 24h at 100°C under vacuum. The solution 
employed was HCl 6N 0.1% phenol w/v containing a known amount of nor-leucine as internal 
standard.  After the hydrolysis, HCl was evaporated under a flow of N2 followed by a wash with 
miliQ water and a evaporation step (SpeedVac Concentrator System, Thermo Fisher Scientific; 
Waltham, MS). Washing was performed twice to ensure the complete elimination of the acid. 
Finally, the hydrolyzed samples were resuspended in citrate buffer and subjected to ion 
exchange chromatography in a high performance amino acid analyzer. Knowing the amino acid 
sequence for each protein, amino acid quantification allowed the determination of protein 
concentration. Each concentration was corrected taking into account the internal standard.  
 
Gel electrophoresis under denaturing conditions was used for protein analysis. 
Polyacrylamide gels were made at 16% or 13% acrylamide (Bio-Rad; Hercules, CA) in the 
presence of SDS. Samples were prepared in loading buffer containing 0.03% bromophenol blue, 
2% SDS, 10% glycerol containing 5% β-mercaptoethanol as reducing agent. Samples were boiled 
for 10 min (99°C) prior SDS-PAGE.  
 Coomassie staining  
Gels were incubated in a solution of 1mg/ml Coomassie Brilliant Blue R-250, 50% 
MeOH, 10% acetic acid for 20 min.  Staining of blue bands was visualized upon destaining  
with a 10% acetic acid, 45% MeOH solution.  
 
 Silver staining 
Gels were fixed for 30 min in fixing solution (40% ethanol, 10% acetic acid) and 
incubated for 30 min in sensitizing solution (30% ethanol, 0.5% glutaraldehyde, 12.6 mM 
sodium thiosulphate, 0.8 M sodium acetate). To eliminate excess solution, gels were 
washed three times in miliQ water for 5 min. Gels were incubated with silver solution 
(0.6 mM silver nitrate, 0.04% formaldehyde) for 20 min, and after a quick wash with 
miliQ water, bands were developed with developing solution (0.2 M sodium carbonate, 
0.02% formaldehyde). To stop the reaction, a 50 mM EDTA (pH 8.0) solution was used.  
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 Western Blot  
Proteins were transferred to a PVDF membrane (Bio-Rad; Hercules, CA ) using either 
a semidry system (1 h 2.3 mA/cm membrane) or a humid chamber (400 mA 1h 40C). 
Membrane was blocked with PBS-T 5% milk for 2h. The primary antibody was diluted in 
PBS-T and incubated overnight at 4°C. After extensive washing of the membrane to 
eliminate unbound antibody, a secondary antibody solution was incubated for 2h at 
room temperature. Washing allowed the elimination of excess of antibody and 
membranes were developed upon incubation with Millipore Immobilon® Western 
Chemiluminescent HRP Substrate (ECL). Images were recorded with ImageQuant 
LAS500 (GE Healthcare; Little Chalfont, UK).  
The primary antibodies used were polyclonal rabbit anti-SP-C 1:1000 (WRAB-76696), 
and rabbit-anti-SP-B 1:1000 (WRAB-48604) from Seven Hills (Cincinnati, OH). The HRP-
conjugated secondary antibody was a swain anti-rabbit 1:2000 (P0217) from Dako 
(Agilent technologies; Santa Clara, CA).  
 
Lipid-protein suspensions, including cholesterol/P-C particles, were prepared as in ATR-FTIR 
experiments (see sample preparation below). 10-40 µg of lipid standards in 
chloroform/methanol (2:1, v/v) and the different lipid-protein preparations were applied 1.5 cm 
from the bottom edge of a silica plate (Merck TLC Silica Gel 60; Merck Millipore; Darmstand, DE) 
and air-dried at room temperature. Lipid suspensions prepared to determine SP-C/Cholesterol 
interactions incorporated the fluorescent cholesterol analog TopFluor cholesterol (23-
(dipyrrometheneboron difluoride)-24-norcholesterol; Avanti Polar Lipids, Alabaster, AL). In 
order to saturate the developing tank atmosphere with solvent vapors, the chamber was filled 
with the mobile phase 20 min before the development. The developing solvent used was 
chloroform/methanol/water (65:25:4, v/v/v) to allow phospholipids separation. To prevent 
drying of the solvent, the chamber was lined on three sides with Whatman No.1 paper 
(Whatman, Inc.) wetted with the mobile phase. TLC was developed at room temperature until 
the solvent front reached approximately 8-9 cm from the samples application point. Afterwards, 
the plate was removed from the chamber and air-dried to further analysis.  
 
 
Two different methods of staining were used according to the detection of lipids or proteins: 
 Iodine staining. A small amount of iodine crystals (Sigma Aldrich, St. Louis, MO) were 
deposited in a chromatographic chamber where the atmosphere saturates with iodine 
vapors upon sublimation. Iodine reacts with lipid C=C bonds resulting in yellowish 
spots appearing after 3-5 minutes incubation. 
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 Phosphomolibdic acid staining. A phosphomolibdic acid solution was employed to 
accurately detect neutral lipids, which are not properly observed upon iodine staining. 
Inorganic and organic molecules react generating intensely blue mixed oxides in which 
Mo (VI) is reduced to Mo (IV) (317). The solution was sprayed on the plate and spots 
were visualized upon incubation at 100oC for at least 30 min.  
 
 Fluorescamine staining. Fluorescamine reacts with primary amines yielding a 
fluorescent product visible under UV light. A 0.5% fluorescamine solution in acetone 
was sprayed on the plate and air dried. Proteins and amino lipids in our case were 
detected. The detection of fluorescence is possible under UV light. Images were 
recorded using a VersaDoc imaging system (Bio-Rad; Hercules, CA) in the 
epifluorescence mode. To confirm the presence of protein in the fluorescent bands 
revealed by fluorescamine staining, spots were scratched out from the silica plate and 
boiled in electrophoresis loading buffer with 5% β-mercaptoethanol 10 min at 99ºC. 
Then, protein bands were resolved by SDS-PAGE in a 13% acrylamide gel stained with 
silver and western blotting. 
Attenuated Total Reflectance Fourier Transform spectroscopy (ATR-FTIR) is a powerful 
technique based on the absorption of light in the medium infrared (MIR). The absorbed energy 
is translated into molecular vibrations with characteristic vibrational modes depending on the 
functional group. Thus, the ATR-FTIR spectrum represents a fingerprint of the molecule of 
interest. 
  
Figure 15. Schematic representation of the internal reflectance phenomenon. A sample film on 
a trapezoidal Internal Reflectance Element (IRE) absorbs energy from the evanescent wave 
generated by infrared light. The beam is reflected until it reaches the detector.   
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In an ATR-FTIR experiment, the sample is deposited on the surface of an internal reflectance 
element (IRE) made of a highly reflective material, a germanium crystal in this particular case. 
When the infrared beam enters the IRE, an evanescent wave is formed because of that internal 
reflectance (Fig. 15). The wave extends beyond the surface of the crystal into the sample (0.5-5 
µm), and is attenuated by sample absorption. The remaining energy is passed back to the IR 
beam, which is reflected several times contacting the surface where the sample sits until it exits 
the IRE towards the detector.   
ATR-FTIR is very useful to characterize lipid-protein samples, since the absorption bands 
associated to proteins and lipids present different frequencies in the spectrum and can be 
simultaneously analyzed (Fig. 16). In this Thesis, lipid-protein samples incorporating SP-C or rSP-
C have been studied to assess the effect of palmitoylation on lipid-protein interactions in 
different lipid systems.  
 
Figure 16. ATR-FTIR spectra of a 
protein (top) and lipid (bottom) film. 
Amide I and II bands (delimited 
between the red vertical lines) and 
lipid characteristic absorption bands 
appear in different wavenumbers. 
 
 
 
 
 
Films were generated by mixing the appropriate amount of lipid or lipid and protein (7 wt%) 
in Chl/MeOH 2:1 v/v, and drying the samples under a stream of N2. Solvent traces were 
eliminated by vacuum for 2 h in a SpeedVac Concentrator System (Thermo Scientific; Waltham, 
MS). Multilamellar vesicles were obtained by resuspending the dry lipid or lipid–protein films to 
a final phospholipid concentration of 10 mg/ml in 5 mM Tris pH 7.0 150 mM NaCl at 50°C for 1 
h with intermittent shacking in a ThermoMixer (Eppendorf; Hamburg, DE). To increase sample 
concentration and eliminate salt excess, samples were centrifuged 1 h 21000g at 4°C and 4/5 of 
the supernatant was removed. The samples were kept at 4°C and resuspended prior 
measurements.  
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 
Oriented lipid multilayers were formed on the surface of the germanium crystal by slow 
evaporation of the lipid or lipid/protein aqueous suspensions under a nitrogen stream (318). 
Orientation of lipid multilayers was confirmed upon observation of the dichroic spectra.  
ATR-FTIR spectra were recorded on a Bruker IFS66 FTIR spectrophotometer (Ettlingen, DE) 
equipped with a liquid nitrogen mercury cadmium telluride detector (MCT) in the double-sided, 
forward-backward mode at 2 cm-1 resolution and an aperture of 3.5 mm. The spectrometer was 
continuously purged with dry air. The internal reflection element was a germanium ATR plate 
with an aperture angle of 45º yielding 25 internal reflections. To improve signal/noise ratio, 256 
accumulations were collected per measurement. Measurements were carried out at 21, 25 and 
37ºC. Temperature control was achieved by a thermostatized IRE support connected to a water 
bath Haake DC30 (Thermo Fisher Scientific Inc.; Waltham, MS). 
Recorded spectra were corrected for the atmospheric water absorbance interferences by 
subtracting a reference atmospheric water spectrum. The subtraction coefficient was computed 
as the ratio of the atmospheric water band in the range 1562-1555 cm-1 on the sample spectrum 
with respect to the reference spectrum. Spectra were smoothed by apodization by a 4 cm-1 
Gaussian line shape. 
 
 
The shape and intensity of the Amide I band is a sum of the contributions of all the secondary 
structure components of the protein or mixture of proteins present in the sample. To obtain the 
proportion of each particular secondary structure from the original spectrum, a deconvolution 
method is required (319). Using this method, the proportion of each structure is obtained by 
calculating the sum of all bands adjusted to a Lorentzian line (FWHH=30 cm-1) and dividing by 
the total area of the amide I band. 
Considering possible interferences due to the analysis method, spectral line shapes were 
directly compared. Subtraction spectra were obtained (SP-C – rSP-C) upon normalization with 
respect to amide I total intensity.  
 
 
The determination of protein molecular orientation by infrared ATR spectroscopy has been 
reviewed by Goormaghtigh et al. (216). For these experiments, a thallium bromoiodiode wire 
grid polarizer KRS-5 (Specac; Kent, UK) was positioned between the IR beam and the IRE. Spectra 
were recorded with a parallel or perpendicular polarized incident light with respect to the plane 
defined by the ATR crystal. The dichroic ratio, RATR, is defined as the ratio of the absorption band 
recorded for the perpendicular polarization (A⊥) with respect to the parallel polarization (A||): 
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                                                                 RATR=A⊥/ A|| 
In ATR, the dichroic ratio for an isotropic sample is different from the unity and is usually 
evaluated as the mean dichroism of the two lipid ester ν(C=O) bonds absorbing between 1762 
and 1716 cm-1. The mean orientation of the molecular axis with respect to the perpendicular of 
the ATR plate was estimated as described before (216). Although there is no consensus in the 
determination of an appropriate value for the orientation of amide I dipole in the α-helical 
structure; a value of 270 was used for the calculations (216). 
 
 
Accurate band position (better than 0.1 cm-1) were obtained by fitting a series of 11 data 
points, i.e. 5 cm-1 before the approximate maximum and 5 cm-1 after, by a third order polynomial 
and finding the roots of its derivative. It needs to be emphasized that this level of accuracy is 
much better than the nominal resolution of the spectrometer, which was set at 2 cm-1, and the 
encoding of the data (every 1 cm-1). 
 
 
Data were analysed with the subroutine Kinetics, (MATLAB R12), developed by Prof. Erik 
Goormatigh in the University of Brussels.  
 
The phenomenon of fluorescence results from the emission of photons by molecules, termed 
fluorophores, in electronically exited states. This form of luminescence requires the previous 
excitation of those fluorophores from the ground state by providing energy in the form of light 
of a certain wavelength.  
Fluorescence properties can be applied in several approaches to analyze molecular 
properties. In this Thesis, we made use of fluorescence anisotropy. The study of fluorescence 
anisotropy allows us to obtain information about the fluidity of a system by assessing the 
behavior of a fluorophore. A fluorophore is preferentially excited by those photons with electric 
vectors aligned parallel to its transition moment (photoselective excitation). When polarized 
light is applied, the selectively excited fluorophores emit photons in a certain direction, this is 
the polarized emission. Fluorescence anisotropy (r) is then calculated according to: 

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Where III is the fluorescence intensity recorded when the intensity of the emission polarizer 
is oriented parallel to the direction of the polarized excitation, and I┴ is that corresponding to 
the intensity with the emission polarizer oriented perpendicular to the polarized excitation.  In 
the absence of artifacts, fluorescence anisotropy is not dependent on fluorophore 
concentration.  
   
 
The affinity of cholesterol for certain membranes can be assessed by measuring the amount 
of its fluorescent analog, CTL, remaining in lipid bilayers upon methyl-β-cyclodextrin (mβCD) 
extraction (230). The concentration of probe can be calculated from the anisotropy values 
considering that the mβCD-CTL complex moves isotropically (low anisotropy values) while within 
a lipid bilayer, CTL motions are restricted (higher anisotropy values). Using different mβCD 
concentrations it is possible to calculate a CTL molar fraction-partitioning coefficient (Kx) 
between the membrane and mβCD. Higher Kx values indicate a higher affinity of CTL for the 
bilayer as compared with mβCD.  
The experiments conducted in this part of the Thesis were done at the laboratory directed 
by Prof. J. Peter Slotte in the Department of Biosciences in the Abo Akademi, Turku, Finland. 
Those experiments were supervised by PhD. Thomas Nyholm and Prof. J. Peter Slotte.  
Lipid stocks were prepared in hexane/2-propanol 3:2 v/v and measured for phosphorus 
content. Vesicles were prepared by mixing phospholipids and CTL (2 mol%) in organic solvent. 
The solvent was evaporated under a stream of nitrogen at 40 ºC. The dried films were thoroughly 
re-dissolved in Chl/MeOH (2:1, v/v) and the indicated amount of protein was added, typically 2 
mol% (~10 wt% for SP-C). In the case of lung surfactant components, all were mixed in one single 
step and dried as described previously. Vesicles prepared for the experiments with synthetic 
phospholipids and the native protein fraction (SP-B+SP-C) included a 5-fold higher 
protein/phospholipid ratio compared to their native proportion in lung surfactant. After an 
additional solvent evaporation cycle, samples were maintained under vacuum overnight to 
eliminate solvent traces. Multilamellar suspensions were obtained by rehydrating lipid or 
lipid/protein films in 5 mM Tris pH 7.0 150 mM NaCl at a temperature above the gel-to-fluid 
transition temperature of phospholipids and vortexing. Large Unilamellar Vesicles (LUVs) were 
formed by extrusion through polycarbonate membranes with 200 nm pores. For vesicle 
curvature experiments, polycarbonate membranes with 30, 50, 100 and 200 nm pore size were 
used to generate unilamellar liposomes by extrusion.  
For the partition assay, LUVs were dispensed into 100 nmol lipid fractions resulting in 10 
tubes (final lipid concentration of 40 μM).  One tube served to measure CTL anisotropy in each 
lipid system in the absence of mβCD, reflecting the motion state of CTL for each particular lipid 
composition. Increasing concentrations of mβCD were added to the remaining tubes (0.04 to 1 
mM) to calculate the partition coefficient as detailed below. 
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For POPC and POPC/PSM vesicles, samples were saturated with argon to prevent oxidation, 
and incubated overnight at room temperature or 2h at 37ºC to allow the partitioning reach the 
equilibrium. For the rest of lipid systems tested, the incubation and measurements were carried 
out at 37ºC. After that, the steady-state anisotropy of CTL (at 23ºC or 37ºC) was measured using 
a PTI Quantamaster 1 (Photon Technology International; Edison, NJ) spectrofluorimeter 
operating in the T-format, with both the excitation and emission slits set to 5 nm.  For CTL 
anisotropy, the samples were excited at 324 nm and the emission was measured at 390 nm. The 
molar concentration of CTL ( LUVCTLC  ) for each sample was calculated from the measured 
anisotropies (230): 
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Where CCTL is the total concentration of CTL in the samples, ri  is the anisotropy of CTL in the 
specific phospholipid bilayer in the absence of cyclodextrin, rLUV is the CTL anisotropy in each 
measured sample, and rmβCD  is the anisotropy of CTL in the CTL- mβCD complex.  The anisotropy 
of the CTL- mβCD complex was 0.175 at room temperature and 0.170 at 37oC. According to Eq. 
1, the total concentration of CTL in the sample tube without mβCD, equals .
LUV
CTLC  
The CTL concentrations calculated above were plotted against the mβCD concentration 
assuming a 2/1 CTL/cyclodextrin stoichiometry in the complexes as previously described (320). 
To calculate the molar fraction partition coefficient (Kx), those curves were fitted to Eq. 2 using 
the software Origin 7.5 (OriginLab corporation; Northampton, MA):  
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Where CL is the concentration of phospholipid; CCTL , the concentration of CTL at the beginning 
of the assay; n, the stoichiometry of the complex CTL/mβCD; CCD, the concentration of 
cyclodextrin and Kx, the partition coefficient. For the calculations, the phospholipid 
concentration was corrected after the CTL partitioning assay by phosphorus content 
determination. 
 
 
Hundred nmol lipid films were prepared by mixing the appropriate amount of the different 
lung surfactant fractions and DPH-PC (1 mol%). Films were dried as described in the previous 
section and maintained under vacuum overnight. The dried films were hydrated in 1 ml of 5 mM 
Tris pH 7.0 150 NaCl as described earlier, and extruded through 200 nm pores. An additional 
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milliliter of buffer was added and the steady-state anisotropy at 37oC was measured in the same 
instrument with the slits at 5 nm. All samples were excited at 358 nm and the fluorescence 
emission was measured at 430 nm. 
Dynamic light scattering (DLS) is a well-stablished technique used to measure size and 
distribution of molecules in the submicron region. It is based on the principle of Brownian 
motion of molecules in a solution, which causes light to be dispersed at different intensities. By 
using the Stokes-Einstein relationship, it is possible to calculate particle size from the 
fluctuations in intensity.  
In this Thesis, DLS measurements were performed to check the size of LUV dispersions using 
a Malvern Z-Sizer (Worcestershire, UK) with 5 mM Tris pH 7.0 150 mM NaCl as reference. Results 
are represented as sizes given by the number distribution.   
 
2H-NMR is a non-perturbing and very powerful technique employed to characterize lipid 
motion and structure in different environments. Replacement of hydrogen atoms by 2H results 
in 2H -labeled molecules suitable to study by 2H-NMR.  
2H nuclei possess a nuclear spin of 1 (s=1), for that reason they are characterized by a 
quadrupolar interaction that governs the 2H-NMR signal. For the resonance to occur, two 
principles must be fulfilled. First, a strong magnetic field needs to be applied in order to split the 
energy levels of the 2H nucleus (Zeeman effect), and second, to induce a transition between 
those levels, the electromagnetic radiation applied has to match the 2H nucleus resonance 
frequency or Larmor frequency. Because of the quadrupolar interaction, the energy levels of the 
2H nucleus lose their degeneracy, and therefore its associated spectrum is characterized by two 
peaks (a doublet). The distance between these two frequencies is termed the quadrupolar 
splitting (ΔνQ) and it is centered in the Larmor frequency (Fig. 3.4).   
The quadrupolar splitting is related to the motion of each particular deuteron and to the 
orientational order parameter (SCD): 
2
1cos3 2 


CDS          (Eq. 3) 
Where θ is the angle between the C-2H bond and the symmetry axis of the motion, that in 
the case of axially symmetric reorientations is the bilayer normal.  These type of reorientations 
are very common in bilayers in the liquid crystalline phase. The quadrupolar splitting, and thus 
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the order parameter, reflects the average orientation of C-2H bonds with respect to the direction 
of the magnetic field.  
 
  
Figure 17. (a) 2H-NMR spectrum for a molecule labeled with a single 2H in membranes oriented 
with their normal perpendicular to the magnetic field. Two peaks are observed because of the 
quadrupolar interaction separated by the quadrupolar splitting. (b) In this case, the 2H-labeled 
molecule forms part of a liposome. The highest signal is obtained for bilayer normals 
perpendicular to the magnetic field, and the lowest, for those in parallel.  
 
 
For a deuterated lipid, every 2H experience different conformational freedom depending on 
their position. In the case of perdeuterated phospholipids, 2H motion along the acyl chain is 
more restricted for positions closer to the polar headgroup. The resulting spectrum will 
represent the contributions of each deuteron, characterized by doublets with particular 
quadrupolar splittings (Fig. 18 top and bottom).   
 
 
 
 
Figure 18. 2H- spectra showing the contribution 
of 2H placed in the indicated positions of the 
POPC molecule for an oriented membrane (top) 
and liposomes (bottom). More mobile positions 
(C16) appear with lower splittings whereas more 
restricted positions (C2) result in larger splittings.  
 
 
 
 
For a multilamellar non-oriented sample, bilayer normal adopts all possible directions and 
the corresponding spectra is termed powder spectra. Higher intensities (represented by Pake 
doublets) are obtained when the bilayer normal is oriented perpendicular to magnetic field, 
whereas when it is located in parallel gives rise to the lowest intensities (Fig. 17b). 
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In the present Thesis, we aimed to characterize the effect of SP-C and cholesterol in lung 
surfactant mimicking membranes. Since SP-C palmitoylation has been observed as an important 
factor related to the SP-C/cholesterol relationship (215), the effects of a recombinant version of 
SP-C (rSP-C) lacking acylation was also analyzed.  
The experiments described in this section were conducted in the laboratories of Dr. Valerie 
Booth and Dr. Michael M. Morrow at the Department of Biochemistry and Department of 
Physics and Physical Oceanography (Faculty of Science) in the Memorial University of 
Newfoundland, in Saint John’s, Newfoundland, Canada.  
For 2H-NMR experiments, the deuterated lipids employed were: 1,2-dipalmitoyl-d62-sn-
glycero-3-phosphocholine (DPPC-d62), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC-d31),  1-palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (POPG-d31) and 5-
Cholesten-3β-ol-2,2,3,4,4,5-d6 (Chol-d6). Deuterated phospholipids were obtained from Avanti 
Polar Lipids (Alabaster, AL) and deuterated cholesterol were from Cambridge Isotope Laboratory 
(Tewksbury, MA). They were combined to configure three equivalent lipid systems: DPPC-
d62/POPC/POPG, DPPC/POPC-d31/POPG and DPPC/POPC/POPG-d31 (50/25/15 w/w/w). To 
observe if cholesterol suffered any specific alteration in mobility, samples of DPPC/POPC/POPG 
+ 10 wt% Chol-d6 were also analyzed. All these systems allowed us to analyze the behavior of 
each component independently either in the pure lipid system or in the presence of SP-C or rSP-
C and/or cholesterol. 
Lipid and lipid-protein samples were prepared by mixing individual components in Chl/MeOH 
2:1 v/v and drying by rotary evaporation at 50oC. 12.6 mg of phospholipid were used per sample 
and 5 wt% protein and/or 10 wt% cholesterol were incorporated when indicated (see results 
section). Solvent traces were removed by vacuum for at least 6 hours and samples were kept at 
-20oC until used. Multilamellar suspensions were obtained by the addition of 5 mM Tris pH 7.0 
150 mM NaCl at 60oC and vortexing yielding a final phospholipid concentration of 45 mg/ml. 
Samples were carefully transferred to 8-mm NMR tubes and sealed.  
For samples containing Chol-d6, the amount of material was increased to 25.5 mg of 
phospholipid. Samples were processed as previously mentioned and hydrated in 350 μl of 5 mM 
Tris pH 7.0 150 mM NaCl.  
 
 
Samples were positioned into a cylindrical coil and the probe was placed into the NMR 
spectrometer. Samples were allowed to equilibrate at the desired temperature for at least 15 
min prior measurement. Temperature was measured and controlled to ±0.1 ºC using a digital 
temperature controller (model 325, Lakeshore Cryotronics, Westerville, OH). 2H-NMR spectra 
were collected in a 9.4 T superconducting solenoid operating at a resonance frequency of 61.42 
mHz for 2H nuclei.  
Free-induction decay (FID) signals fades rapidly since 2H-NMR  line shapes are very broad. To 
collect those signals is thus problematic, since most of the FID signal is lost during the receiver 
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recovery time. A way to overcome this is to employ an echo pulse sequence (π/2− τ −π/ 2−acq ) 
(321). The two pulses are separated by a time τ, delaying the echo formation a time 2τ, after 
which the receiver has already recovered and can start data collection. For these experiments, 
π/2 pulses were in a range of 5-6 μs separated by τ 35μs and acquired during 0.9 s as observed 
in the scheme in Fig. 19. 
 
 
Figure 19. Schematic representation of the 
quadrupole echo sequence employed for the 
2H-NMR experiments carried out in this section.   
 
 
 
A dwell time of 1 μs was employed and 8192 points were collected. Oversampling by a factor 
of 4 was applied to give an effective dwell time of 4 μs corresponding to a frequency of 250 kHz, 
appropriate for a liquid crystalline spectrum (322). The FID was left-shifted to place the echo 
maximum at the first point and Fourier transformed to obtain the spectra in the frequency 
domain. All the spectra presented here have been previously phase-corrected and normalized.  
For each spectrum of samples containing DPPC-d62, 40,000-48,000 transients were averaged. 
For samples containing POPC-d31, 80,000 transients were averaged, and for POPG-d31, 96000. In 
the case of samples with deuterated cholesterol, 176,000 transients were accumulated. 
Deuterium has a natural abundance of 0.016%, thus, the narrow peak obtained in the center of 
most spectra likely arises from isotropic reorientations of deuterium molecules present in the 
buffer. 
ESR, also termed Electronic Paramagnetic Resonance (EPR), is a non-perturbing 
spectroscopic technique based on the properties of molecules possessing unpaired electrons. 
As well as 2H-NMR, it has been widely employed to characterize membrane fluidity and order. 
Besides, it constitutes a very sensitive technique, since it allows the detection of amounts of 
probe in the order of ~0.05 pmol in 10-50 μl. 
As occurs for 2H nuclei in 2H-NMR, under a magnetic field the energy levels of an unpaired 
electron split (Zeeman effect). A transition between those levels can take place by applying an 
electromagnetic radiation. Unlike 2H-NMR frequency, for these experiments is fixed to 10 GHz 
and the magnetic field is varied until the resonance is registered, being that resonance the 
absorbance of frequency of a defined energy to perform a transition.  
Since no unpaired electrons are usually present in biological membranes, spin-labels are 
employed to generate extrinsic spin-labeled probes. Different chemical groups, such as nitroxide 
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radicals, can be employed as spin-labels. These labels can be placed in different positions along 
the aliphatic chain of phospholipids, providing information on the degree of mobility at different 
depths in the membrane.  For the studies performed here, the modified acyl chain is in the sn-2 
position of a phosphatidylcholine. Because of that, these spin labels receive the name of n-PCSL, 
being n the position the nitroxide group occupies along the hydrocarbon chain.  
In the nitroxide group, the spins of the oxygen electron and the nitrogen nucleus interact in 
what is designated as hyperfine coupling. Because of this phenomenon, the Zeeman energy 
levels are perturbed resulting in ESR spectra characterized by three lines (a typical ESR spectrum 
is represented in a first-derivate form). Depending on the rate and amplitude of the rotation of 
the spin-labeled position in the phospholipid, the spectral features of these lines differ. For fluid 
systems, a higher lipid mobility averages the orientational anisotropy of motion, resulting in 
narrower spectra. In contrast, for motionally restricted molecules, spectra are wider and exhibit 
shoulders as a consequence of their highly anisotropic movement. 
Several spectral parameters can be used to characterize an ESR spectrum, but the more 
widely employed is the outer hyperfine splitting constant (2Amax). This is measured as the 
spectral width from the first maximum in the low-field wing of the spectrum and the last 
minimum of the high-field segment of the spectrum as illustrated in Fig. 20. 
 
 
Figure 20. ESR spectra of 5-PCSL and 12-PCSL at 25oC and 45oC included in multilamellar vesicles 
of DPPC/POPC/POPG 50/25/15 (w/w/w). The outer hyperfine coupling constant (2Amax) is 
indicated below each set of spectra. 2Amax decreases with temperature as encounter a more 
fluid system. Depending on the n-position of the label along the acyl chain, 2Amax also adopts 
different values. Positions with a restricted mobility, such as those close to the polar headgroup, 
results in higher 2Amax values, as can be deduced from the comparison between 5-PCSL and 12-
PCSL spectra. 
 
In this Thesis, to sample motions close to the polar region and hydrophobic core of the 
membrane respectively, two spin-labeled lipids have been used, 5-PCSL and 12-PCSL. These 
modified lipids, 1-palmitoyl-2-stearoyl-(n-doxyl)-sn-glycero-3-phosphocholine, with n=5 or n=12 
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were purchased from Avanti Polar Lipids (Alabaster, AL). 1mg/ml stocks of each probe were 
prepared in Chl/MeOH 2:1 v/v and used without further analysis.   
0.9 mg of lipid or lipid/protein samples were prepared by mixing individual components in 
Chl/MeOH 2:1 v/v. 1 mol% of probe was added in organic solvent. Samples were dried under a 
constant stream of nitrogen and solvent traces were vacuum-evaporated for 2 hours using an 
SpeedVac Concentrator System (Thermo Fisher Scientific; Waltham, MS). Until hydrated, 
samples were kept at -20oC.   
Hydration was carried out at 55ºC for 1h by addition of 5 mM Tris pH 7.0 150 mM NaCl to a 
final phospholipid concentration of 11.25 mg/ml in a ThermoMixer (Eppendorf; Hamburg, DE) 
with intermittent shacking. Samples were transferred to 1-mm capillaries and spun down at 
21100g at 4ºC using a Sorvall microfuge equipped with a capillaries rotor.  Excess of supernatant 
was removed and capillaries were flame-sealed before measurements.  
 
 
ESR experiments were performed in the Research Support Center (Resonance facility) in the 
Complutense University, Madrid. ESR spectra were recorded on a Bruker EMX 10/12 equipped 
with a nitrogen flow temperature regulation system. Sample capillaries were inserted into a 
quartz tube with silicone oil for thermal stability. Typically, 2 scans were accumulated to improve 
signal/noise ratio with 4-min scan time.  
Spectra were collected using the WinEPR software with the following instrumental settings:  
10 mW microwave power, 1.25-G modulation amplitude, 100 kHz modulation frequency, 0.33 s 
time constant, 100-G scan range and 3360-G center field. 
Flow cytometry is a widely employed technique to characterize cell properties in a qualitative 
and quantitative manner. Cell size (measured by the Forward Scatter, FSC), internal complexity 
(measured with the Side Scatter, SSC) and other properties, including the presence of specific 
markers, can be investigated simultaneously by the use of cell optical properties and different 
fluorescent probes (Fig. 21). 
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Figure 21. Schematic representation of a flow cytometry experiment. 
The cytometer creates a laminar flow in which every single cell pass independently through 
a beam of monochromatic light (Fig. 21). At the intersection point, light is emitted in all 
directions and collected by the optical unit of the cytometer. The amplification of the signal 
(photomultiplier tubes) and the detection of concrete wavelengths (dichroic mirrors and 
detectors) allows the profiling of a particular sample in terms of fluorescence intensity for a 
defined fluorochrome, and relative proportion of positive events/cells with respect to measured 
events. Typically, results are presented as a histogram or a two-dimensional dot-plot graph.  
To analyze the engulfment of lipid vesicles by alveolar macrophages, cells incubated with 
different types of fluorescently labeled vesicles were analyzed by flow cytometry using a 
MACSQuant 10 analyzer (Miltenyi Biotech, Cologne, DE). These experiments were done in 
collaboration with Prof. Matthias Ochs´s group (Department of Functional and Applied 
Anatomy, Hannover Medical School, Germany) under the supervision of Dr. Elena López-
Rodríguez. 
 
 
Lipids and proteins in Chl/MeOH were mixed in the indicated proportions and labeled with 5 
wt% of TopFluor cholesterol (23-(dipyrrometheneboron difluoride)-24-norcholesterol, Avanti 
Polar Lipids) in Chl/MeOH 2:1 v/v. When indicated, samples were labeled with 5wt% Bodipy PC 
(Bis-BODIPY® FL C11-PC; 1,2-Bis-(4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-
Undecanoyl)-sn-Glycero-3-Phosphocholine); Thermo Fisher Scientific; Waltham, MS).Samples 
were protected from light to avoid fluorescence bleaching.  Solvents were evaporated in a fume 
hood at 40oC and samples maintained in a vacuum oven at 50oC overnight. Lipid films were 
hydrated to 0.5 mg/ml with 50 mM Tris pH 7.0 150 mM NaCl at 60oC for 1h at 1400 rpm in a 
Thermo–Shaker TS-100C (BioSan, Riga, LV).   
5 wt% of TopFluor cholesterol (TFC) was also employed to label a clinical surfactant 
preparation (Curosurf, Chiesi Farmaceutici, Parma, IT). The calculated amount of probe was 
added to a tube as an organic solution and dried at room temperature. For cholesterol-
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containing Curosuf samples, the required amount of cholesterol was also supplied as an organic 
solution and dried at the bottom of the tube. After drying, Curosurf was diluted to 0.5 mg/ml 
with 50 mM Tris pH 7.0 150 mM NaCl, and both labeling and cholesterol incorporation (when 
necessary) were performed at 500C for 1h in a Thermo-Shaker TS-100C (BioSan, Riga, LV).  
The multilamellar lipid suspensions and Curosurf were diluted with 50 mM Tris pH 7.0 150 
mM NaCl to add 10 μl per well of a p96 plate at the corresponding concentration (see Results).  
For the cytometry experiments, 105 cells/well in 90 μl PBS were administrated 10 μl lipid 
suspensions and incubated at room temperature for the indicated times and lipid 
concentrations (see Results). Cells were re-suspended by pipetting before and after lipid 
addition and just prior flow cytometry measurements. At least 10.000 events were recorded per 
sample. Vesicle engulfment was detected in the FITC channel and quantified by stablishing a 
thershold according to the fluorescence detected from non-treated cells.  
Data were analyzed with MacsQuant software (Miltenyi Biotec; Cologne, DE) and GraphPad 
Prism 5 (La Jolla, CA).  
 
 
 
Endocytosis inhibitors, amantadine, cytochalasin D, chlorpromazine, methyl-β-cyclodextrin, 
genistein and bafilomycin A1, were from Sigma Aldrich (St. Louis, MO). Blocking anti-mouse 
CD14 antibody was from Biolegend (Cambridge, UK) and anti-mouse CD45 antibody, from 
Miltenyi Biotech (Cologne, DE). 
Inhibitors or antibodies were applied and incubated for 30 min at room temperature and 40C 
in darkness respectively. Cells were washed after treatment and resuspended in PBS for the 
engulfment assay.  
 
The transcriptional response of MH-S cells to lipid engulfment was analyzed by qPCR. 106 
cells in 1ml of PBS were treated for 1h at room temperature with 2.5 µg of lipid suspension 
prepared as detailed above. After treatment, cells were washed with PBS and cell pellets were 
re-suspended in lysis buffer (RNA mini Kit; Bioline; Berlin, DE) and kept at -200C until employed. 
Total RNA was isolated from 106 cells with the RNA mini Kit (Bioline, Berlin, DE) and quantified 
by measuring the absorbance at 260 nm in a Nanodrop. 1 µg of total RNA was reversed 
transcripted in a thermocycler (MasterCycler, Eppendorf; Hamburg, DE) employing the iScript 
cDNA Synthesis Kit (Bio-Rad; Hercules, CA). Real-time PCR was performed with iQ SYBR Green 
Supermix (Bio-Rad; Hercules, CA) starting from 50 ng cDNA and a primer concentration of 100 
nM. Antibody-mediated hotstart iTaq DNA polymerase was activated after an initial 3-min 
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denaturation step at 95°C. Denaturation of DNA was accomplished by holding further 95°C for 
10 s. Annealing and extension temperature was set to 59°C (30 s) for 40 cycles in a Bio-Rad CFX96 
Real Time PCR system (Bio-Rad; Hercules, CA).  
qPCR data was analyzed using the Livak method (323) and represented as fold change with 
respect to the control sample (un-treated cells) and the gene for β-actin (Actb) as reference 
gene. Data was clustered according to target gene and type of sample using the corresponding 
tool in BioRad CFXManager (Bio-Rad; Hercules, CA.) 
Primers were designed employing a NCBI tool (https://www.ncbi.nlm.nih.gov/tools/primer-
blast/) and sequences are shown in Table 1.  
 
Table 1. Sequence of the primers used of qPCR experiments. 
Gene name Forward Reverse 
Nr1h3 CAGGTTGGGTGTTTTCTGGC GAAGAACCCTGCACAAAGTGG 
Nr1h2 CTCGGTCCAGGAGATTGTGG CTGTCTCGTGGTTGTAGCGT 
Abca1 GCGACCATGAAAGTGACACG CAGCACATAGGTCAGCTCGT 
Abcg1 GGATTTCATCGTCCTGGGCA TGGCTTGGAGGCGGTTTTTA 
Cyp2711 GGTCGGAGGATTGCAGAACT TCACCTTCTTGCTGGGAACC 
Cd36 ATGAATGGTTGAGACCCCGTG GATTGGCTTCAGGGAGACTGT 
Msr1 CCTTTCACCTCTGGACAAGTCA ATGTCAATGGAGGCCCCAAC 
Srebf2 TGATGATCACCCCGACGTTC GTCACGAGGCTTTGCACTTG 
Hmgcr TTGGAGTTGGCACCATGTCA CTCTAGGACCAGCGACACAC 
Ldl-r TCAGTGCCAATCGACTCACG GTCTCACACCAGTTCACCCC 
Npc1 AAAGGCAACGTGTTCTTCACAG GTTAAAACCCATGAGCGTTGTCT 
Npc2 CATTGTCCCCCGAGATAGCC CCATCCTGTCTGGTGGAACC 
Lipa CCACCAAGTAGGTGTAGGCAC TGCATCTTCCGGGAGTGGT 
Dhcr24 GATGAATGGTCAACGCGAGC TTTGGGTGACACAGGTTGCT 
Ch25h CGTCCAGCTCCTAAGTCACG AGGACGAGTTCTGGTGATGC 
Lpla2 ACCCCAGCAAGAGGAATGTG CCGTTTTCATTTGGGGCTCG 
Pparg CGGTGAACCACTGATATTCAGGA CGGTGAACCACTGATATTCAGGA 
Actb ATCCTCTTCCTCCCTGGAGA AGGATTCCATACCCAAGAAGGA 
   
 
Cell morphology was analyzed after staining with a Diff-Quik kit (Medion Grifols Diagnostics; 
Düdingen, CH), in a Zeiss microscope equipped with a Leica DM6000B camera (Leica; Weztlar, 
DE). 
Fluorescent microscopy allows visualizing specific fluorophores in a sample. The preparations 
were observed using a Leica DM-400B microscope (Weztlar, DE) illuminated with a mercury 
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lamp (LEICA EL6000) and equipped with L5 and TX2 fluorescence filter sets. Micrographs were 
recorded with a cooled digital camera (Model C10600-10B ORCA-R2, Hamamatsu). 
 
 
MH-S cells were treated with lipid suspensions (16 µg lipid/ 106 cells) prepared as detailed 
above (see Engulfment assay above) incorporating 10 wt% of fluorescently labelled SP-C (TxR-
SP-C). Non-engulfed vesicles were removed by cell washing with PBS. Treated and non-treated 
cells were spun down on a slide using a Thermo Shandon cytospin 3 (Thermo Scientific; 
Waltham, MS). Cells were fixed with ice-cold acetone/MeOH 3:2 v/v for 5 min and washed 
extensively with PBS. DAPI (1:10000) was used to counterstain nuclei and excess was removed 
by washing with PBS. Finally, cell preparations were mounted with a fluorescence mounting 
medium (Leica; Weztlar, DE).  
Transmission Electron Microscopy (TEM) employs electrons as a light source, achieving 
resolutions at the amstrong (Å) scale.  The electron beam goes through the sample of study and 
it is scattered depending on sample density. Unscattered electrons hit a fluorescent screen 
giving the final image. TEM micrographs were obtained in a Morgagni 268 microscope 
(Eindhoven, NL) equipped with a digital camera (Olympus Soft Imaging Systems; Münster, DE) 
at a final 9000x magnification. 
 
 
5·106 MH-S cells were treated with 12.5 µg of lipid suspension (0.25 µg lipid/ 105 cells) for 1h 
at room temperature. Cells were centrifuged and fixed with 4% paraformaldehyde in PBS for at 
least 30 min. After that, cells were again concentrated by centrifugation and embedded in low 
melting point agarose (Sigma Aldrich, St. Louis, MO) previously dissolved in PBS at 400C. The 
agarose block was diced into small cubes and further fixed by immersion in 4% 
paraformaldehyde in PBS for 24 h at 4°C. Cubes were embedded in Epon (Serva, Heidelberg, DE), 
and contrasted with 1% osmium tetroxide (EMS, Hatfield, PA) and 4% uranyl acetate (Serva, 
Heidelberg, DE) for analysis by electron microscopy. 
 
Cryo-TEM is a high-resolution EM technique in which samples are studied at cryogenic 
temperatures without the need of staining. Cryogenized samples preserve their morphology and 
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ultrastructure, making this technique particularly useful to study membrane structure from 
vesicle solutions.  
Freshly prepared LUVs made of DPPC/POPC/POPG (50:25:15, w/w/w), in the absence or 
presence of SP-C, were applied to holey carbon copper grids (R2/2; Quantifoil, Großlöbichau, 
DE) and vitrified using a Cryoplunge (Gatan, Pleasanton, CA). The grids were imaged in a JEM-
1230 transmission electron microscope (JEOL; Tokyo, JP) operated at 100 kV and recorded at a 
final magnification of 5.68 Å/px using an F416 CMOS camera from TVIPS (Gauting, DE). 
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